Sentence	entity_1	entity_2	entity_3	entity_4	entity_5	entity_6	json	split
In this study we investigated the serum VEGF level ( s - VEGF) in patients with renal cell carcinoma ( RCC).	serum,34,39,Organism_substance	VEGF,40,44,Gene_or_gene_product	VEGF,57,61,Gene_or_gene_product	patients,66,74,Organism	renal cell carcinoma,80,100,Cancer	RCC,103,106,Cancer	"[{""token"": ""serum"", ""start_span"": 34, ""end_span"": 39, ""type"": ""Organism_substance""}, {""token"": ""VEGF"", ""start_span"": 40, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 57, ""end_span"": 61, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 66, ""end_span"": 74, ""type"": ""Organism""}, {""token"": ""renal cell carcinoma"", ""start_span"": 80, ""end_span"": 100, ""type"": ""Cancer""}, {""token"": ""RCC"", ""start_span"": 103, ""end_span"": 106, ""type"": ""Cancer""}]"	train
s - VEGF in peripheral blood samples was analyzed in 40 RCC patients and 40 patients without cancer ( controls) using a sandwich enzyme - linked immunoassay.	VEGF,4,8,Gene_or_gene_product	peripheral blood samples,12,36,Organism_substance	RCC,56,59,Cancer	patients,60,68,Organism	patients,76,84,Organism	cancer,93,99,Cancer	"[{""token"": ""VEGF"", ""start_span"": 4, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""peripheral blood samples"", ""start_span"": 12, ""end_span"": 36, ""type"": ""Organism_substance""}, {""token"": ""RCC"", ""start_span"": 56, ""end_span"": 59, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 60, ""end_span"": 68, ""type"": ""Organism""}, {""token"": ""patients"", ""start_span"": 76, ""end_span"": 84, ""type"": ""Organism""}, {""token"": ""cancer"", ""start_span"": 93, ""end_span"": 99, ""type"": ""Cancer""}]"	train
The results indicate that tumor tissue of RCC liberates VEGF into the systemic blood flow and that s - VEGF is a possible marker for RCC.	tumor tissue,26,38,Tissue	RCC,42,45,Cancer	VEGF,56,60,Gene_or_gene_product	blood,79,84,Organism_substance	VEGF,103,107,Gene_or_gene_product	RCC,133,136,Cancer	"[{""token"": ""tumor tissue"", ""start_span"": 26, ""end_span"": 38, ""type"": ""Tissue""}, {""token"": ""RCC"", ""start_span"": 42, ""end_span"": 45, ""type"": ""Cancer""}, {""token"": ""VEGF"", ""start_span"": 56, ""end_span"": 60, ""type"": ""Gene_or_gene_product""}, {""token"": ""blood"", ""start_span"": 79, ""end_span"": 84, ""type"": ""Organism_substance""}, {""token"": ""VEGF"", ""start_span"": 103, ""end_span"": 107, ""type"": ""Gene_or_gene_product""}, {""token"": ""RCC"", ""start_span"": 133, ""end_span"": 136, ""type"": ""Cancer""}]"	train
To examine the mechanisms by which insulin regulates VEGF expression, human retinal pigment epithelial ( RPE) cells were exposed to insulin, and VEGF mRNA levels were quantified with RNase protection assays ( RPAs).	insulin,35,42,Gene_or_gene_product	VEGF,53,57,Gene_or_gene_product	human,70,75,Organism	insulin,132,139,Gene_or_gene_product	VEGF,145,149,Gene_or_gene_product	RNase,183,188,Gene_or_gene_product	"[{""token"": ""insulin"", ""start_span"": 35, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 53, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 70, ""end_span"": 75, ""type"": ""Organism""}, {""token"": ""insulin"", ""start_span"": 132, ""end_span"": 139, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 145, ""end_span"": 149, ""type"": ""Gene_or_gene_product""}, {""token"": ""RNase"", ""start_span"": 183, ""end_span"": 188, ""type"": ""Gene_or_gene_product""}]"	train
In vivo nuclear magnetic resonance analysis of tumor blood flow in linomide - treated animals showed localization of blood vessels almost exclusively to the periphery of the poorly vascularized tumors with a significant reduction of both vascular functionality and vasodilation.	tumor,47,52,Cancer	blood,53,58,Organism_substance	linomide,67,75,Chemical	blood vessels,117,130,Multi	tumors,194,200,Cancer	vascular,238,246,Multi	"[{""token"": ""tumor"", ""start_span"": 47, ""end_span"": 52, ""type"": ""Cancer""}, {""token"": ""blood"", ""start_span"": 53, ""end_span"": 58, ""type"": ""Organism_substance""}, {""token"": ""linomide"", ""start_span"": 67, ""end_span"": 75, ""type"": ""Chemical""}, {""token"": ""blood vessels"", ""start_span"": 117, ""end_span"": 130, ""type"": ""Multi""}, {""token"": ""tumors"", ""start_span"": 194, ""end_span"": 200, ""type"": ""Cancer""}, {""token"": ""vascular"", ""start_span"": 238, ""end_span"": 246, ""type"": ""Multi""}]"	train
The ras - transformed, ATX - secreting subclones had enhanced motility to ATX as chemoattractant, but there was little difference in the motility responses of NIH3T3 cells transfected with atx, an inactive mutant gene, or empty vector.	ras,4,7,Gene_or_gene_product	ATX,23,26,Gene_or_gene_product	subclones,39,48,Cell	ATX,74,77,Gene_or_gene_product	NIH3T3 cells,159,171,Cell	atx,189,192,Gene_or_gene_product	"[{""token"": ""ras"", ""start_span"": 4, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""ATX"", ""start_span"": 23, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""subclones"", ""start_span"": 39, ""end_span"": 48, ""type"": ""Cell""}, {""token"": ""ATX"", ""start_span"": 74, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}, {""token"": ""NIH3T3 cells"", ""start_span"": 159, ""end_span"": 171, ""type"": ""Cell""}, {""token"": ""atx"", ""start_span"": 189, ""end_span"": 192, ""type"": ""Gene_or_gene_product""}]"	train
Ciprofloxacin mediated cell growth inhibition, S / G2 - M cell cycle arrest, and apoptosis in a human transitional cell carcinoma of the bladder cell line.	Ciprofloxacin,0,13,Chemical	cell,23,27,Cell	cell,58,62,Cell	human,96,101,Organism	transitional cell carcinoma,102,129,Cancer	bladder cell line,137,154,Cell	"[{""token"": ""Ciprofloxacin"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Chemical""}, {""token"": ""cell"", ""start_span"": 23, ""end_span"": 27, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 58, ""end_span"": 62, ""type"": ""Cell""}, {""token"": ""human"", ""start_span"": 96, ""end_span"": 101, ""type"": ""Organism""}, {""token"": ""transitional cell carcinoma"", ""start_span"": 102, ""end_span"": 129, ""type"": ""Cancer""}, {""token"": ""bladder cell line"", ""start_span"": 137, ""end_span"": 154, ""type"": ""Cell""}]"	train
Hence, the down - regulation of p21WAF1, together with the alterations in Bax and cdk2 as observed in our studies, may define a novel mechanism by which ciprofloxacin inhibits tumor cell growth and induces apoptotic cell death.	p21WAF1,32,39,Gene_or_gene_product	Bax,74,77,Gene_or_gene_product	cdk2,82,86,Gene_or_gene_product	ciprofloxacin,153,166,Chemical	tumor cell,176,186,Cell	cell,216,220,Cell	"[{""token"": ""p21WAF1"", ""start_span"": 32, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bax"", ""start_span"": 74, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}, {""token"": ""cdk2"", ""start_span"": 82, ""end_span"": 86, ""type"": ""Gene_or_gene_product""}, {""token"": ""ciprofloxacin"", ""start_span"": 153, ""end_span"": 166, ""type"": ""Chemical""}, {""token"": ""tumor cell"", ""start_span"": 176, ""end_span"": 186, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 216, ""end_span"": 220, ""type"": ""Cell""}]"	train
Alpha - melanocyte - stimulating hormone modulates activation of NF - kappa B and AP - 1 and secretion of interleukin - 8 in human dermal fibroblasts.	Alpha - melanocyte - stimulating hormone,0,40,Gene_or_gene_product	NF - kappa B,65,77,Gene_or_gene_product	AP - 1,82,88,Gene_or_gene_product	interleukin - 8,106,121,Gene_or_gene_product	human,125,130,Organism	dermal fibroblasts,131,149,Cell	"[{""token"": ""Alpha - melanocyte - stimulating hormone"", ""start_span"": 0, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""NF - kappa B"", ""start_span"": 65, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}, {""token"": ""AP - 1"", ""start_span"": 82, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""interleukin - 8"", ""start_span"": 106, ""end_span"": 121, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 125, ""end_span"": 130, ""type"": ""Organism""}, {""token"": ""dermal fibroblasts"", ""start_span"": 131, ""end_span"": 149, ""type"": ""Cell""}]"	train
By use of electric mobility shift assays, we demonstrate that alpha - MSH ( 10 ( - 6) to 10 ( - 14) M) activates AP - 1 in human dermal fibroblasts, whereas coincubation with interleukin - 1 beta ( IL - 1 beta) results in suppression of its activation.	alpha - MSH,62,73,Gene_or_gene_product	AP - 1,113,119,Gene_or_gene_product	human,123,128,Organism	dermal fibroblasts,129,147,Cell	interleukin - 1 beta,175,195,Gene_or_gene_product	IL - 1 beta,198,209,Gene_or_gene_product	"[{""token"": ""alpha - MSH"", ""start_span"": 62, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""AP - 1"", ""start_span"": 113, ""end_span"": 119, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 123, ""end_span"": 128, ""type"": ""Organism""}, {""token"": ""dermal fibroblasts"", ""start_span"": 129, ""end_span"": 147, ""type"": ""Cell""}, {""token"": ""interleukin - 1 beta"", ""start_span"": 175, ""end_span"": 195, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 1 beta"", ""start_span"": 198, ""end_span"": 209, ""type"": ""Gene_or_gene_product""}]"	train
Patients whose tumors were CD40 - negative showed a significantly better N stage, overall stage at presentation and survival than those patients with CD40 - positive patients.	Patients,0,8,Organism	tumors,15,21,Cancer	CD40,27,31,Gene_or_gene_product	patients,136,144,Organism	CD40,150,154,Gene_or_gene_product	patients,166,174,Organism	"[{""token"": ""Patients"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Organism""}, {""token"": ""tumors"", ""start_span"": 15, ""end_span"": 21, ""type"": ""Cancer""}, {""token"": ""CD40"", ""start_span"": 27, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 136, ""end_span"": 144, ""type"": ""Organism""}, {""token"": ""CD40"", ""start_span"": 150, ""end_span"": 154, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 166, ""end_span"": 174, ""type"": ""Organism""}]"	train
When BB - 94, a matrix metalloproteinase inhibitor, was added to the culture medium of Ras - expressing cells, it caused a cell aggregation phenotype similar to that caused by TEL expression.	BB - 94,5,12,Chemical	matrix metalloproteinase,16,40,Gene_or_gene_product	Ras,87,90,Gene_or_gene_product	cells,104,109,Cell	cell,123,127,Cell	TEL,176,179,Gene_or_gene_product	"[{""token"": ""BB - 94"", ""start_span"": 5, ""end_span"": 12, ""type"": ""Chemical""}, {""token"": ""matrix metalloproteinase"", ""start_span"": 16, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ras"", ""start_span"": 87, ""end_span"": 90, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 104, ""end_span"": 109, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 123, ""end_span"": 127, ""type"": ""Cell""}, {""token"": ""TEL"", ""start_span"": 176, ""end_span"": 179, ""type"": ""Gene_or_gene_product""}]"	train
Vasodilator - stimulated phosphoprotein ( VASP) is highly expressed in vascular endothelial cells, where it has been implicated in cellular reorganization during angiogenesis, as well as in endothelial retraction and changes in vessel permeability.	Vasodilator - stimulated phosphoprotein,0,39,Gene_or_gene_product	VASP,42,46,Gene_or_gene_product	vascular endothelial cells,71,97,Cell	cellular,131,139,Cell	endothelial,190,201,Cell	vessel,228,234,Multi	"[{""token"": ""Vasodilator - stimulated phosphoprotein"", ""start_span"": 0, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""VASP"", ""start_span"": 42, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular endothelial cells"", ""start_span"": 71, ""end_span"": 97, ""type"": ""Cell""}, {""token"": ""cellular"", ""start_span"": 131, ""end_span"": 139, ""type"": ""Cell""}, {""token"": ""endothelial"", ""start_span"": 190, ""end_span"": 201, ""type"": ""Cell""}, {""token"": ""vessel"", ""start_span"": 228, ""end_span"": 234, ""type"": ""Multi""}]"	train
Further analysis reveals that although LMP1 ( TRADD) promotes cell growth, it does not prevent the eventual onset of senescence and the expression of tumor suppressor p16 ( Ink4a).	LMP1,39,43,Gene_or_gene_product	TRADD,46,51,Gene_or_gene_product	cell,62,66,Cell	tumor,150,155,Cancer	p16,167,170,Gene_or_gene_product	Ink4a,173,178,Gene_or_gene_product	"[{""token"": ""LMP1"", ""start_span"": 39, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""TRADD"", ""start_span"": 46, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 62, ""end_span"": 66, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 150, ""end_span"": 155, ""type"": ""Cancer""}, {""token"": ""p16"", ""start_span"": 167, ""end_span"": 170, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ink4a"", ""start_span"": 173, ""end_span"": 178, ""type"": ""Gene_or_gene_product""}]"	train
Here we studied the effects of cell morphology on the migration of bovine aortic ECs by culturing cells on micropatterned strips of collagen matrix ( 60 -, 30 -, and 15 - microm wide).	cell,31,35,Cell	bovine,67,73,Organism	aortic ECs,74,84,Cell	cells,98,103,Cell	collagen,132,140,Gene_or_gene_product	matrix,141,147,Cellular_component	"[{""token"": ""cell"", ""start_span"": 31, ""end_span"": 35, ""type"": ""Cell""}, {""token"": ""bovine"", ""start_span"": 67, ""end_span"": 73, ""type"": ""Organism""}, {""token"": ""aortic ECs"", ""start_span"": 74, ""end_span"": 84, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 98, ""end_span"": 103, ""type"": ""Cell""}, {""token"": ""collagen"", ""start_span"": 132, ""end_span"": 140, ""type"": ""Gene_or_gene_product""}, {""token"": ""matrix"", ""start_span"": 141, ""end_span"": 147, ""type"": ""Cellular_component""}]"	train
Relationship of p53 and Helicobacter pylori to clinicopathological features of human remnant stomach cancer after gastric surgery for primary gastric cancer.	p53,16,19,Gene_or_gene_product	Helicobacter pylori,24,43,Organism	human,79,84,Organism	remnant stomach cancer,85,107,Cancer	gastric,114,121,Organ	gastric cancer,142,156,Cancer	"[{""token"": ""p53"", ""start_span"": 16, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""Helicobacter pylori"", ""start_span"": 24, ""end_span"": 43, ""type"": ""Organism""}, {""token"": ""human"", ""start_span"": 79, ""end_span"": 84, ""type"": ""Organism""}, {""token"": ""remnant stomach cancer"", ""start_span"": 85, ""end_span"": 107, ""type"": ""Cancer""}, {""token"": ""gastric"", ""start_span"": 114, ""end_span"": 121, ""type"": ""Organ""}, {""token"": ""gastric cancer"", ""start_span"": 142, ""end_span"": 156, ""type"": ""Cancer""}]"	train
Evi - 1 associates with CtBP1 through one of the CtBP - binding consensus motifs within the region from amino acid 544 to 607, and this association is required for the efficient inhibition of TGF - beta signaling.	Evi - 1,0,7,Gene_or_gene_product	CtBP1,24,29,Gene_or_gene_product	CtBP,49,53,Gene_or_gene_product	amino acid 544,104,118,Amino_acid	607,122,125,Amino_acid	TGF - beta,192,202,Gene_or_gene_product	"[{""token"": ""Evi - 1"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""CtBP1"", ""start_span"": 24, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""CtBP"", ""start_span"": 49, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""amino acid 544"", ""start_span"": 104, ""end_span"": 118, ""type"": ""Amino_acid""}, {""token"": ""607"", ""start_span"": 122, ""end_span"": 125, ""type"": ""Amino_acid""}, {""token"": ""TGF - beta"", ""start_span"": 192, ""end_span"": 202, ""type"": ""Gene_or_gene_product""}]"	train
Antibodies to PA - 1 dose - dependently, and significantly, inhibited the invasive and migratory potential of human HT1080 fibrosarcoma cells, as did an antibody to uPA and the plasmin inhibitor aprotinin.	PA - 1,14,20,Gene_or_gene_product	human,110,115,Organism	HT1080 fibrosarcoma cells,116,141,Cell	uPA,165,168,Gene_or_gene_product	plasmin,177,184,Gene_or_gene_product	aprotinin,195,204,Gene_or_gene_product	"[{""token"": ""PA - 1"", ""start_span"": 14, ""end_span"": 20, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 110, ""end_span"": 115, ""type"": ""Organism""}, {""token"": ""HT1080 fibrosarcoma cells"", ""start_span"": 116, ""end_span"": 141, ""type"": ""Cell""}, {""token"": ""uPA"", ""start_span"": 165, ""end_span"": 168, ""type"": ""Gene_or_gene_product""}, {""token"": ""plasmin"", ""start_span"": 177, ""end_span"": 184, ""type"": ""Gene_or_gene_product""}, {""token"": ""aprotinin"", ""start_span"": 195, ""end_span"": 204, ""type"": ""Gene_or_gene_product""}]"	train
We also report that SPARC arrests monomeric collagen - supported smooth muscle cell proliferation in the late G1 - phase of the cell cycle in the absence of an effect on cell shape or on levels of cyclin - dependent kinase inhibitors.	SPARC,20,25,Gene_or_gene_product	collagen,44,52,Gene_or_gene_product	smooth muscle cell,65,83,Cell	cell,128,132,Cell	cell,170,174,Cell	cyclin - dependent kinase inhibitors,197,233,Chemical	"[{""token"": ""SPARC"", ""start_span"": 20, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""collagen"", ""start_span"": 44, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""smooth muscle cell"", ""start_span"": 65, ""end_span"": 83, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 128, ""end_span"": 132, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 170, ""end_span"": 174, ""type"": ""Cell""}, {""token"": ""cyclin - dependent kinase inhibitors"", ""start_span"": 197, ""end_span"": 233, ""type"": ""Chemical""}]"	train
Cyclin - dependent kinase - 2 activity, p107 and cyclin A levels, and retinoblastoma protein phosphorylation are markedly reduced in response to the addition of exogenous SPARC and / or peptides derived from specific domains of SPARC.	Cyclin - dependent kinase - 2,0,29,Gene_or_gene_product	p107,40,44,Gene_or_gene_product	cyclin A,49,57,Gene_or_gene_product	retinoblastoma protein,70,92,Gene_or_gene_product	SPARC,171,176,Gene_or_gene_product	SPARC,228,233,Gene_or_gene_product	"[{""token"": ""Cyclin - dependent kinase - 2"", ""start_span"": 0, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""p107"", ""start_span"": 40, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""cyclin A"", ""start_span"": 49, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""retinoblastoma protein"", ""start_span"": 70, ""end_span"": 92, ""type"": ""Gene_or_gene_product""}, {""token"": ""SPARC"", ""start_span"": 171, ""end_span"": 176, ""type"": ""Gene_or_gene_product""}, {""token"": ""SPARC"", ""start_span"": 228, ""end_span"": 233, ""type"": ""Gene_or_gene_product""}]"	train
At protein level, VEGF - B and C, Flt - 1, and KDR were not detectable in tissue lysates, whereas VEGF - A was increased in stages III and IV.	VEGF - B,18,26,Gene_or_gene_product	C,31,32,Gene_or_gene_product	Flt - 1,34,41,Gene_or_gene_product	KDR,47,50,Gene_or_gene_product	tissue lysates,74,88,Organism_substance	VEGF - A,98,106,Gene_or_gene_product	"[{""token"": ""VEGF - B"", ""start_span"": 18, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""C"", ""start_span"": 31, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""Flt - 1"", ""start_span"": 34, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""KDR"", ""start_span"": 47, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""tissue lysates"", ""start_span"": 74, ""end_span"": 88, ""type"": ""Organism_substance""}, {""token"": ""VEGF - A"", ""start_span"": 98, ""end_span"": 106, ""type"": ""Gene_or_gene_product""}]"	train
Up - regulation of MMP activity, favoring proteolytic degradation of the basement membrane and extracellular matrix, has been linked to tumor growth and metastasis, as well as tumor - associated angiogenesis, whereas inhibition of MMP activity appears to restrict these processes.	MMP,19,22,Gene_or_gene_product	basement membrane,73,90,Cellular_component	extracellular matrix,95,115,Cellular_component	tumor,136,141,Cancer	tumor,176,181,Cancer	MMP,231,234,Gene_or_gene_product	"[{""token"": ""MMP"", ""start_span"": 19, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""basement membrane"", ""start_span"": 73, ""end_span"": 90, ""type"": ""Cellular_component""}, {""token"": ""extracellular matrix"", ""start_span"": 95, ""end_span"": 115, ""type"": ""Cellular_component""}, {""token"": ""tumor"", ""start_span"": 136, ""end_span"": 141, ""type"": ""Cancer""}, {""token"": ""tumor"", ""start_span"": 176, ""end_span"": 181, ""type"": ""Cancer""}, {""token"": ""MMP"", ""start_span"": 231, ""end_span"": 234, ""type"": ""Gene_or_gene_product""}]"	train
Brn - 3a, a member of the POU gene family ( so - called because of the similarity with the group of transcription factors Pit, Oct, and Unc), was found in neuronal cells engaged in the transcription activity of the p1 and p2 promoters of the most powerful antiapoptotic gene, namely, Bcl - 2.	Brn - 3a,0,8,Gene_or_gene_product	Pit,122,125,Gene_or_gene_product	Oct,127,130,Gene_or_gene_product	Unc,136,139,Gene_or_gene_product	neuronal cells,155,169,Cell	Bcl - 2,284,291,Gene_or_gene_product	"[{""token"": ""Brn - 3a"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""Pit"", ""start_span"": 122, ""end_span"": 125, ""type"": ""Gene_or_gene_product""}, {""token"": ""Oct"", ""start_span"": 127, ""end_span"": 130, ""type"": ""Gene_or_gene_product""}, {""token"": ""Unc"", ""start_span"": 136, ""end_span"": 139, ""type"": ""Gene_or_gene_product""}, {""token"": ""neuronal cells"", ""start_span"": 155, ""end_span"": 169, ""type"": ""Cell""}, {""token"": ""Bcl - 2"", ""start_span"": 284, ""end_span"": 291, ""type"": ""Gene_or_gene_product""}]"	train
Although DU145 prostate cancer cells are resistant to exogenously applied Fas agonist CH - 11 ( anti - Fas monoclonal antibody), Fas - resistance can be overcome using a FasL expressing adenovirus ( AdGFPFasL ( TET)) [ Hyer et al., Molecular Therapy, 2000; 2: 348 - 58 ( ref. 12)].	DU145 prostate cancer cells,9,36,Cell	Fas,74,77,Gene_or_gene_product	Fas,103,106,Gene_or_gene_product	Fas,129,132,Gene_or_gene_product	FasL,170,174,Gene_or_gene_product	adenovirus,186,196,Organism	"[{""token"": ""DU145 prostate cancer cells"", ""start_span"": 9, ""end_span"": 36, ""type"": ""Cell""}, {""token"": ""Fas"", ""start_span"": 74, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}, {""token"": ""Fas"", ""start_span"": 103, ""end_span"": 106, ""type"": ""Gene_or_gene_product""}, {""token"": ""Fas"", ""start_span"": 129, ""end_span"": 132, ""type"": ""Gene_or_gene_product""}, {""token"": ""FasL"", ""start_span"": 170, ""end_span"": 174, ""type"": ""Gene_or_gene_product""}, {""token"": ""adenovirus"", ""start_span"": 186, ""end_span"": 196, ""type"": ""Organism""}]"	train
We show that both substitution of glucose for pyruvate and treatment with 2 - deoxyglucose enhanced apoptosis induced by tumor necrosis factor ( TNF) - alpha, CD95 agonistic antibody, and TNF - related apoptosis - inducing ligand ( TRAIL).	glucose,34,41,Chemical	pyruvate,46,54,Chemical	2 - deoxyglucose,74,90,Chemical	CD95,159,163,Gene_or_gene_product	TNF - related apoptosis - inducing ligand,188,229,Gene_or_gene_product	TRAIL,232,237,Gene_or_gene_product	"[{""token"": ""glucose"", ""start_span"": 34, ""end_span"": 41, ""type"": ""Chemical""}, {""token"": ""pyruvate"", ""start_span"": 46, ""end_span"": 54, ""type"": ""Chemical""}, {""token"": ""2 - deoxyglucose"", ""start_span"": 74, ""end_span"": 90, ""type"": ""Chemical""}, {""token"": ""CD95"", ""start_span"": 159, ""end_span"": 163, ""type"": ""Gene_or_gene_product""}, {""token"": ""TNF - related apoptosis - inducing ligand"", ""start_span"": 188, ""end_span"": 229, ""type"": ""Gene_or_gene_product""}, {""token"": ""TRAIL"", ""start_span"": 232, ""end_span"": 237, ""type"": ""Gene_or_gene_product""}]"	train
It involves endothelial cell activation, basal membrane degradation, leukocyte invasion, proliferation of vascular cells, neointima formation ( in most species studied), and changes of the extracellular matrix.	endothelial cell,12,28,Cell	basal membrane,41,55,Cellular_component	leukocyte,69,78,Cell	vascular cells,106,120,Cell	neointima,122,131,Tissue	extracellular matrix,189,209,Cellular_component	"[{""token"": ""endothelial cell"", ""start_span"": 12, ""end_span"": 28, ""type"": ""Cell""}, {""token"": ""basal membrane"", ""start_span"": 41, ""end_span"": 55, ""type"": ""Cellular_component""}, {""token"": ""leukocyte"", ""start_span"": 69, ""end_span"": 78, ""type"": ""Cell""}, {""token"": ""vascular cells"", ""start_span"": 106, ""end_span"": 120, ""type"": ""Cell""}, {""token"": ""neointima"", ""start_span"": 122, ""end_span"": 131, ""type"": ""Tissue""}, {""token"": ""extracellular matrix"", ""start_span"": 189, ""end_span"": 209, ""type"": ""Cellular_component""}]"	train
Injection of indomethacin, a nonselective COX inhibitor, on the day of ovulation and the following day decreased serum levels of progesterone, as did injection of the selective COX - II inhibitor NS - 398.	indomethacin,13,25,Chemical	COX,42,45,Gene_or_gene_product	serum,113,118,Organism_substance	progesterone,129,141,Chemical	COX - II,177,185,Gene_or_gene_product	NS - 398,196,204,Chemical	"[{""token"": ""indomethacin"", ""start_span"": 13, ""end_span"": 25, ""type"": ""Chemical""}, {""token"": ""COX"", ""start_span"": 42, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""serum"", ""start_span"": 113, ""end_span"": 118, ""type"": ""Organism_substance""}, {""token"": ""progesterone"", ""start_span"": 129, ""end_span"": 141, ""type"": ""Chemical""}, {""token"": ""COX - II"", ""start_span"": 177, ""end_span"": 185, ""type"": ""Gene_or_gene_product""}, {""token"": ""NS - 398"", ""start_span"": 196, ""end_span"": 204, ""type"": ""Chemical""}]"	train
Compared with values measured at the edge of the ear and in the contralateral ear, leukocyte adhesion was found to be diminished significantly in vessels inside the ear tumor in both mouse models.	ear,49,52,Organ	ear,78,81,Organ	leukocyte,83,92,Cell	vessels,146,153,Tissue	ear tumor,165,174,Cancer	mouse,183,188,Organism	"[{""token"": ""ear"", ""start_span"": 49, ""end_span"": 52, ""type"": ""Organ""}, {""token"": ""ear"", ""start_span"": 78, ""end_span"": 81, ""type"": ""Organ""}, {""token"": ""leukocyte"", ""start_span"": 83, ""end_span"": 92, ""type"": ""Cell""}, {""token"": ""vessels"", ""start_span"": 146, ""end_span"": 153, ""type"": ""Tissue""}, {""token"": ""ear tumor"", ""start_span"": 165, ""end_span"": 174, ""type"": ""Cancer""}, {""token"": ""mouse"", ""start_span"": 183, ""end_span"": 188, ""type"": ""Organism""}]"	train
Treatment of mice bearing a small ear tumor with a humanized antivascular endothelial growth factor antibody prevented the down - regulation of leukocyte - vessel wall interactions inside the tumor vessels compared with the nontreated group.	mice,13,17,Organism	ear tumor,34,43,Cancer	antivascular endothelial growth factor antibody,61,108,Gene_or_gene_product	leukocyte,144,153,Cell	vessel wall,156,167,Multi	tumor vessels,192,205,Multi	"[{""token"": ""mice"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Organism""}, {""token"": ""ear tumor"", ""start_span"": 34, ""end_span"": 43, ""type"": ""Cancer""}, {""token"": ""antivascular endothelial growth factor antibody"", ""start_span"": 61, ""end_span"": 108, ""type"": ""Gene_or_gene_product""}, {""token"": ""leukocyte"", ""start_span"": 144, ""end_span"": 153, ""type"": ""Cell""}, {""token"": ""vessel wall"", ""start_span"": 156, ""end_span"": 167, ""type"": ""Multi""}, {""token"": ""tumor vessels"", ""start_span"": 192, ""end_span"": 205, ""type"": ""Multi""}]"	train
Fluorescence - activated cell sorter analysis showed that isolated tumor ECs have suppressed levels of intercellular adhesion molecule 1 as compared with ECs from normal mouse tissues.	cell,25,29,Cell	tumor ECs,67,76,Cell	intercellular adhesion molecule 1,103,136,Gene_or_gene_product	ECs,154,157,Cell	mouse,170,175,Organism	tissues,176,183,Tissue	"[{""token"": ""cell"", ""start_span"": 25, ""end_span"": 29, ""type"": ""Cell""}, {""token"": ""tumor ECs"", ""start_span"": 67, ""end_span"": 76, ""type"": ""Cell""}, {""token"": ""intercellular adhesion molecule 1"", ""start_span"": 103, ""end_span"": 136, ""type"": ""Gene_or_gene_product""}, {""token"": ""ECs"", ""start_span"": 154, ""end_span"": 157, ""type"": ""Cell""}, {""token"": ""mouse"", ""start_span"": 170, ""end_span"": 175, ""type"": ""Organism""}, {""token"": ""tissues"", ""start_span"": 176, ""end_span"": 183, ""type"": ""Tissue""}]"	train
In cultured b. END5 cells the tumor necrosis factor alpha - induced up - regulation of intercellular adhesion molecule 1 and vascular cell adhesion molecule 1 was reduced in ECs that were preincubated with basic fibroblast growth factor or vascular endothelial growth factor.	tumor necrosis factor alpha,30,57,Gene_or_gene_product	intercellular adhesion molecule 1,87,120,Gene_or_gene_product	vascular cell adhesion molecule 1,125,158,Gene_or_gene_product	ECs,174,177,Cell	basic fibroblast growth factor,206,236,Gene_or_gene_product	vascular endothelial growth factor,240,274,Gene_or_gene_product	"[{""token"": ""tumor necrosis factor alpha"", ""start_span"": 30, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""intercellular adhesion molecule 1"", ""start_span"": 87, ""end_span"": 120, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular cell adhesion molecule 1"", ""start_span"": 125, ""end_span"": 158, ""type"": ""Gene_or_gene_product""}, {""token"": ""ECs"", ""start_span"": 174, ""end_span"": 177, ""type"": ""Cell""}, {""token"": ""basic fibroblast growth factor"", ""start_span"": 206, ""end_span"": 236, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 240, ""end_span"": 274, ""type"": ""Gene_or_gene_product""}]"	train
Organ biodistribution studies revealed that galectin - 3C localized in the liver, kidneys, and spleen but not in the heart or lungs.	galectin - 3C,44,57,Gene_or_gene_product	liver,75,80,Organ	kidneys,82,89,Organ	spleen,95,101,Organ	heart,117,122,Organ	lungs,126,131,Organ	"[{""token"": ""galectin - 3C"", ""start_span"": 44, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""liver"", ""start_span"": 75, ""end_span"": 80, ""type"": ""Organ""}, {""token"": ""kidneys"", ""start_span"": 82, ""end_span"": 89, ""type"": ""Organ""}, {""token"": ""spleen"", ""start_span"": 95, ""end_span"": 101, ""type"": ""Organ""}, {""token"": ""heart"", ""start_span"": 117, ""end_span"": 122, ""type"": ""Organ""}, {""token"": ""lungs"", ""start_span"": 126, ""end_span"": 131, ""type"": ""Organ""}]"	train
We found that the mean tumor volumes and weights were statistically significantly less in mice treated with galectin - 3C compared with control mice, and that fewer numbers of mice exhibited lymph node metastases in the treated group compared with the control group.	tumor,23,28,Cancer	mice,90,94,Organism	galectin - 3C,108,121,Gene_or_gene_product	mice,144,148,Organism	mice,176,180,Organism	lymph node,191,201,Multi	"[{""token"": ""tumor"", ""start_span"": 23, ""end_span"": 28, ""type"": ""Cancer""}, {""token"": ""mice"", ""start_span"": 90, ""end_span"": 94, ""type"": ""Organism""}, {""token"": ""galectin - 3C"", ""start_span"": 108, ""end_span"": 121, ""type"": ""Gene_or_gene_product""}, {""token"": ""mice"", ""start_span"": 144, ""end_span"": 148, ""type"": ""Organism""}, {""token"": ""mice"", ""start_span"": 176, ""end_span"": 180, ""type"": ""Organism""}, {""token"": ""lymph node"", ""start_span"": 191, ""end_span"": 201, ""type"": ""Multi""}]"	train
CONCLUSIONS: Galectin - 3C is not overtly toxic, and is efficacious in reducing metastases and tumor volumes and weights in primary tumors in an orthotopic nude mouse model of human breast cancer.	Galectin - 3C,13,26,Gene_or_gene_product	tumor,95,100,Cancer	tumors,132,138,Cancer	nude mouse,156,166,Organism	human,176,181,Organism	breast cancer,182,195,Cancer	"[{""token"": ""Galectin - 3C"", ""start_span"": 13, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 95, ""end_span"": 100, ""type"": ""Cancer""}, {""token"": ""tumors"", ""start_span"": 132, ""end_span"": 138, ""type"": ""Cancer""}, {""token"": ""nude mouse"", ""start_span"": 156, ""end_span"": 166, ""type"": ""Organism""}, {""token"": ""human"", ""start_span"": 176, ""end_span"": 181, ""type"": ""Organism""}, {""token"": ""breast cancer"", ""start_span"": 182, ""end_span"": 195, ""type"": ""Cancer""}]"	train
The effect of wild - type or mutant survivin was investigated on capillary network stability, endothelial cell viability, and caspase activation in vitro and on kinetics of tumor growth and development of angiogenesis in a breast cancer xenograft model in vivo.	survivin,36,44,Gene_or_gene_product	capillary network,65,82,Multi	endothelial cell,94,110,Cell	caspase,126,133,Gene_or_gene_product	tumor,173,178,Cancer	breast cancer xenograft,223,246,Cancer	"[{""token"": ""survivin"", ""start_span"": 36, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""capillary network"", ""start_span"": 65, ""end_span"": 82, ""type"": ""Multi""}, {""token"": ""endothelial cell"", ""start_span"": 94, ""end_span"": 110, ""type"": ""Cell""}, {""token"": ""caspase"", ""start_span"": 126, ""end_span"": 133, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 173, ""end_span"": 178, ""type"": ""Cancer""}, {""token"": ""breast cancer xenograft"", ""start_span"": 223, ""end_span"": 246, ""type"": ""Cancer""}]"	train
This was associated with a approximately 60% reduction in tumor - derived blood vessels by quantitative morphometry of CD31 - stained tumor areas, and appearance of endothelial cell apoptosis by internucleosomal DNA fragmentation in vivo.	tumor,58,63,Cancer	blood vessels,74,87,Multi	CD31,119,123,Gene_or_gene_product	tumor,134,139,Cancer	endothelial cell,165,181,Cell	DNA,212,215,Cellular_component	"[{""token"": ""tumor"", ""start_span"": 58, ""end_span"": 63, ""type"": ""Cancer""}, {""token"": ""blood vessels"", ""start_span"": 74, ""end_span"": 87, ""type"": ""Multi""}, {""token"": ""CD31"", ""start_span"": 119, ""end_span"": 123, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 134, ""end_span"": 139, ""type"": ""Cancer""}, {""token"": ""endothelial cell"", ""start_span"": 165, ""end_span"": 181, ""type"": ""Cell""}, {""token"": ""DNA"", ""start_span"": 212, ""end_span"": 215, ""type"": ""Cellular_component""}]"	train
Tail vein injection of N - ( 1 - ( 2, 3 - dioleoyloxy) propyl) - N, N, N - trimethylammonium chloride ( DOTAP) / cholesterol lipoplexes resulted in increased lipoplex entrapment in hypervascularized liver but did not boost luciferase expression, suggesting that lipoplex delivery is not a sufficient condition for efficient organ lipofection.	Tail vein,0,9,Multi	lipoplex,125,133,Chemical	liver,199,204,Organ	luciferase,223,233,Gene_or_gene_product	lipoplex,262,270,Chemical	organ,324,329,Organ	"[{""token"": ""Tail vein"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Multi""}, {""token"": ""lipoplex"", ""start_span"": 125, ""end_span"": 133, ""type"": ""Chemical""}, {""token"": ""liver"", ""start_span"": 199, ""end_span"": 204, ""type"": ""Organ""}, {""token"": ""luciferase"", ""start_span"": 223, ""end_span"": 233, ""type"": ""Gene_or_gene_product""}, {""token"": ""lipoplex"", ""start_span"": 262, ""end_span"": 270, ""type"": ""Chemical""}, {""token"": ""organ"", ""start_span"": 324, ""end_span"": 329, ""type"": ""Organ""}]"	train
Because the intravenously injected lipoplexes migrated within seconds to lungs, we checked whether the effects of immediate contact with serum correlate with lung lipofection efficiency of different DOTAP - based formulations.	intravenously,12,25,Immaterial_anatomical_entity	lipoplexes,35,45,Chemical	lungs,73,78,Organ	serum,137,142,Organism_substance	lung,158,162,Organ	DOTAP,199,204,Chemical	"[{""token"": ""intravenously"", ""start_span"": 12, ""end_span"": 25, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""lipoplexes"", ""start_span"": 35, ""end_span"": 45, ""type"": ""Chemical""}, {""token"": ""lungs"", ""start_span"": 73, ""end_span"": 78, ""type"": ""Organ""}, {""token"": ""serum"", ""start_span"": 137, ""end_span"": 142, ""type"": ""Organism_substance""}, {""token"": ""lung"", ""start_span"": 158, ""end_span"": 162, ""type"": ""Organ""}, {""token"": ""DOTAP"", ""start_span"": 199, ""end_span"": 204, ""type"": ""Chemical""}]"	train
Under conditions mimicking the injection environment, the lipoplex - serum interaction was strongly dependent on helper lipid and ionic strength: lipoplexes prepared in 150 mM NaCl or lipoplexes with high ( greater than 33 mol%) cholesterol were found to aggregate immediately.	lipoplex,58,66,Chemical	serum,69,74,Organism_substance	lipid,120,125,Chemical	lipoplexes,146,156,Chemical	lipoplexes,184,194,Chemical	cholesterol,229,240,Chemical	"[{""token"": ""lipoplex"", ""start_span"": 58, ""end_span"": 66, ""type"": ""Chemical""}, {""token"": ""serum"", ""start_span"": 69, ""end_span"": 74, ""type"": ""Organism_substance""}, {""token"": ""lipid"", ""start_span"": 120, ""end_span"": 125, ""type"": ""Chemical""}, {""token"": ""lipoplexes"", ""start_span"": 146, ""end_span"": 156, ""type"": ""Chemical""}, {""token"": ""lipoplexes"", ""start_span"": 184, ""end_span"": 194, ""type"": ""Chemical""}, {""token"": ""cholesterol"", ""start_span"": 229, ""end_span"": 240, ""type"": ""Chemical""}]"	train
Bone destruction is primarily mediated by osteoclastic bone resorption, and cancer cells stimulate the formation and activation of osteoclasts next to metastatic foci.	Bone,0,4,Tissue	osteoclastic,42,54,Cell	bone,55,59,Tissue	cancer cells,76,88,Cell	osteoclasts,131,142,Cell	foci,162,166,Cell	"[{""token"": ""Bone"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Tissue""}, {""token"": ""osteoclastic"", ""start_span"": 42, ""end_span"": 54, ""type"": ""Cell""}, {""token"": ""bone"", ""start_span"": 55, ""end_span"": 59, ""type"": ""Tissue""}, {""token"": ""cancer cells"", ""start_span"": 76, ""end_span"": 88, ""type"": ""Cell""}, {""token"": ""osteoclasts"", ""start_span"": 131, ""end_span"": 142, ""type"": ""Cell""}, {""token"": ""foci"", ""start_span"": 162, ""end_span"": 166, ""type"": ""Cell""}]"	train
We report that neuronal death resulting from focal cerebral ischaemia ( middle cerebral artery occlusion, 24 h) is significantly inhibited ( by 50%) in rats injected with a recombinant IL - 1 receptor antagonist ( IL - 1ra, 10 micrograms, icv 30 min before and 10 min after ischaemia).	neuronal,15,23,Cell	cerebral,51,59,Organ	cerebral artery,79,94,Multi	rats,152,156,Organism	IL - 1 receptor antagonist,185,211,Gene_or_gene_product	IL - 1ra,214,222,Gene_or_gene_product	"[{""token"": ""neuronal"", ""start_span"": 15, ""end_span"": 23, ""type"": ""Cell""}, {""token"": ""cerebral"", ""start_span"": 51, ""end_span"": 59, ""type"": ""Organ""}, {""token"": ""cerebral artery"", ""start_span"": 79, ""end_span"": 94, ""type"": ""Multi""}, {""token"": ""rats"", ""start_span"": 152, ""end_span"": 156, ""type"": ""Organism""}, {""token"": ""IL - 1 receptor antagonist"", ""start_span"": 185, ""end_span"": 211, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 1ra"", ""start_span"": 214, ""end_span"": 222, ""type"": ""Gene_or_gene_product""}]"	train
We investigated here whether 6 popular antitumor compounds modify the cytotoxic activity of NaF against human squamous cell carcinoma ( HSC - 2) and human promyelocytic leukemia ( HL - 60) cell lines.	antitumor,39,48,Cancer	NaF,92,95,Chemical	human,104,109,Organism	squamous cell carcinoma,110,133,Cancer	human,149,154,Organism	promyelocytic leukemia,155,177,Cancer	"[{""token"": ""antitumor"", ""start_span"": 39, ""end_span"": 48, ""type"": ""Cancer""}, {""token"": ""NaF"", ""start_span"": 92, ""end_span"": 95, ""type"": ""Chemical""}, {""token"": ""human"", ""start_span"": 104, ""end_span"": 109, ""type"": ""Organism""}, {""token"": ""squamous cell carcinoma"", ""start_span"": 110, ""end_span"": 133, ""type"": ""Cancer""}, {""token"": ""human"", ""start_span"": 149, ""end_span"": 154, ""type"": ""Organism""}, {""token"": ""promyelocytic leukemia"", ""start_span"": 155, ""end_span"": 177, ""type"": ""Cancer""}]"	train
Bovine lactoferrin, a multifunctional glycoprotein, has been shown to strongly inhibit development of azoxymethane ( AOM) - induced rat colon tumors.	Bovine,0,6,Organism	lactoferrin,7,18,Gene_or_gene_product	azoxymethane,102,114,Chemical	AOM,117,120,Chemical	rat,132,135,Organism	colon tumors,136,148,Cancer	"[{""token"": ""Bovine"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Organism""}, {""token"": ""lactoferrin"", ""start_span"": 7, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""azoxymethane"", ""start_span"": 102, ""end_span"": 114, ""type"": ""Chemical""}, {""token"": ""AOM"", ""start_span"": 117, ""end_span"": 120, ""type"": ""Chemical""}, {""token"": ""rat"", ""start_span"": 132, ""end_span"": 135, ""type"": ""Organism""}, {""token"": ""colon tumors"", ""start_span"": 136, ""end_span"": 148, ""type"": ""Cancer""}]"	train
Immunohistochemical analysis revealed Fas - positive cells and apoptotic cells preferentially within the proximal colon region, clearly at the site of bovine lactoferrin - mediated tumor inhibition.	Fas,38,41,Gene_or_gene_product	apoptotic cells,63,78,Cell	colon,114,119,Organ	bovine,151,157,Organism	lactoferrin,158,169,Gene_or_gene_product	tumor,181,186,Cancer	"[{""token"": ""Fas"", ""start_span"": 38, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""apoptotic cells"", ""start_span"": 63, ""end_span"": 78, ""type"": ""Cell""}, {""token"": ""colon"", ""start_span"": 114, ""end_span"": 119, ""type"": ""Organ""}, {""token"": ""bovine"", ""start_span"": 151, ""end_span"": 157, ""type"": ""Organism""}, {""token"": ""lactoferrin"", ""start_span"": 158, ""end_span"": 169, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 181, ""end_span"": 186, ""type"": ""Cancer""}]"	train
Pak1 - DLC1 interaction plays an essential role in cell survival, which depends on Pak1 ' s phosphorylation of DLC1 on Ser88.	Pak1,0,4,Gene_or_gene_product	DLC1,7,11,Gene_or_gene_product	cell,51,55,Cell	Pak1,83,87,Gene_or_gene_product	DLC1,111,115,Gene_or_gene_product	Ser88,119,124,Amino_acid	"[{""token"": ""Pak1"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""DLC1"", ""start_span"": 7, ""end_span"": 11, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 51, ""end_span"": 55, ""type"": ""Cell""}, {""token"": ""Pak1"", ""start_span"": 83, ""end_span"": 87, ""type"": ""Gene_or_gene_product""}, {""token"": ""DLC1"", ""start_span"": 111, ""end_span"": 115, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ser88"", ""start_span"": 119, ""end_span"": 124, ""type"": ""Amino_acid""}]"	train
Matrix metalloproteinase activity and immunohistochemical profile of matrix metalloproteinase - 2 and - 9 and tissue inhibitor of metalloproteinase - 1 during human dermal wound healing.	Matrix metalloproteinase,0,24,Gene_or_gene_product	matrix metalloproteinase - 2,69,97,Gene_or_gene_product	- 9,102,105,Gene_or_gene_product	tissue inhibitor of metalloproteinase - 1,110,151,Gene_or_gene_product	human,159,164,Organism	dermal wound,165,177,Pathological_formation	"[{""token"": ""Matrix metalloproteinase"", ""start_span"": 0, ""end_span"": 24, ""type"": ""Gene_or_gene_product""}, {""token"": ""matrix metalloproteinase - 2"", ""start_span"": 69, ""end_span"": 97, ""type"": ""Gene_or_gene_product""}, {""token"": ""- 9"", ""start_span"": 102, ""end_span"": 105, ""type"": ""Gene_or_gene_product""}, {""token"": ""tissue inhibitor of metalloproteinase - 1"", ""start_span"": 110, ""end_span"": 151, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 159, ""end_span"": 164, ""type"": ""Organism""}, {""token"": ""dermal wound"", ""start_span"": 165, ""end_span"": 177, ""type"": ""Pathological_formation""}]"	train
Breast tissue taken at varying postoperative times ( n = 92) or during surgery ( controls, n = 17), was used to investigate the temporal and spatial activity of matrix metalloproteinase - 2 and - 9 and tissue inhibitor of metalloproteinase - 1 during human wound healing.	Breast tissue,0,13,Tissue	matrix metalloproteinase - 2,161,189,Gene_or_gene_product	- 9,194,197,Gene_or_gene_product	tissue inhibitor of metalloproteinase - 1,202,243,Gene_or_gene_product	human,251,256,Organism	wound,257,262,Pathological_formation	"[{""token"": ""Breast tissue"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Tissue""}, {""token"": ""matrix metalloproteinase - 2"", ""start_span"": 161, ""end_span"": 189, ""type"": ""Gene_or_gene_product""}, {""token"": ""- 9"", ""start_span"": 194, ""end_span"": 197, ""type"": ""Gene_or_gene_product""}, {""token"": ""tissue inhibitor of metalloproteinase - 1"", ""start_span"": 202, ""end_span"": 243, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 251, ""end_span"": 256, ""type"": ""Organism""}, {""token"": ""wound"", ""start_span"": 257, ""end_span"": 262, ""type"": ""Pathological_formation""}]"	train
This finding may be explained by a stimulatory effect of GM - CSF and IL - 3 on ara - C phosphorylating enzymes and a more rapid incorporation of ara - CTP into the DNA of leukemic blasts.	GM - CSF,57,65,Gene_or_gene_product	IL - 3,70,76,Gene_or_gene_product	ara - C,80,87,Chemical	ara - CTP,146,155,Chemical	DNA,165,168,Cellular_component	leukemic blasts,172,187,Cell	"[{""token"": ""GM - CSF"", ""start_span"": 57, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 3"", ""start_span"": 70, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}, {""token"": ""ara - C"", ""start_span"": 80, ""end_span"": 87, ""type"": ""Chemical""}, {""token"": ""ara - CTP"", ""start_span"": 146, ""end_span"": 155, ""type"": ""Chemical""}, {""token"": ""DNA"", ""start_span"": 165, ""end_span"": 168, ""type"": ""Cellular_component""}, {""token"": ""leukemic blasts"", ""start_span"": 172, ""end_span"": 187, ""type"": ""Cell""}]"	train
We hypothesized that 1) MCT expression in malignant tumors may differ from normal tissue in quantity, isoform, or both; and 2) silencing MCT expression would induce intracellular acidification, resulting in decreased proliferation and / or increased cell death.	MCT,24,27,Gene_or_gene_product	malignant tumors,42,58,Cancer	normal tissue,75,88,Tissue	MCT,137,140,Gene_or_gene_product	intracellular,165,178,Immaterial_anatomical_entity	cell,250,254,Cell	"[{""token"": ""MCT"", ""start_span"": 24, ""end_span"": 27, ""type"": ""Gene_or_gene_product""}, {""token"": ""malignant tumors"", ""start_span"": 42, ""end_span"": 58, ""type"": ""Cancer""}, {""token"": ""normal tissue"", ""start_span"": 75, ""end_span"": 88, ""type"": ""Tissue""}, {""token"": ""MCT"", ""start_span"": 137, ""end_span"": 140, ""type"": ""Gene_or_gene_product""}, {""token"": ""intracellular"", ""start_span"": 165, ""end_span"": 178, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""cell"", ""start_span"": 250, ""end_span"": 254, ""type"": ""Cell""}]"	train
MCTs that were abundant or specific to glioma then were targeted in the model U - 87 MG glioma cell line via small interfering ribonucleic acid - mediated gene silencing and tested for inhibition of lactate efflux, intracellular pH changes, reduced proliferation, and / or induction of cell death.	MCTs,0,4,Gene_or_gene_product	glioma,39,45,Cancer	U - 87 MG glioma cell line,78,104,Cell	lactate,199,206,Chemical	intracellular,215,228,Immaterial_anatomical_entity	cell,286,290,Cell	"[{""token"": ""MCTs"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""glioma"", ""start_span"": 39, ""end_span"": 45, ""type"": ""Cancer""}, {""token"": ""U - 87 MG glioma cell line"", ""start_span"": 78, ""end_span"": 104, ""type"": ""Cell""}, {""token"": ""lactate"", ""start_span"": 199, ""end_span"": 206, ""type"": ""Chemical""}, {""token"": ""intracellular"", ""start_span"": 215, ""end_span"": 228, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""cell"", ""start_span"": 286, ""end_span"": 290, ""type"": ""Cell""}]"	train
Small interfering ribonucleic acid specific for MCT 1 and 2 reduced expression of these isoforms in U - 87 MG cells to barely detectable levels and reduced lactate efflux by 30% individually and 85% in combination, with a concomitant decrease of intracellular pH by 0. 6 units ( a fourfold increase in intracellular H ( +)).	MCT 1,48,53,Gene_or_gene_product	2,58,59,Gene_or_gene_product	U - 87 MG cells,100,115,Cell	lactate,156,163,Chemical	intracellular,246,259,Immaterial_anatomical_entity	intracellular,302,315,Immaterial_anatomical_entity	"[{""token"": ""MCT 1"", ""start_span"": 48, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""2"", ""start_span"": 58, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""U - 87 MG cells"", ""start_span"": 100, ""end_span"": 115, ""type"": ""Cell""}, {""token"": ""lactate"", ""start_span"": 156, ""end_span"": 163, ""type"": ""Chemical""}, {""token"": ""intracellular"", ""start_span"": 246, ""end_span"": 259, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""intracellular"", ""start_span"": 302, ""end_span"": 315, ""type"": ""Immaterial_anatomical_entity""}]"	train
Finally, in vivo, in a xenograft model of head and neck squamous cell carcinoma using UM - SCC - 11A cells, 2ME2 exhibited antitumor and antiangiogenic activity, as measured by CD31 immunostaining.	xenograft,23,32,Cancer	head and neck squamous cell carcinoma,42,79,Cancer	UM - SCC - 11A cells,86,106,Cell	2ME2,108,112,Chemical	antitumor,123,132,Cancer	CD31,177,181,Gene_or_gene_product	"[{""token"": ""xenograft"", ""start_span"": 23, ""end_span"": 32, ""type"": ""Cancer""}, {""token"": ""head and neck squamous cell carcinoma"", ""start_span"": 42, ""end_span"": 79, ""type"": ""Cancer""}, {""token"": ""UM - SCC - 11A cells"", ""start_span"": 86, ""end_span"": 106, ""type"": ""Cell""}, {""token"": ""2ME2"", ""start_span"": 108, ""end_span"": 112, ""type"": ""Chemical""}, {""token"": ""antitumor"", ""start_span"": 123, ""end_span"": 132, ""type"": ""Cancer""}, {""token"": ""CD31"", ""start_span"": 177, ""end_span"": 181, ""type"": ""Gene_or_gene_product""}]"	train
Vascular endothelial growth factor ( VEGF), an endothelial cell - specific mitogen, can act in tumor - induced angiogenesis by binding to specific receptors on the surface of endothelial cells.	Vascular endothelial growth factor,0,34,Gene_or_gene_product	VEGF,37,41,Gene_or_gene_product	endothelial cell,47,63,Cell	tumor,95,100,Cancer	surface,164,171,Cellular_component	endothelial cells,175,192,Cell	"[{""token"": ""Vascular endothelial growth factor"", ""start_span"": 0, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cell"", ""start_span"": 47, ""end_span"": 63, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 95, ""end_span"": 100, ""type"": ""Cancer""}, {""token"": ""surface"", ""start_span"": 164, ""end_span"": 171, ""type"": ""Cellular_component""}, {""token"": ""endothelial cells"", ""start_span"": 175, ""end_span"": 192, ""type"": ""Cell""}]"	train
Mitochondrial complex II, or succinate dehydrogenase, is a key enzymatic complex involved in both the tricarboxylic acid ( TCA) cycle and oxidative phosphorylation as part of the mitochondrial respiratory chain.	Mitochondrial,0,13,Cellular_component	complex II,14,24,Gene_or_gene_product	succinate dehydrogenase,29,52,Gene_or_gene_product	tricarboxylic acid,102,120,Chemical	TCA,123,126,Chemical	mitochondrial,179,192,Cellular_component	"[{""token"": ""Mitochondrial"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Cellular_component""}, {""token"": ""complex II"", ""start_span"": 14, ""end_span"": 24, ""type"": ""Gene_or_gene_product""}, {""token"": ""succinate dehydrogenase"", ""start_span"": 29, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""tricarboxylic acid"", ""start_span"": 102, ""end_span"": 120, ""type"": ""Chemical""}, {""token"": ""TCA"", ""start_span"": 123, ""end_span"": 126, ""type"": ""Chemical""}, {""token"": ""mitochondrial"", ""start_span"": 179, ""end_span"": 192, ""type"": ""Cellular_component""}]"	train
Similarly, the human INK4B locus encodes the p15 ( INK4B) tumor suppressor and one alternatively spliced form, termed as p10.	human,15,20,Organism	INK4B,21,26,Gene_or_gene_product	p15,45,48,Gene_or_gene_product	INK4B,51,56,Gene_or_gene_product	tumor,58,63,Cancer	p10,121,124,Gene_or_gene_product	"[{""token"": ""human"", ""start_span"": 15, ""end_span"": 20, ""type"": ""Organism""}, {""token"": ""INK4B"", ""start_span"": 21, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""p15"", ""start_span"": 45, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""INK4B"", ""start_span"": 51, ""end_span"": 56, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 58, ""end_span"": 63, ""type"": ""Cancer""}, {""token"": ""p10"", ""start_span"": 121, ""end_span"": 124, ""type"": ""Gene_or_gene_product""}]"	train
Similarly to mouse p15 ( INK4B), p10 expression is also induced by oncogenic insults and transforming growth factor - beta treatment and acts as a cell cycle inhibitor.	mouse,13,18,Organism	p15,19,22,Gene_or_gene_product	INK4B,25,30,Gene_or_gene_product	p10,33,36,Gene_or_gene_product	transforming growth factor - beta,89,122,Gene_or_gene_product	cell,147,151,Cell	"[{""token"": ""mouse"", ""start_span"": 13, ""end_span"": 18, ""type"": ""Organism""}, {""token"": ""p15"", ""start_span"": 19, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""INK4B"", ""start_span"": 25, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""p10"", ""start_span"": 33, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""transforming growth factor - beta"", ""start_span"": 89, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 147, ""end_span"": 151, ""type"": ""Cell""}]"	train
Human cervical cancer cells ( CaSki and SiHa) were injected into the flanks of nude mice.	Human,0,5,Organism	cervical cancer cells,6,27,Cell	CaSki,30,35,Cell	SiHa,40,44,Cell	flanks,69,75,Organism_subdivision	nude mice,79,88,Organism	"[{""token"": ""Human"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Organism""}, {""token"": ""cervical cancer cells"", ""start_span"": 6, ""end_span"": 27, ""type"": ""Cell""}, {""token"": ""CaSki"", ""start_span"": 30, ""end_span"": 35, ""type"": ""Cell""}, {""token"": ""SiHa"", ""start_span"": 40, ""end_span"": 44, ""type"": ""Cell""}, {""token"": ""flanks"", ""start_span"": 69, ""end_span"": 75, ""type"": ""Organism_subdivision""}, {""token"": ""nude mice"", ""start_span"": 79, ""end_span"": 88, ""type"": ""Organism""}]"	train
Tumor sections were stained for: endothelial cells with CD31 and PAS or hypoxia inducible factor 1alpha ( HIF).	Tumor sections,0,14,Cancer	endothelial cells,33,50,Cell	CD31,56,60,Gene_or_gene_product	PAS,65,68,Chemical	hypoxia inducible factor 1alpha,72,103,Gene_or_gene_product	HIF,106,109,Gene_or_gene_product	"[{""token"": ""Tumor sections"", ""start_span"": 0, ""end_span"": 14, ""type"": ""Cancer""}, {""token"": ""endothelial cells"", ""start_span"": 33, ""end_span"": 50, ""type"": ""Cell""}, {""token"": ""CD31"", ""start_span"": 56, ""end_span"": 60, ""type"": ""Gene_or_gene_product""}, {""token"": ""PAS"", ""start_span"": 65, ""end_span"": 68, ""type"": ""Chemical""}, {""token"": ""hypoxia inducible factor 1alpha"", ""start_span"": 72, ""end_span"": 103, ""type"": ""Gene_or_gene_product""}, {""token"": ""HIF"", ""start_span"": 106, ""end_span"": 109, ""type"": ""Gene_or_gene_product""}]"	train
Tumors greater than 35 mm3 treated with IR 24 hours previously or with TEMF had decreased blood vessels in the subcortex and more endothelial pseudopods projecting into hypoxic, HIF positive areas than tumors from the control group.	Tumors,0,6,Cancer	blood vessels,90,103,Multi	subcortex,111,120,Cancer	endothelial pseudopods,130,152,Cellular_component	HIF,178,181,Gene_or_gene_product	tumors,202,208,Cancer	"[{""token"": ""Tumors"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Cancer""}, {""token"": ""blood vessels"", ""start_span"": 90, ""end_span"": 103, ""type"": ""Multi""}, {""token"": ""subcortex"", ""start_span"": 111, ""end_span"": 120, ""type"": ""Cancer""}, {""token"": ""endothelial pseudopods"", ""start_span"": 130, ""end_span"": 152, ""type"": ""Cellular_component""}, {""token"": ""HIF"", ""start_span"": 178, ""end_span"": 181, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 202, ""end_span"": 208, ""type"": ""Cancer""}]"	train
In the embryonic stem cells homozygous for these hypomorphic Apc alleles, the level of the APC protein was inversely correlated with both the beta - catenin accumulation and beta - catenin / T - cell factor transcriptional activity.	embryonic stem cells,7,27,Cell	Apc,61,64,Gene_or_gene_product	APC,91,94,Gene_or_gene_product	beta - catenin,142,156,Gene_or_gene_product	beta - catenin,174,188,Gene_or_gene_product	T - cell factor,191,206,Gene_or_gene_product	"[{""token"": ""embryonic stem cells"", ""start_span"": 7, ""end_span"": 27, ""type"": ""Cell""}, {""token"": ""Apc"", ""start_span"": 61, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""APC"", ""start_span"": 91, ""end_span"": 94, ""type"": ""Gene_or_gene_product""}, {""token"": ""beta - catenin"", ""start_span"": 142, ""end_span"": 156, ""type"": ""Gene_or_gene_product""}, {""token"": ""beta - catenin"", ""start_span"": 174, ""end_span"": 188, ""type"": ""Gene_or_gene_product""}, {""token"": ""T - cell factor"", ""start_span"": 191, ""end_span"": 206, ""type"": ""Gene_or_gene_product""}]"	train
Domain 5 ( D5) of cleaved high molecular weight kininogen ( HKa) inhibits angiogenesis in vivo and endothelial cell migration in vitro, but the cell signaling pathways involved in HKa and D5 inhibition of endothelial cell migration are incompletely delineated.	high molecular weight kininogen,26,57,Gene_or_gene_product	HKa,60,63,Gene_or_gene_product	endothelial cell,99,115,Cell	cell,144,148,Cell	HKa,180,183,Gene_or_gene_product	endothelial cell,205,221,Cell	"[{""token"": ""high molecular weight kininogen"", ""start_span"": 26, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""HKa"", ""start_span"": 60, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cell"", ""start_span"": 99, ""end_span"": 115, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 144, ""end_span"": 148, ""type"": ""Cell""}, {""token"": ""HKa"", ""start_span"": 180, ""end_span"": 183, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cell"", ""start_span"": 205, ""end_span"": 221, ""type"": ""Cell""}]"	train
Additional analysis of the mechanism of action of Go6976 ( RT - PCR, Western blots, and immunohistochemistry) of the changes in the phosphorylated and nonphosphorylated forms of PKCalpha in the cell membrane and cytoplasm confirmed the specificity of PKCalpha inhibition by Go6976.	Go6976,50,56,Chemical	PKCalpha,178,186,Gene_or_gene_product	cell membrane,194,207,Cellular_component	cytoplasm,212,221,Organism_substance	PKCalpha,251,259,Gene_or_gene_product	Go6976,274,280,Chemical	"[{""token"": ""Go6976"", ""start_span"": 50, ""end_span"": 56, ""type"": ""Chemical""}, {""token"": ""PKCalpha"", ""start_span"": 178, ""end_span"": 186, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell membrane"", ""start_span"": 194, ""end_span"": 207, ""type"": ""Cellular_component""}, {""token"": ""cytoplasm"", ""start_span"": 212, ""end_span"": 221, ""type"": ""Organism_substance""}, {""token"": ""PKCalpha"", ""start_span"": 251, ""end_span"": 259, ""type"": ""Gene_or_gene_product""}, {""token"": ""Go6976"", ""start_span"": 274, ""end_span"": 280, ""type"": ""Chemical""}]"	train
p63, a p53 homologue, is a myoepithelial cell marker in the normal mammary gland but p63 - positive neoplastic cells may be found in up to 11% of invasive breast carcinomas.	p63,0,3,Gene_or_gene_product	p53,7,10,Gene_or_gene_product	myoepithelial cell,27,45,Cell	mammary gland,67,80,Organ	p63,85,88,Gene_or_gene_product	invasive breast carcinomas,146,172,Cancer	"[{""token"": ""p63"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 7, ""end_span"": 10, ""type"": ""Gene_or_gene_product""}, {""token"": ""myoepithelial cell"", ""start_span"": 27, ""end_span"": 45, ""type"": ""Cell""}, {""token"": ""mammary gland"", ""start_span"": 67, ""end_span"": 80, ""type"": ""Organ""}, {""token"": ""p63"", ""start_span"": 85, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""invasive breast carcinomas"", ""start_span"": 146, ""end_span"": 172, ""type"": ""Cancer""}]"	train
The transcription factor NF - kappaB and associated regulatory factors ( including IkappaB kinase subunits and the IkappaB family member Bcl - 3) are strongly implicated in a variety of hematologic and solid tumor malignancies.	NF - kappaB,25,36,Gene_or_gene_product	IkappaB,83,90,Gene_or_gene_product	IkappaB,115,122,Gene_or_gene_product	Bcl - 3,137,144,Gene_or_gene_product	hematologic,186,197,Cancer	solid tumor malignancies,202,226,Cancer	"[{""token"": ""NF - kappaB"", ""start_span"": 25, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""IkappaB"", ""start_span"": 83, ""end_span"": 90, ""type"": ""Gene_or_gene_product""}, {""token"": ""IkappaB"", ""start_span"": 115, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bcl - 3"", ""start_span"": 137, ""end_span"": 144, ""type"": ""Gene_or_gene_product""}, {""token"": ""hematologic"", ""start_span"": 186, ""end_span"": 197, ""type"": ""Cancer""}, {""token"": ""solid tumor malignancies"", ""start_span"": 202, ""end_span"": 226, ""type"": ""Cancer""}]"	train
Thus, CECs, EPCs and EMPs may represent potentially novel methods for evaluating the vascular status of cancer patients.	CECs,6,10,Cell	EPCs,12,16,Cell	EMPs,21,25,Cellular_component	vascular,85,93,Multi	cancer,104,110,Cancer	patients,111,119,Organism	"[{""token"": ""CECs"", ""start_span"": 6, ""end_span"": 10, ""type"": ""Cell""}, {""token"": ""EPCs"", ""start_span"": 12, ""end_span"": 16, ""type"": ""Cell""}, {""token"": ""EMPs"", ""start_span"": 21, ""end_span"": 25, ""type"": ""Cellular_component""}, {""token"": ""vascular"", ""start_span"": 85, ""end_span"": 93, ""type"": ""Multi""}, {""token"": ""cancer"", ""start_span"": 104, ""end_span"": 110, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 111, ""end_span"": 119, ""type"": ""Organism""}]"	train
We herein report the effects of novel developed material, collagen - poly glycolic acid fiber hybrid matrix, being used together with basic fibroblast growth factor to promote wound healing of full - thickness skin defects on the back of type 2 diabetic Lepr ( db) mice.	collagen,58,66,Gene_or_gene_product	poly glycolic acid,69,87,Chemical	basic fibroblast growth factor,134,164,Gene_or_gene_product	wound,176,181,Pathological_formation	skin,210,214,Organ	Lepr,254,258,Gene_or_gene_product	"[{""token"": ""collagen"", ""start_span"": 58, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""poly glycolic acid"", ""start_span"": 69, ""end_span"": 87, ""type"": ""Chemical""}, {""token"": ""basic fibroblast growth factor"", ""start_span"": 134, ""end_span"": 164, ""type"": ""Gene_or_gene_product""}, {""token"": ""wound"", ""start_span"": 176, ""end_span"": 181, ""type"": ""Pathological_formation""}, {""token"": ""skin"", ""start_span"": 210, ""end_span"": 214, ""type"": ""Organ""}, {""token"": ""Lepr"", ""start_span"": 254, ""end_span"": 258, ""type"": ""Gene_or_gene_product""}]"	train
The remaining wild - type Men1 allele was lost in most tumors from Men1 ( + / -) mice but was retained in most tumors from p18 ( - / -); Men1 ( + / -) mice.	Men1,26,30,Gene_or_gene_product	tumors,55,61,Cancer	Men1,67,71,Gene_or_gene_product	tumors,111,117,Cancer	p18,123,126,Gene_or_gene_product	Men1,137,141,Gene_or_gene_product	"[{""token"": ""Men1"", ""start_span"": 26, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 55, ""end_span"": 61, ""type"": ""Cancer""}, {""token"": ""Men1"", ""start_span"": 67, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 111, ""end_span"": 117, ""type"": ""Cancer""}, {""token"": ""p18"", ""start_span"": 123, ""end_span"": 126, ""type"": ""Gene_or_gene_product""}, {""token"": ""Men1"", ""start_span"": 137, ""end_span"": 141, ""type"": ""Gene_or_gene_product""}]"	train
The use of juice, peel and oil have also been shown to possess anticancer activities, including interference with tumor cell proliferation, cell cycle, invasion and angiogenesis.	juice,11,16,Organism_substance	peel,18,22,Tissue	oil,27,30,Organism_substance	anticancer,63,73,Cancer	tumor cell,114,124,Cell	cell,140,144,Cell	"[{""token"": ""juice"", ""start_span"": 11, ""end_span"": 16, ""type"": ""Organism_substance""}, {""token"": ""peel"", ""start_span"": 18, ""end_span"": 22, ""type"": ""Tissue""}, {""token"": ""oil"", ""start_span"": 27, ""end_span"": 30, ""type"": ""Organism_substance""}, {""token"": ""anticancer"", ""start_span"": 63, ""end_span"": 73, ""type"": ""Cancer""}, {""token"": ""tumor cell"", ""start_span"": 114, ""end_span"": 124, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 140, ""end_span"": 144, ""type"": ""Cell""}]"	train
The results revealed that the metastatic tumors in mouse lung were markedly decreased in a dose - dependent manner and acute lung injury induced by B16F10 melanoma metastasis was diminished by systemic rk - 2 treatment.	tumors,41,47,Cancer	mouse,51,56,Organism	lung,57,61,Organ	lung,125,129,Organ	B16F10 melanoma,148,163,Cancer	rk - 2,202,208,Gene_or_gene_product	"[{""token"": ""tumors"", ""start_span"": 41, ""end_span"": 47, ""type"": ""Cancer""}, {""token"": ""mouse"", ""start_span"": 51, ""end_span"": 56, ""type"": ""Organism""}, {""token"": ""lung"", ""start_span"": 57, ""end_span"": 61, ""type"": ""Organ""}, {""token"": ""lung"", ""start_span"": 125, ""end_span"": 129, ""type"": ""Organ""}, {""token"": ""B16F10 melanoma"", ""start_span"": 148, ""end_span"": 163, ""type"": ""Cancer""}, {""token"": ""rk - 2"", ""start_span"": 202, ""end_span"": 208, ""type"": ""Gene_or_gene_product""}]"	train
Also, rk - 2 diminished the expression of matrix metalloproteinase - 2 and - 9 in the mouse lung which induces tumor metastasis and angiogenesis.	rk - 2,6,12,Gene_or_gene_product	matrix metalloproteinase - 2,42,70,Gene_or_gene_product	- 9,75,78,Gene_or_gene_product	mouse,86,91,Organism	lung,92,96,Organ	tumor,111,116,Cancer	"[{""token"": ""rk - 2"", ""start_span"": 6, ""end_span"": 12, ""type"": ""Gene_or_gene_product""}, {""token"": ""matrix metalloproteinase - 2"", ""start_span"": 42, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""- 9"", ""start_span"": 75, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""mouse"", ""start_span"": 86, ""end_span"": 91, ""type"": ""Organism""}, {""token"": ""lung"", ""start_span"": 92, ""end_span"": 96, ""type"": ""Organ""}, {""token"": ""tumor"", ""start_span"": 111, ""end_span"": 116, ""type"": ""Cancer""}]"	train
The 20 - HETE agonist markedly increased superoxide formation as reflected by an increase in dihydroethidium staining of EC, and this increase was inhibited by PEG - SOD but not by apocynin.	20 - HETE,4,13,Chemical	superoxide,41,51,Chemical	dihydroethidium,93,108,Chemical	EC,121,123,Cell	PEG - SOD,160,169,Chemical	apocynin,181,189,Chemical	"[{""token"": ""20 - HETE"", ""start_span"": 4, ""end_span"": 13, ""type"": ""Chemical""}, {""token"": ""superoxide"", ""start_span"": 41, ""end_span"": 51, ""type"": ""Chemical""}, {""token"": ""dihydroethidium"", ""start_span"": 93, ""end_span"": 108, ""type"": ""Chemical""}, {""token"": ""EC"", ""start_span"": 121, ""end_span"": 123, ""type"": ""Cell""}, {""token"": ""PEG - SOD"", ""start_span"": 160, ""end_span"": 169, ""type"": ""Chemical""}, {""token"": ""apocynin"", ""start_span"": 181, ""end_span"": 189, ""type"": ""Chemical""}]"	train
These data suggest that 20 - HETE stimulates superoxide formation by pathways other than apocynin - sensitive NAD ( P) H oxidase, thereby activating MAPK and then enhancing VEGF synthesis that drives EC proliferation.	20 - HETE,24,33,Chemical	superoxide,45,55,Chemical	apocynin,89,97,Chemical	MAPK,149,153,Gene_or_gene_product	VEGF,173,177,Gene_or_gene_product	EC,200,202,Cell	"[{""token"": ""20 - HETE"", ""start_span"": 24, ""end_span"": 33, ""type"": ""Chemical""}, {""token"": ""superoxide"", ""start_span"": 45, ""end_span"": 55, ""type"": ""Chemical""}, {""token"": ""apocynin"", ""start_span"": 89, ""end_span"": 97, ""type"": ""Chemical""}, {""token"": ""MAPK"", ""start_span"": 149, ""end_span"": 153, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 173, ""end_span"": 177, ""type"": ""Gene_or_gene_product""}, {""token"": ""EC"", ""start_span"": 200, ""end_span"": 202, ""type"": ""Cell""}]"	train
Cooperative activation of Meis1 and Hoxa9 perturbs myeloid differentiation and eventually leads myeloid progenitors to leukemia, yet it remains to be clarified what kinds of subsequent molecular processes are required for development of overt leukemia.	Meis1,26,31,Gene_or_gene_product	Hoxa9,36,41,Gene_or_gene_product	myeloid,51,58,Cell	myeloid progenitors,96,115,Cell	leukemia,119,127,Cancer	overt leukemia,237,251,Cancer	"[{""token"": ""Meis1"", ""start_span"": 26, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""Hoxa9"", ""start_span"": 36, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""myeloid"", ""start_span"": 51, ""end_span"": 58, ""type"": ""Cell""}, {""token"": ""myeloid progenitors"", ""start_span"": 96, ""end_span"": 115, ""type"": ""Cell""}, {""token"": ""leukemia"", ""start_span"": 119, ""end_span"": 127, ""type"": ""Cancer""}, {""token"": ""overt leukemia"", ""start_span"": 237, ""end_span"": 251, ""type"": ""Cancer""}]"	train
A greater accumulation of peroxidative products ( thiobarbituric acid - reactive substances), inflammation and decreased levels of GSH and total antioxidant reserves were also observed in the skin of DMBA - Cum - OOH - exposed mice.	thiobarbituric acid,50,69,Chemical	GSH,131,134,Chemical	skin,192,196,Organ	DMBA,200,204,Chemical	Cum - OOH,207,216,Chemical	mice,227,231,Organism	"[{""token"": ""thiobarbituric acid"", ""start_span"": 50, ""end_span"": 69, ""type"": ""Chemical""}, {""token"": ""GSH"", ""start_span"": 131, ""end_span"": 134, ""type"": ""Chemical""}, {""token"": ""skin"", ""start_span"": 192, ""end_span"": 196, ""type"": ""Organ""}, {""token"": ""DMBA"", ""start_span"": 200, ""end_span"": 204, ""type"": ""Chemical""}, {""token"": ""Cum - OOH"", ""start_span"": 207, ""end_span"": 216, ""type"": ""Chemical""}, {""token"": ""mice"", ""start_span"": 227, ""end_span"": 231, ""type"": ""Organism""}]"	train
v - Src morphologically transformed MEFs lacking SWAP - 70, but growth of the transformed cells in culture was slower than that of cells supplemented with exogenous SWAP - 70.	v - Src,0,7,Gene_or_gene_product	MEFs,36,40,Cell	SWAP - 70,49,58,Gene_or_gene_product	cells,90,95,Cell	cells,131,136,Cell	SWAP - 70,165,174,Gene_or_gene_product	"[{""token"": ""v - Src"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""MEFs"", ""start_span"": 36, ""end_span"": 40, ""type"": ""Cell""}, {""token"": ""SWAP - 70"", ""start_span"": 49, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 90, ""end_span"": 95, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 131, ""end_span"": 136, ""type"": ""Cell""}, {""token"": ""SWAP - 70"", ""start_span"": 165, ""end_span"": 174, ""type"": ""Gene_or_gene_product""}]"	train
When transplanted in nude mice, tumors formed by the v - Src transformed SWAP - 70 ( - / -) MEFs were smaller than those formed by cells expressing exogenous SWAP - 70.	nude mice,21,30,Organism	tumors,32,38,Cancer	v - Src,53,60,Gene_or_gene_product	SWAP - 70,73,82,Gene_or_gene_product	cells,131,136,Cell	SWAP - 70,158,167,Gene_or_gene_product	"[{""token"": ""nude mice"", ""start_span"": 21, ""end_span"": 30, ""type"": ""Organism""}, {""token"": ""tumors"", ""start_span"": 32, ""end_span"": 38, ""type"": ""Cancer""}, {""token"": ""v - Src"", ""start_span"": 53, ""end_span"": 60, ""type"": ""Gene_or_gene_product""}, {""token"": ""SWAP - 70"", ""start_span"": 73, ""end_span"": 82, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 131, ""end_span"": 136, ""type"": ""Cell""}, {""token"": ""SWAP - 70"", ""start_span"": 158, ""end_span"": 167, ""type"": ""Gene_or_gene_product""}]"	train
Previous studies reported that the Tumor Susceptibility Gene 101 ( TSG101) is upregulated in selected human malignancies, and the expression of exogenous Tsg101 was suggested to transform immortalized fibroblasts in culture.	Tumor Susceptibility Gene 101,35,64,Gene_or_gene_product	TSG101,67,73,Gene_or_gene_product	human,102,107,Organism	malignancies,108,120,Cancer	Tsg101,154,160,Gene_or_gene_product	fibroblasts,201,212,Cell	"[{""token"": ""Tumor Susceptibility Gene 101"", ""start_span"": 35, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""TSG101"", ""start_span"": 67, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 102, ""end_span"": 107, ""type"": ""Organism""}, {""token"": ""malignancies"", ""start_span"": 108, ""end_span"": 120, ""type"": ""Cancer""}, {""token"": ""Tsg101"", ""start_span"": 154, ""end_span"": 160, ""type"": ""Gene_or_gene_product""}, {""token"": ""fibroblasts"", ""start_span"": 201, ""end_span"": 212, ""type"": ""Cell""}]"	train
Expression of Bcl - xL, Bax, and p53 in primary tumors and lymph node metastases in oral squamous cell carcinoma.	Bcl - xL,14,22,Gene_or_gene_product	Bax,24,27,Gene_or_gene_product	p53,33,36,Gene_or_gene_product	primary tumors,40,54,Cancer	lymph node,59,69,Multi	oral squamous cell carcinoma,84,112,Cancer	"[{""token"": ""Bcl - xL"", ""start_span"": 14, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bax"", ""start_span"": 24, ""end_span"": 27, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 33, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""primary tumors"", ""start_span"": 40, ""end_span"": 54, ""type"": ""Cancer""}, {""token"": ""lymph node"", ""start_span"": 59, ""end_span"": 69, ""type"": ""Multi""}, {""token"": ""oral squamous cell carcinoma"", ""start_span"": 84, ""end_span"": 112, ""type"": ""Cancer""}]"	train
Platelet - derived growth factor ( PDGF) and its receptors ( PDGFR) play important roles in tumorigenesis through stimulating tumor growth and promoting angiogenesis via enhancing pericyte recruitment and vessel maturation.	Platelet - derived growth factor,0,32,Gene_or_gene_product	PDGF,35,39,Gene_or_gene_product	PDGFR,61,66,Gene_or_gene_product	tumor,92,97,Cancer	pericyte,180,188,Cell	vessel,205,211,Multi	"[{""token"": ""Platelet - derived growth factor"", ""start_span"": 0, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""PDGF"", ""start_span"": 35, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""PDGFR"", ""start_span"": 61, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 92, ""end_span"": 97, ""type"": ""Cancer""}, {""token"": ""pericyte"", ""start_span"": 180, ""end_span"": 188, ""type"": ""Cell""}, {""token"": ""vessel"", ""start_span"": 205, ""end_span"": 211, ""type"": ""Multi""}]"	train
In this study, we investigated the effects of caffeine on HIF - 1 protein accumulation and on VEGF and IL - 8 expression in the human colon cancer cell line HT29 under hypoxic conditions.	caffeine,46,54,Chemical	HIF - 1,58,65,Gene_or_gene_product	VEGF,94,98,Gene_or_gene_product	IL - 8,103,109,Gene_or_gene_product	human,128,133,Organism	colon cancer cell line HT29,134,161,Cell	"[{""token"": ""caffeine"", ""start_span"": 46, ""end_span"": 54, ""type"": ""Chemical""}, {""token"": ""HIF - 1"", ""start_span"": 58, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 94, ""end_span"": 98, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 8"", ""start_span"": 103, ""end_span"": 109, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 128, ""end_span"": 133, ""type"": ""Organism""}, {""token"": ""colon cancer cell line HT29"", ""start_span"": 134, ""end_span"": 161, ""type"": ""Cell""}]"	train
Pretreatment of cells with caffeine significantly reduces adenosine - induced VEGF promoter activity and VEGF and IL - 8 expression.	cells,16,21,Cell	caffeine,27,35,Chemical	adenosine,58,67,Chemical	VEGF,78,82,Gene_or_gene_product	VEGF,105,109,Gene_or_gene_product	IL - 8,114,120,Gene_or_gene_product	"[{""token"": ""cells"", ""start_span"": 16, ""end_span"": 21, ""type"": ""Cell""}, {""token"": ""caffeine"", ""start_span"": 27, ""end_span"": 35, ""type"": ""Chemical""}, {""token"": ""adenosine"", ""start_span"": 58, ""end_span"": 67, ""type"": ""Chemical""}, {""token"": ""VEGF"", ""start_span"": 78, ""end_span"": 82, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 105, ""end_span"": 109, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 8"", ""start_span"": 114, ""end_span"": 120, ""type"": ""Gene_or_gene_product""}]"	train
The metastatic potentials of several human prostate cancer xenograft models, LAPC - 4, LAPC - 9, PC3 and CWR22Rv - 1 were compared.	human,37,42,Organism	prostate cancer xenograft,43,68,Cancer	LAPC - 4,77,85,Cell	LAPC - 9,87,95,Cell	PC3,97,100,Cell	CWR22Rv - 1,105,116,Cell	"[{""token"": ""human"", ""start_span"": 37, ""end_span"": 42, ""type"": ""Organism""}, {""token"": ""prostate cancer xenograft"", ""start_span"": 43, ""end_span"": 68, ""type"": ""Cancer""}, {""token"": ""LAPC - 4"", ""start_span"": 77, ""end_span"": 85, ""type"": ""Cell""}, {""token"": ""LAPC - 9"", ""start_span"": 87, ""end_span"": 95, ""type"": ""Cell""}, {""token"": ""PC3"", ""start_span"": 97, ""end_span"": 100, ""type"": ""Cell""}, {""token"": ""CWR22Rv - 1"", ""start_span"": 105, ""end_span"": 116, ""type"": ""Cell""}]"	train
The effect of taxol, cobalt chloride and a heparin - steroid combination was tested in the fat tissue assay and compared to the validated human placental vein angiogenesis model ( HPVAM).	taxol,14,19,Chemical	cobalt chloride,21,36,Chemical	heparin - steroid,43,60,Chemical	fat tissue,91,101,Tissue	human,138,143,Organism	placental vein,144,158,Multi	"[{""token"": ""taxol"", ""start_span"": 14, ""end_span"": 19, ""type"": ""Chemical""}, {""token"": ""cobalt chloride"", ""start_span"": 21, ""end_span"": 36, ""type"": ""Chemical""}, {""token"": ""heparin - steroid"", ""start_span"": 43, ""end_span"": 60, ""type"": ""Chemical""}, {""token"": ""fat tissue"", ""start_span"": 91, ""end_span"": 101, ""type"": ""Tissue""}, {""token"": ""human"", ""start_span"": 138, ""end_span"": 143, ""type"": ""Organism""}, {""token"": ""placental vein"", ""start_span"": 144, ""end_span"": 158, ""type"": ""Multi""}]"	train
Cobalt chloride, a stimulator of vascular endothelial growth factor ( VEGF) stimulated angiogenesis initiation at 10 ( - 9) M in fat tissue and the HPVAM, but at 10 ( - 10) M blood vessel growth was stimulated only in the fat assay.	Cobalt chloride,0,15,Chemical	vascular endothelial growth factor,33,67,Gene_or_gene_product	VEGF,70,74,Gene_or_gene_product	fat tissue,129,139,Tissue	blood vessel,175,187,Multi	fat,222,225,Tissue	"[{""token"": ""Cobalt chloride"", ""start_span"": 0, ""end_span"": 15, ""type"": ""Chemical""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 33, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 70, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""fat tissue"", ""start_span"": 129, ""end_span"": 139, ""type"": ""Tissue""}, {""token"": ""blood vessel"", ""start_span"": 175, ""end_span"": 187, ""type"": ""Multi""}, {""token"": ""fat"", ""start_span"": 222, ""end_span"": 225, ""type"": ""Tissue""}]"	train
BAG - 1 is expressed ubiquitously in human cells as three major isoforms of 50 kDa ( BAG - 1L), 46 kDa ( BAG - 1M) and 36 kDa ( BAG - 1S) from a single mRNA.	BAG - 1,0,7,Gene_or_gene_product	human,37,42,Organism	cells,43,48,Cell	BAG - 1L,85,93,Gene_or_gene_product	BAG - 1M,105,113,Gene_or_gene_product	BAG - 1S,128,136,Gene_or_gene_product	"[{""token"": ""BAG - 1"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 37, ""end_span"": 42, ""type"": ""Organism""}, {""token"": ""cells"", ""start_span"": 43, ""end_span"": 48, ""type"": ""Cell""}, {""token"": ""BAG - 1L"", ""start_span"": 85, ""end_span"": 93, ""type"": ""Gene_or_gene_product""}, {""token"": ""BAG - 1M"", ""start_span"": 105, ""end_span"": 113, ""type"": ""Gene_or_gene_product""}, {""token"": ""BAG - 1S"", ""start_span"": 128, ""end_span"": 136, ""type"": ""Gene_or_gene_product""}]"	train
The breast epithelium comprises cells at different stages of differentiation, including stem cells, progenitor cells, and more differentiated epithelial and myoepithelial cells.	breast epithelium,4,21,Tissue	cells,32,37,Cell	stem cells,88,98,Cell	progenitor cells,100,116,Cell	epithelial,142,152,Cell	myoepithelial cells,157,176,Cell	"[{""token"": ""breast epithelium"", ""start_span"": 4, ""end_span"": 21, ""type"": ""Tissue""}, {""token"": ""cells"", ""start_span"": 32, ""end_span"": 37, ""type"": ""Cell""}, {""token"": ""stem cells"", ""start_span"": 88, ""end_span"": 98, ""type"": ""Cell""}, {""token"": ""progenitor cells"", ""start_span"": 100, ""end_span"": 116, ""type"": ""Cell""}, {""token"": ""epithelial"", ""start_span"": 142, ""end_span"": 152, ""type"": ""Cell""}, {""token"": ""myoepithelial cells"", ""start_span"": 157, ""end_span"": 176, ""type"": ""Cell""}]"	train
Among 18 BCR - ABL + leukemias presenting acquired trisomy of chromosome 21, we report a high frequency ( 33%) of recurrent point mutations ( 4 in myeloid blast crisis [ BC] CML and one in chronic phase CML) within the DNA - binding region of RUNX1.	BCR,9,12,Gene_or_gene_product	ABL,15,18,Gene_or_gene_product	chromosome 21,62,75,Cellular_component	chronic phase CML,189,206,Cancer	DNA,219,222,Cellular_component	RUNX1,243,248,Gene_or_gene_product	"[{""token"": ""BCR"", ""start_span"": 9, ""end_span"": 12, ""type"": ""Gene_or_gene_product""}, {""token"": ""ABL"", ""start_span"": 15, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""chromosome 21"", ""start_span"": 62, ""end_span"": 75, ""type"": ""Cellular_component""}, {""token"": ""chronic phase CML"", ""start_span"": 189, ""end_span"": 206, ""type"": ""Cancer""}, {""token"": ""DNA"", ""start_span"": 219, ""end_span"": 222, ""type"": ""Cellular_component""}, {""token"": ""RUNX1"", ""start_span"": 243, ""end_span"": 248, ""type"": ""Gene_or_gene_product""}]"	train
These events are associated with a short survival and support the concept of a cooperative effect of BCR - ABL with molecular RUNX1 abnormalities on the differentiation arrest phenotype observed during progression of CML and in BCR - ABL + ALL.	BCR,101,104,Gene_or_gene_product	ABL,107,110,Gene_or_gene_product	RUNX1,126,131,Gene_or_gene_product	CML,217,220,Cancer	BCR,228,231,Gene_or_gene_product	ABL,234,237,Gene_or_gene_product	"[{""token"": ""BCR"", ""start_span"": 101, ""end_span"": 104, ""type"": ""Gene_or_gene_product""}, {""token"": ""ABL"", ""start_span"": 107, ""end_span"": 110, ""type"": ""Gene_or_gene_product""}, {""token"": ""RUNX1"", ""start_span"": 126, ""end_span"": 131, ""type"": ""Gene_or_gene_product""}, {""token"": ""CML"", ""start_span"": 217, ""end_span"": 220, ""type"": ""Cancer""}, {""token"": ""BCR"", ""start_span"": 228, ""end_span"": 231, ""type"": ""Gene_or_gene_product""}, {""token"": ""ABL"", ""start_span"": 234, ""end_span"": 237, ""type"": ""Gene_or_gene_product""}]"	train
In this study, we determined the effectiveness of vasostatin delivered by recombinant pseudotype adeno - associated virus 2 / 5 ( rAAV2 / 5 - VAS) as a gene therapy approach for lung cancer treatment.	vasostatin,50,60,Gene_or_gene_product	recombinant pseudotype adeno - associated virus 2,74,123,Organism	5,126,127,Organism	rAAV2,130,135,Organism	5 - VAS,138,145,Organism	lung cancer,178,189,Cancer	"[{""token"": ""vasostatin"", ""start_span"": 50, ""end_span"": 60, ""type"": ""Gene_or_gene_product""}, {""token"": ""recombinant pseudotype adeno - associated virus 2"", ""start_span"": 74, ""end_span"": 123, ""type"": ""Organism""}, {""token"": ""5"", ""start_span"": 126, ""end_span"": 127, ""type"": ""Organism""}, {""token"": ""rAAV2"", ""start_span"": 130, ""end_span"": 135, ""type"": ""Organism""}, {""token"": ""5 - VAS"", ""start_span"": 138, ""end_span"": 145, ""type"": ""Organism""}, {""token"": ""lung cancer"", ""start_span"": 178, ""end_span"": 189, ""type"": ""Cancer""}]"	train
In the orthotopic xenograft model, rAAV2 / 5 - VAS suppressed metastasis of A549 tumors to mediastinal lymph nodes and contralateral lung.	xenograft,18,27,Cancer	rAAV2,35,40,Organism	5 - VAS,43,50,Organism	A549 tumors,76,87,Cancer	lymph nodes,103,114,Multi	lung,133,137,Organ	"[{""token"": ""xenograft"", ""start_span"": 18, ""end_span"": 27, ""type"": ""Cancer""}, {""token"": ""rAAV2"", ""start_span"": 35, ""end_span"": 40, ""type"": ""Organism""}, {""token"": ""5 - VAS"", ""start_span"": 43, ""end_span"": 50, ""type"": ""Organism""}, {""token"": ""A549 tumors"", ""start_span"": 76, ""end_span"": 87, ""type"": ""Cancer""}, {""token"": ""lymph nodes"", ""start_span"": 103, ""end_span"": 114, ""type"": ""Multi""}, {""token"": ""lung"", ""start_span"": 133, ""end_span"": 137, ""type"": ""Organ""}]"	train
The UFO proto - oncogene maps to human chromosome 19q13. 1 and is transcribed into two 5. 0 kb and 3. 2 kb mRNAs in human bone marrow and human tumor cell lines.	UFO,4,7,Gene_or_gene_product	human,33,38,Organism	human,116,121,Organism	bone marrow,122,133,Multi	human,138,143,Organism	tumor cell lines,144,160,Cell	"[{""token"": ""UFO"", ""start_span"": 4, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 33, ""end_span"": 38, ""type"": ""Organism""}, {""token"": ""human"", ""start_span"": 116, ""end_span"": 121, ""type"": ""Organism""}, {""token"": ""bone marrow"", ""start_span"": 122, ""end_span"": 133, ""type"": ""Multi""}, {""token"": ""human"", ""start_span"": 138, ""end_span"": 143, ""type"": ""Organism""}, {""token"": ""tumor cell lines"", ""start_span"": 144, ""end_span"": 160, ""type"": ""Cell""}]"	train
After confirming the results in agar - processed cell lines, annexin II and beta ( 2) - tubulin expression were found to be lower in tumor cells than in adjacent normal epithelial cells in 100% and 90% of the patients ' specimens, respectively.	cell lines,49,59,Cell	annexin II,61,71,Gene_or_gene_product	tumor cells,133,144,Cell	normal epithelial cells,162,185,Cell	patients,209,217,Organism	specimens,220,229,Cell	"[{""token"": ""cell lines"", ""start_span"": 49, ""end_span"": 59, ""type"": ""Cell""}, {""token"": ""annexin II"", ""start_span"": 61, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor cells"", ""start_span"": 133, ""end_span"": 144, ""type"": ""Cell""}, {""token"": ""normal epithelial cells"", ""start_span"": 162, ""end_span"": 185, ""type"": ""Cell""}, {""token"": ""patients"", ""start_span"": 209, ""end_span"": 217, ""type"": ""Organism""}, {""token"": ""specimens"", ""start_span"": 220, ""end_span"": 229, ""type"": ""Cell""}]"	train
MMTV - cre - mediated fur inactivation concomitant with PLAG1 proto - oncogene activation delays salivary gland tumorigenesis in mice.	MMTV,0,4,Organism	cre,7,10,Gene_or_gene_product	fur,22,25,Gene_or_gene_product	PLAG1,56,61,Gene_or_gene_product	salivary gland,97,111,Multi	mice,129,133,Organism	"[{""token"": ""MMTV"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Organism""}, {""token"": ""cre"", ""start_span"": 7, ""end_span"": 10, ""type"": ""Gene_or_gene_product""}, {""token"": ""fur"", ""start_span"": 22, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""PLAG1"", ""start_span"": 56, ""end_span"": 61, ""type"": ""Gene_or_gene_product""}, {""token"": ""salivary gland"", ""start_span"": 97, ""end_span"": 111, ""type"": ""Multi""}, {""token"": ""mice"", ""start_span"": 129, ""end_span"": 133, ""type"": ""Organism""}]"	train
Tumor cells express the glycolytic regulator pyruvate kinase subtype M2 ( M2 - PK), which can occur in a tetrameric form with high affinity to its substrate phosphoenolpyruvate ( PEP) and a dimeric form with a low PEP affinity.	Tumor cells,0,11,Cell	pyruvate kinase subtype M2,45,71,Gene_or_gene_product	M2 - PK,74,81,Gene_or_gene_product	phosphoenolpyruvate,157,176,Chemical	PEP,179,182,Chemical	PEP,214,217,Chemical	"[{""token"": ""Tumor cells"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Cell""}, {""token"": ""pyruvate kinase subtype M2"", ""start_span"": 45, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""M2 - PK"", ""start_span"": 74, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}, {""token"": ""phosphoenolpyruvate"", ""start_span"": 157, ""end_span"": 176, ""type"": ""Chemical""}, {""token"": ""PEP"", ""start_span"": 179, ""end_span"": 182, ""type"": ""Chemical""}, {""token"": ""PEP"", ""start_span"": 214, ""end_span"": 217, ""type"": ""Chemical""}]"	train
Atypically, abundant capillaries were observed; however, the cystic proliferation of epithelioid cells with vacuoles and immunohistochemical profile of the epithelioid element were consistent with hepatic adenomatoid tumour.	capillaries,21,32,Tissue	cystic,61,67,Pathological_formation	epithelioid cells,85,102,Cell	vacuoles,108,116,Cellular_component	epithelioid element,156,175,Tissue	hepatic adenomatoid tumour,197,223,Cancer	"[{""token"": ""capillaries"", ""start_span"": 21, ""end_span"": 32, ""type"": ""Tissue""}, {""token"": ""cystic"", ""start_span"": 61, ""end_span"": 67, ""type"": ""Pathological_formation""}, {""token"": ""epithelioid cells"", ""start_span"": 85, ""end_span"": 102, ""type"": ""Cell""}, {""token"": ""vacuoles"", ""start_span"": 108, ""end_span"": 116, ""type"": ""Cellular_component""}, {""token"": ""epithelioid element"", ""start_span"": 156, ""end_span"": 175, ""type"": ""Tissue""}, {""token"": ""hepatic adenomatoid tumour"", ""start_span"": 197, ""end_span"": 223, ""type"": ""Cancer""}]"	train
Comparisons of presymposium and postsymposium responses and between the 2 groups of attendees indicated that the pediatric dentistry and endodontic communities agree that formocresol will be replaced as a primary tooth pulpotomy agent, that mineral trioxide is the first choice to take its place, that IPT in primary teeth holds hope as a replacement for pulpotomy, and that IPT is an acceptable pulp therapy technique for cariously involved young permanent teeth.	formocresol,171,182,Chemical	tooth,213,218,Organ	mineral trioxide,241,257,Chemical	teeth,317,322,Organ	pulp,355,359,Tissue	teeth,458,463,Organ	"[{""token"": ""formocresol"", ""start_span"": 171, ""end_span"": 182, ""type"": ""Chemical""}, {""token"": ""tooth"", ""start_span"": 213, ""end_span"": 218, ""type"": ""Organ""}, {""token"": ""mineral trioxide"", ""start_span"": 241, ""end_span"": 257, ""type"": ""Chemical""}, {""token"": ""teeth"", ""start_span"": 317, ""end_span"": 322, ""type"": ""Organ""}, {""token"": ""pulp"", ""start_span"": 355, ""end_span"": 359, ""type"": ""Tissue""}, {""token"": ""teeth"", ""start_span"": 458, ""end_span"": 463, ""type"": ""Organ""}]"	train
Similar to in vivo FdG - PET or primary breast cancers, rates of glycolysis were diverse, being higher in cells expressing both c - Myc and HIF - 1alpha and lower in cell lines low or negative in both transcription factors.	FdG,19,22,Chemical	primary breast cancers,32,54,Cancer	cells,106,111,Cell	c - Myc,128,135,Gene_or_gene_product	HIF - 1alpha,140,152,Gene_or_gene_product	cell lines,166,176,Cell	"[{""token"": ""FdG"", ""start_span"": 19, ""end_span"": 22, ""type"": ""Chemical""}, {""token"": ""primary breast cancers"", ""start_span"": 32, ""end_span"": 54, ""type"": ""Cancer""}, {""token"": ""cells"", ""start_span"": 106, ""end_span"": 111, ""type"": ""Cell""}, {""token"": ""c - Myc"", ""start_span"": 128, ""end_span"": 135, ""type"": ""Gene_or_gene_product""}, {""token"": ""HIF - 1alpha"", ""start_span"": 140, ""end_span"": 152, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell lines"", ""start_span"": 166, ""end_span"": 176, ""type"": ""Cell""}]"	train
The grafts are extensively vascularized with capillaries composed of nonfenestrated endothelium; intercellular junctions are evident at sites of apposition between endothelial cells.	grafts,4,10,Tissue	capillaries,45,56,Tissue	endothelium,84,95,Tissue	intercellular junctions,97,120,Cellular_component	sites of apposition,136,155,Cellular_component	endothelial cells,164,181,Cell	"[{""token"": ""grafts"", ""start_span"": 4, ""end_span"": 10, ""type"": ""Tissue""}, {""token"": ""capillaries"", ""start_span"": 45, ""end_span"": 56, ""type"": ""Tissue""}, {""token"": ""endothelium"", ""start_span"": 84, ""end_span"": 95, ""type"": ""Tissue""}, {""token"": ""intercellular junctions"", ""start_span"": 97, ""end_span"": 120, ""type"": ""Cellular_component""}, {""token"": ""sites of apposition"", ""start_span"": 136, ""end_span"": 155, ""type"": ""Cellular_component""}, {""token"": ""endothelial cells"", ""start_span"": 164, ""end_span"": 181, ""type"": ""Cell""}]"	train
Using a construct containing the VEGF promoter linked to a luciferase reporter, we found that a mutation reducing HIF binding to the VEGF promoter had no significant effect on luciferase production induced by M - CSF stimulation.	VEGF,33,37,Gene_or_gene_product	luciferase,59,69,Gene_or_gene_product	HIF,114,117,Gene_or_gene_product	VEGF,133,137,Gene_or_gene_product	luciferase,176,186,Gene_or_gene_product	M - CSF,209,216,Gene_or_gene_product	"[{""token"": ""VEGF"", ""start_span"": 33, ""end_span"": 37, ""type"": ""Gene_or_gene_product""}, {""token"": ""luciferase"", ""start_span"": 59, ""end_span"": 69, ""type"": ""Gene_or_gene_product""}, {""token"": ""HIF"", ""start_span"": 114, ""end_span"": 117, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 133, ""end_span"": 137, ""type"": ""Gene_or_gene_product""}, {""token"": ""luciferase"", ""start_span"": 176, ""end_span"": 186, ""type"": ""Gene_or_gene_product""}, {""token"": ""M - CSF"", ""start_span"": 209, ""end_span"": 216, ""type"": ""Gene_or_gene_product""}]"	train
CONCLUSION: These data delineate an ERK - and Sp1 - dependent mechanism of M - CSF induced VEGF production and demonstrate for the first time the ability of M - CSF to induce angiogenesis via VEGF in vivo.	ERK,36,39,Gene_or_gene_product	Sp1,46,49,Gene_or_gene_product	M - CSF,75,82,Gene_or_gene_product	VEGF,91,95,Gene_or_gene_product	M - CSF,157,164,Gene_or_gene_product	VEGF,192,196,Gene_or_gene_product	"[{""token"": ""ERK"", ""start_span"": 36, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""Sp1"", ""start_span"": 46, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""M - CSF"", ""start_span"": 75, ""end_span"": 82, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 91, ""end_span"": 95, ""type"": ""Gene_or_gene_product""}, {""token"": ""M - CSF"", ""start_span"": 157, ""end_span"": 164, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 192, ""end_span"": 196, ""type"": ""Gene_or_gene_product""}]"	train
PI3K / Akt - dependent transcriptional regulation and activation of BMP - 2 - Smad signaling by NF - kappaB in metastatic prostate cancer cells.	PI3K,0,4,Gene_or_gene_product	Akt,7,10,Gene_or_gene_product	BMP - 2,68,75,Gene_or_gene_product	Smad,78,82,Gene_or_gene_product	NF - kappaB,96,107,Gene_or_gene_product	prostate cancer cells,122,143,Cell	"[{""token"": ""PI3K"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 7, ""end_span"": 10, ""type"": ""Gene_or_gene_product""}, {""token"": ""BMP - 2"", ""start_span"": 68, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}, {""token"": ""Smad"", ""start_span"": 78, ""end_span"": 82, ""type"": ""Gene_or_gene_product""}, {""token"": ""NF - kappaB"", ""start_span"": 96, ""end_span"": 107, ""type"": ""Gene_or_gene_product""}, {""token"": ""prostate cancer cells"", ""start_span"": 122, ""end_span"": 143, ""type"": ""Cell""}]"	train
In the presence of high levels of VEGF, Ang - 2 also promotes rapid increase in capillary diameter, remodeling of the basal lamina, proliferation and migration of endothelial cells, and stimulates sprouting of new blood vessels.	VEGF,34,38,Gene_or_gene_product	Ang - 2,40,47,Gene_or_gene_product	capillary,80,89,Tissue	basal lamina,118,130,Cellular_component	endothelial cells,163,180,Cell	blood vessels,214,227,Multi	"[{""token"": ""VEGF"", ""start_span"": 34, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ang - 2"", ""start_span"": 40, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""capillary"", ""start_span"": 80, ""end_span"": 89, ""type"": ""Tissue""}, {""token"": ""basal lamina"", ""start_span"": 118, ""end_span"": 130, ""type"": ""Cellular_component""}, {""token"": ""endothelial cells"", ""start_span"": 163, ""end_span"": 180, ""type"": ""Cell""}, {""token"": ""blood vessels"", ""start_span"": 214, ""end_span"": 227, ""type"": ""Multi""}]"	train
The heart functions ( left ventricle ejection fraction ( LVEF), left ventricle fractional shortening ( LVFS)) were improved more significantly in the old donor - derived MSCs group than in the control group and the heart function in the young donor - derived MSCs group further improved ( P less than 0. 05).	heart,4,9,Organ	ventricle,27,36,Multi	ventricle,69,78,Multi	MSCs,170,174,Cell	heart,215,220,Organ	MSCs,259,263,Cell	"[{""token"": ""heart"", ""start_span"": 4, ""end_span"": 9, ""type"": ""Organ""}, {""token"": ""ventricle"", ""start_span"": 27, ""end_span"": 36, ""type"": ""Multi""}, {""token"": ""ventricle"", ""start_span"": 69, ""end_span"": 78, ""type"": ""Multi""}, {""token"": ""MSCs"", ""start_span"": 170, ""end_span"": 174, ""type"": ""Cell""}, {""token"": ""heart"", ""start_span"": 215, ""end_span"": 220, ""type"": ""Organ""}, {""token"": ""MSCs"", ""start_span"": 259, ""end_span"": 263, ""type"": ""Cell""}]"	train
We investigated the presence of COUP - TFII in human colorectal cancer tissues and adjacent normal tissues from 95 primary colorectal cancer patients by immunohistochemistry.	COUP - TFII,32,43,Gene_or_gene_product	human,47,52,Organism	colorectal cancer tissues,53,78,Tissue	normal tissues,92,106,Tissue	colorectal cancer,123,140,Cancer	patients,141,149,Organism	"[{""token"": ""COUP - TFII"", ""start_span"": 32, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 47, ""end_span"": 52, ""type"": ""Organism""}, {""token"": ""colorectal cancer tissues"", ""start_span"": 53, ""end_span"": 78, ""type"": ""Tissue""}, {""token"": ""normal tissues"", ""start_span"": 92, ""end_span"": 106, ""type"": ""Tissue""}, {""token"": ""colorectal cancer"", ""start_span"": 123, ""end_span"": 140, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 141, ""end_span"": 149, ""type"": ""Organism""}]"	train
Downstream targets of Plexin C1 signaling in human melanocytes include cofilin and LIM kinase II, both of which are critical mediators of cell adhesion and migration.	Plexin C1,22,31,Gene_or_gene_product	human,45,50,Organism	melanocytes,51,62,Cell	cofilin,71,78,Gene_or_gene_product	LIM kinase II,83,96,Gene_or_gene_product	cell,138,142,Cell	"[{""token"": ""Plexin C1"", ""start_span"": 22, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 45, ""end_span"": 50, ""type"": ""Organism""}, {""token"": ""melanocytes"", ""start_span"": 51, ""end_span"": 62, ""type"": ""Cell""}, {""token"": ""cofilin"", ""start_span"": 71, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""LIM kinase II"", ""start_span"": 83, ""end_span"": 96, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 138, ""end_span"": 142, ""type"": ""Cell""}]"	train
Our data show a significant loss of Plexin C1 in metastatic melanoma compared with primary melanoma, suggesting the possibility that the Plexin C1 receptor is a tumor suppressor protein for melanoma.	Plexin C1,36,45,Gene_or_gene_product	metastatic melanoma,49,68,Cancer	primary melanoma,83,99,Cancer	Plexin C1,137,146,Gene_or_gene_product	tumor,161,166,Cancer	melanoma,190,198,Cancer	"[{""token"": ""Plexin C1"", ""start_span"": 36, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""metastatic melanoma"", ""start_span"": 49, ""end_span"": 68, ""type"": ""Cancer""}, {""token"": ""primary melanoma"", ""start_span"": 83, ""end_span"": 99, ""type"": ""Cancer""}, {""token"": ""Plexin C1"", ""start_span"": 137, ""end_span"": 146, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 161, ""end_span"": 166, ""type"": ""Cancer""}, {""token"": ""melanoma"", ""start_span"": 190, ""end_span"": 198, ""type"": ""Cancer""}]"	train
FOXO3a elicits a pro - apoptotic transcription program and cellular response to human lung carcinogen nicotine - derived nitrosaminoketone ( NNK).	FOXO3a,0,6,Gene_or_gene_product	cellular,59,67,Cell	human,80,85,Organism	lung,86,90,Organ	nicotine - derived nitrosaminoketone,102,138,Chemical	NNK,141,144,Chemical	"[{""token"": ""FOXO3a"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene_or_gene_product""}, {""token"": ""cellular"", ""start_span"": 59, ""end_span"": 67, ""type"": ""Cell""}, {""token"": ""human"", ""start_span"": 80, ""end_span"": 85, ""type"": ""Organism""}, {""token"": ""lung"", ""start_span"": 86, ""end_span"": 90, ""type"": ""Organ""}, {""token"": ""nicotine - derived nitrosaminoketone"", ""start_span"": 102, ""end_span"": 138, ""type"": ""Chemical""}, {""token"": ""NNK"", ""start_span"": 141, ""end_span"": 144, ""type"": ""Chemical""}]"	train
Inhibition of the UV - induced activation of Erbb2 also resulted in milder epidermal hyperplasia, S - phase accumulation, and decreased levels of the cell cycle regulator Cdc25a, suggesting altered cell cycle regulation on inhibition of Erbb2.	Erbb2,45,50,Gene_or_gene_product	epidermal hyperplasia,75,96,Pathological_formation	cell,150,154,Cell	Cdc25a,171,177,Gene_or_gene_product	cell,198,202,Cell	Erbb2,237,242,Gene_or_gene_product	"[{""token"": ""Erbb2"", ""start_span"": 45, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""epidermal hyperplasia"", ""start_span"": 75, ""end_span"": 96, ""type"": ""Pathological_formation""}, {""token"": ""cell"", ""start_span"": 150, ""end_span"": 154, ""type"": ""Cell""}, {""token"": ""Cdc25a"", ""start_span"": 171, ""end_span"": 177, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 198, ""end_span"": 202, ""type"": ""Cell""}, {""token"": ""Erbb2"", ""start_span"": 237, ""end_span"": 242, ""type"": ""Gene_or_gene_product""}]"	train
Ectopic expression of Cdc25a prevented UV - induced S - phase arrest in keratinocytes lacking Erbb2 activity, demonstrating that maintenance of Cdc25a by Erbb2 suppresses cell cycle arrest.	Cdc25a,22,28,Gene_or_gene_product	keratinocytes,72,85,Cell	Erbb2,94,99,Gene_or_gene_product	Cdc25a,144,150,Gene_or_gene_product	Erbb2,154,159,Gene_or_gene_product	cell,171,175,Cell	"[{""token"": ""Cdc25a"", ""start_span"": 22, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""keratinocytes"", ""start_span"": 72, ""end_span"": 85, ""type"": ""Cell""}, {""token"": ""Erbb2"", ""start_span"": 94, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}, {""token"": ""Cdc25a"", ""start_span"": 144, ""end_span"": 150, ""type"": ""Gene_or_gene_product""}, {""token"": ""Erbb2"", ""start_span"": 154, ""end_span"": 159, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 171, ""end_span"": 175, ""type"": ""Cell""}]"	train
Thus, UV - induced Erbb2 activation increases skin tumorigenesis through inhibitory phosphorylation of Chk1, Cdc25a maintenance, and suppression of S - phase arrest via a PI3K / Akt - dependent mechanism.	Erbb2,19,24,Gene_or_gene_product	skin,46,50,Organ	Chk1,103,107,Gene_or_gene_product	Cdc25a,109,115,Gene_or_gene_product	PI3K,171,175,Gene_or_gene_product	Akt,178,181,Gene_or_gene_product	"[{""token"": ""Erbb2"", ""start_span"": 19, ""end_span"": 24, ""type"": ""Gene_or_gene_product""}, {""token"": ""skin"", ""start_span"": 46, ""end_span"": 50, ""type"": ""Organ""}, {""token"": ""Chk1"", ""start_span"": 103, ""end_span"": 107, ""type"": ""Gene_or_gene_product""}, {""token"": ""Cdc25a"", ""start_span"": 109, ""end_span"": 115, ""type"": ""Gene_or_gene_product""}, {""token"": ""PI3K"", ""start_span"": 171, ""end_span"": 175, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 178, ""end_span"": 181, ""type"": ""Gene_or_gene_product""}]"	train
Pathological analyses indicate that a significant large population of human ductal cancers may utilize the EGFR - GEP100 - Arf6 - AMAP1 pathway for their malignancy.	human,70,75,Organism	ductal cancers,76,90,Cancer	EGFR,107,111,Gene_or_gene_product	GEP100,114,120,Gene_or_gene_product	Arf6,123,127,Gene_or_gene_product	AMAP1,130,135,Gene_or_gene_product	"[{""token"": ""human"", ""start_span"": 70, ""end_span"": 75, ""type"": ""Organism""}, {""token"": ""ductal cancers"", ""start_span"": 76, ""end_span"": 90, ""type"": ""Cancer""}, {""token"": ""EGFR"", ""start_span"": 107, ""end_span"": 111, ""type"": ""Gene_or_gene_product""}, {""token"": ""GEP100"", ""start_span"": 114, ""end_span"": 120, ""type"": ""Gene_or_gene_product""}, {""token"": ""Arf6"", ""start_span"": 123, ""end_span"": 127, ""type"": ""Gene_or_gene_product""}, {""token"": ""AMAP1"", ""start_span"": 130, ""end_span"": 135, ""type"": ""Gene_or_gene_product""}]"	train
We used a cellular model of tumor invasion to investigate the effect of activated platelets on the human ovarian cancer cell line, SKOV3.	cellular,10,18,Cell	tumor,28,33,Cancer	platelets,82,91,Cell	human,99,104,Organism	ovarian cancer cell line,105,129,Cell	SKOV3,131,136,Cell	"[{""token"": ""cellular"", ""start_span"": 10, ""end_span"": 18, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 28, ""end_span"": 33, ""type"": ""Cancer""}, {""token"": ""platelets"", ""start_span"": 82, ""end_span"": 91, ""type"": ""Cell""}, {""token"": ""human"", ""start_span"": 99, ""end_span"": 104, ""type"": ""Organism""}, {""token"": ""ovarian cancer cell line"", ""start_span"": 105, ""end_span"": 129, ""type"": ""Cell""}, {""token"": ""SKOV3"", ""start_span"": 131, ""end_span"": 136, ""type"": ""Cell""}]"	train
SKOV3 cells were exposed to washed, thrombin receptor activating peptide ( TRAP) - activated or TRAP - naive platelets under various experimental conditions, and tumor cell invasion was assayed in Matrigel chambers.	SKOV3 cells,0,11,Cell	thrombin receptor activating peptide,36,72,Gene_or_gene_product	TRAP,75,79,Gene_or_gene_product	TRAP,96,100,Gene_or_gene_product	platelets,109,118,Cell	tumor cell,162,172,Cell	"[{""token"": ""SKOV3 cells"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Cell""}, {""token"": ""thrombin receptor activating peptide"", ""start_span"": 36, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""TRAP"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""TRAP"", ""start_span"": 96, ""end_span"": 100, ""type"": ""Gene_or_gene_product""}, {""token"": ""platelets"", ""start_span"": 109, ""end_span"": 118, ""type"": ""Cell""}, {""token"": ""tumor cell"", ""start_span"": 162, ""end_span"": 172, ""type"": ""Cell""}]"	train
A further study found that FGFR2 - positive fibroblasts were only observed inside the tumor tissues and not in tumor - surrounding stromal tissues, suggesting that FGFR2 could be used as a TF - specific marker in ESCC.	FGFR2,27,32,Gene_or_gene_product	tumor tissues,86,99,Tissue	tumor - surrounding stromal tissues,111,146,Tissue	FGFR2,164,169,Gene_or_gene_product	TF,189,191,Cell	ESCC,213,217,Cancer	"[{""token"": ""FGFR2"", ""start_span"": 27, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor tissues"", ""start_span"": 86, ""end_span"": 99, ""type"": ""Tissue""}, {""token"": ""tumor - surrounding stromal tissues"", ""start_span"": 111, ""end_span"": 146, ""type"": ""Tissue""}, {""token"": ""FGFR2"", ""start_span"": 164, ""end_span"": 169, ""type"": ""Gene_or_gene_product""}, {""token"": ""TF"", ""start_span"": 189, ""end_span"": 191, ""type"": ""Cell""}, {""token"": ""ESCC"", ""start_span"": 213, ""end_span"": 217, ""type"": ""Cancer""}]"	train
FA induced GR - mediated transcription in Ca3 / 7 cells transfected with a luciferase reporter gene under the control of glucocorticoid response element ( GRE), but DMI alone did not affect GR - mediated transcription.	FA,0,2,Chemical	GR,11,13,Gene_or_gene_product	Ca3 / 7 cells,42,55,Cell	luciferase reporter gene,75,99,Gene_or_gene_product	DMI,165,168,Chemical	GR,190,192,Gene_or_gene_product	"[{""token"": ""FA"", ""start_span"": 0, ""end_span"": 2, ""type"": ""Chemical""}, {""token"": ""GR"", ""start_span"": 11, ""end_span"": 13, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ca3 / 7 cells"", ""start_span"": 42, ""end_span"": 55, ""type"": ""Cell""}, {""token"": ""luciferase reporter gene"", ""start_span"": 75, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}, {""token"": ""DMI"", ""start_span"": 165, ""end_span"": 168, ""type"": ""Chemical""}, {""token"": ""GR"", ""start_span"": 190, ""end_span"": 192, ""type"": ""Gene_or_gene_product""}]"	train
In a xenograft model metronomic CPT - 11, but not 5 - FU and L - OHP, significantly inhibits HT - 29 tumor growth and microvessel density in the absence of toxicity.	xenograft,5,14,Cancer	CPT - 11,32,40,Chemical	5 - FU,50,56,Chemical	L - OHP,61,68,Chemical	HT - 29 tumor,93,106,Cancer	microvessel,118,129,Tissue	"[{""token"": ""xenograft"", ""start_span"": 5, ""end_span"": 14, ""type"": ""Cancer""}, {""token"": ""CPT - 11"", ""start_span"": 32, ""end_span"": 40, ""type"": ""Chemical""}, {""token"": ""5 - FU"", ""start_span"": 50, ""end_span"": 56, ""type"": ""Chemical""}, {""token"": ""L - OHP"", ""start_span"": 61, ""end_span"": 68, ""type"": ""Chemical""}, {""token"": ""HT - 29 tumor"", ""start_span"": 93, ""end_span"": 106, ""type"": ""Cancer""}, {""token"": ""microvessel"", ""start_span"": 118, ""end_span"": 129, ""type"": ""Tissue""}]"	train
All genes except those encoding angiotensinogen and epoxide hydrolase ( that were decreased), and 12 - lipoxygenase and vascular endothelial growth factor ( that showed no change), were significantly up - regulated in GK islets.	angiotensinogen,32,47,Gene_or_gene_product	epoxide hydrolase,52,69,Gene_or_gene_product	12 - lipoxygenase,98,115,Gene_or_gene_product	vascular endothelial growth factor,120,154,Gene_or_gene_product	GK,218,220,Organism	islets,221,227,Multi	"[{""token"": ""angiotensinogen"", ""start_span"": 32, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""epoxide hydrolase"", ""start_span"": 52, ""end_span"": 69, ""type"": ""Gene_or_gene_product""}, {""token"": ""12 - lipoxygenase"", ""start_span"": 98, ""end_span"": 115, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 120, ""end_span"": 154, ""type"": ""Gene_or_gene_product""}, {""token"": ""GK"", ""start_span"": 218, ""end_span"": 220, ""type"": ""Organism""}, {""token"": ""islets"", ""start_span"": 221, ""end_span"": 227, ""type"": ""Multi""}]"	train
From these data, as well as earlier evidence demonstrating that the reduced nicotinamide adenine dinucleotide ( NADH) shuttle in these cells requires a transaminase step and is thus identified as the malate - aspartate shuttle ( W. V. V. Greenhouse and A. L. Lehninger, Cancer Res., 36: 1392 - 1396, 1976), metabolic flux diagrams were constructed for the five cell lines.	nicotinamide adenine dinucleotide,76,109,Chemical	NADH,112,116,Chemical	cells,135,140,Cell	malate,200,206,Chemical	aspartate,209,218,Chemical	cell lines,361,371,Cell	"[{""token"": ""nicotinamide adenine dinucleotide"", ""start_span"": 76, ""end_span"": 109, ""type"": ""Chemical""}, {""token"": ""NADH"", ""start_span"": 112, ""end_span"": 116, ""type"": ""Chemical""}, {""token"": ""cells"", ""start_span"": 135, ""end_span"": 140, ""type"": ""Cell""}, {""token"": ""malate"", ""start_span"": 200, ""end_span"": 206, ""type"": ""Chemical""}, {""token"": ""aspartate"", ""start_span"": 209, ""end_span"": 218, ""type"": ""Chemical""}, {""token"": ""cell lines"", ""start_span"": 361, ""end_span"": 371, ""type"": ""Cell""}]"	train
In parallel, we assessed several human melanoma biopsy samples and found again that AKT2 was the predominantly activated AKT in these human melanoma biopsies.	human,33,38,Organism	melanoma biopsy samples,39,62,Tissue	AKT2,84,88,Gene_or_gene_product	AKT,121,124,Gene_or_gene_product	human,134,139,Organism	melanoma biopsies,140,157,Tissue	"[{""token"": ""human"", ""start_span"": 33, ""end_span"": 38, ""type"": ""Organism""}, {""token"": ""melanoma biopsy samples"", ""start_span"": 39, ""end_span"": 62, ""type"": ""Tissue""}, {""token"": ""AKT2"", ""start_span"": 84, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""AKT"", ""start_span"": 121, ""end_span"": 124, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 134, ""end_span"": 139, ""type"": ""Organism""}, {""token"": ""melanoma biopsies"", ""start_span"": 140, ""end_span"": 157, ""type"": ""Tissue""}]"	train
In addition, a reduction in tumor volume of Grm1 - mouse - melanocytic - allografts was detected in the presence of small interfering AKT2 RNA ( siAKT2).	tumor,28,33,Cancer	Grm1,44,48,Gene_or_gene_product	mouse,51,56,Organism	melanocytic - allografts,59,83,Tissue	AKT2,134,138,Gene_or_gene_product	siAKT2,145,151,Gene_or_gene_product	"[{""token"": ""tumor"", ""start_span"": 28, ""end_span"": 33, ""type"": ""Cancer""}, {""token"": ""Grm1"", ""start_span"": 44, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""mouse"", ""start_span"": 51, ""end_span"": 56, ""type"": ""Organism""}, {""token"": ""melanocytic - allografts"", ""start_span"": 59, ""end_span"": 83, ""type"": ""Tissue""}, {""token"": ""AKT2"", ""start_span"": 134, ""end_span"": 138, ""type"": ""Gene_or_gene_product""}, {""token"": ""siAKT2"", ""start_span"": 145, ""end_span"": 151, ""type"": ""Gene_or_gene_product""}]"	train
A significantly reduced expression of SEMA3B ( 83 kDa), SEMA3F ( 90 kDa), and plexin - A3 was observed in ovarian cancer cell lines when compared with normal human ovarian surface epithelial cells.	SEMA3B,38,44,Gene_or_gene_product	SEMA3F,56,62,Gene_or_gene_product	plexin - A3,78,89,Gene_or_gene_product	ovarian cancer cell lines,106,131,Cell	human,158,163,Organism	ovarian surface epithelial cells,164,196,Cell	"[{""token"": ""SEMA3B"", ""start_span"": 38, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""SEMA3F"", ""start_span"": 56, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""plexin - A3"", ""start_span"": 78, ""end_span"": 89, ""type"": ""Gene_or_gene_product""}, {""token"": ""ovarian cancer cell lines"", ""start_span"": 106, ""end_span"": 131, ""type"": ""Cell""}, {""token"": ""human"", ""start_span"": 158, ""end_span"": 163, ""type"": ""Organism""}, {""token"": ""ovarian surface epithelial cells"", ""start_span"": 164, ""end_span"": 196, ""type"": ""Cell""}]"	train
The expression of NP - 1, NP - 2, and plexin - A1 was not altered in human ovarian surface epithelial and ovarian cancer cells.	NP - 1,18,24,Gene_or_gene_product	NP - 2,26,32,Gene_or_gene_product	plexin - A1,38,49,Gene_or_gene_product	human,69,74,Organism	ovarian surface epithelial,75,101,Cell	ovarian cancer cells,106,126,Cell	"[{""token"": ""NP - 1"", ""start_span"": 18, ""end_span"": 24, ""type"": ""Gene_or_gene_product""}, {""token"": ""NP - 2"", ""start_span"": 26, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""plexin - A1"", ""start_span"": 38, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 69, ""end_span"": 74, ""type"": ""Organism""}, {""token"": ""ovarian surface epithelial"", ""start_span"": 75, ""end_span"": 101, ""type"": ""Cell""}, {""token"": ""ovarian cancer cells"", ""start_span"": 106, ""end_span"": 126, ""type"": ""Cell""}]"	train
Overexpression of SEMA3B and SEMA3F reduced focal adhesion kinase phosphorylation and matrix metalloproteinase - 2 and matrix metalloproteinase - 9 expression in ovarian cancer cells.	SEMA3B,18,24,Gene_or_gene_product	SEMA3F,29,35,Gene_or_gene_product	focal adhesion kinase,44,65,Gene_or_gene_product	matrix metalloproteinase - 2,86,114,Gene_or_gene_product	matrix metalloproteinase - 9,119,147,Gene_or_gene_product	ovarian cancer cells,162,182,Cell	"[{""token"": ""SEMA3B"", ""start_span"": 18, ""end_span"": 24, ""type"": ""Gene_or_gene_product""}, {""token"": ""SEMA3F"", ""start_span"": 29, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""focal adhesion kinase"", ""start_span"": 44, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""matrix metalloproteinase - 2"", ""start_span"": 86, ""end_span"": 114, ""type"": ""Gene_or_gene_product""}, {""token"": ""matrix metalloproteinase - 9"", ""start_span"": 119, ""end_span"": 147, ""type"": ""Gene_or_gene_product""}, {""token"": ""ovarian cancer cells"", ""start_span"": 162, ""end_span"": 182, ""type"": ""Cell""}]"	train
Here we demonstrate that repetitive exposure to tobacco smoke promotes tumor development both in carcinogen - treated mice and in transgenic mice undergoing sporadic K - ras activation in lung epithelial cells.	tobacco,48,55,Organism	tumor,71,76,Cancer	mice,118,122,Organism	mice,141,145,Organism	K - ras,166,173,Gene_or_gene_product	lung epithelial cells,188,209,Cell	"[{""token"": ""tobacco"", ""start_span"": 48, ""end_span"": 55, ""type"": ""Organism""}, {""token"": ""tumor"", ""start_span"": 71, ""end_span"": 76, ""type"": ""Cancer""}, {""token"": ""mice"", ""start_span"": 118, ""end_span"": 122, ""type"": ""Organism""}, {""token"": ""mice"", ""start_span"": 141, ""end_span"": 145, ""type"": ""Organism""}, {""token"": ""K - ras"", ""start_span"": 166, ""end_span"": 173, ""type"": ""Gene_or_gene_product""}, {""token"": ""lung epithelial cells"", ""start_span"": 188, ""end_span"": 209, ""type"": ""Cell""}]"	train
Tumor promotion is due to induction of inflammation that results in enhanced pneumocyte proliferation and is abrogated by IKKbeta ablation in myeloid cells or inactivation of JNK1.	Tumor,0,5,Cancer	inflammation,39,51,Pathological_formation	pneumocyte,77,87,Cell	IKKbeta,122,129,Gene_or_gene_product	myeloid cells,142,155,Cell	JNK1,175,179,Gene_or_gene_product	"[{""token"": ""Tumor"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Cancer""}, {""token"": ""inflammation"", ""start_span"": 39, ""end_span"": 51, ""type"": ""Pathological_formation""}, {""token"": ""pneumocyte"", ""start_span"": 77, ""end_span"": 87, ""type"": ""Cell""}, {""token"": ""IKKbeta"", ""start_span"": 122, ""end_span"": 129, ""type"": ""Gene_or_gene_product""}, {""token"": ""myeloid cells"", ""start_span"": 142, ""end_span"": 155, ""type"": ""Cell""}, {""token"": ""JNK1"", ""start_span"": 175, ""end_span"": 179, ""type"": ""Gene_or_gene_product""}]"	train
Unlike the majority of somatic cells, in which hTERT and telomerase activity are generally silent, normal lymphocytes show transient physiological hTERT expression and telomerase activity according to their differentiation / activation status.	somatic cells,23,36,Cell	hTERT,47,52,Gene_or_gene_product	telomerase,57,67,Gene_or_gene_product	lymphocytes,106,117,Cell	hTERT,147,152,Gene_or_gene_product	telomerase,168,178,Gene_or_gene_product	"[{""token"": ""somatic cells"", ""start_span"": 23, ""end_span"": 36, ""type"": ""Cell""}, {""token"": ""hTERT"", ""start_span"": 47, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""telomerase"", ""start_span"": 57, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymphocytes"", ""start_span"": 106, ""end_span"": 117, ""type"": ""Cell""}, {""token"": ""hTERT"", ""start_span"": 147, ""end_span"": 152, ""type"": ""Gene_or_gene_product""}, {""token"": ""telomerase"", ""start_span"": 168, ""end_span"": 178, ""type"": ""Gene_or_gene_product""}]"	train
The results showed that betulin significantly inhibited cell viability in cervix carcinoma HeLa cells, hepatoma HepG2 cells, lung adenocarcinoma A549 cells, and breast cancer MCF - 7 cells with IC ( 50) values ranging from 10 to 15 microg / mL.	betulin,24,31,Chemical	cell,56,60,Cell	cervix carcinoma HeLa cells,74,101,Cell	hepatoma HepG2 cells,103,123,Cell	lung adenocarcinoma A549 cells,125,155,Cell	breast cancer MCF - 7 cells,161,188,Cell	"[{""token"": ""betulin"", ""start_span"": 24, ""end_span"": 31, ""type"": ""Chemical""}, {""token"": ""cell"", ""start_span"": 56, ""end_span"": 60, ""type"": ""Cell""}, {""token"": ""cervix carcinoma HeLa cells"", ""start_span"": 74, ""end_span"": 101, ""type"": ""Cell""}, {""token"": ""hepatoma HepG2 cells"", ""start_span"": 103, ""end_span"": 123, ""type"": ""Cell""}, {""token"": ""lung adenocarcinoma A549 cells"", ""start_span"": 125, ""end_span"": 155, ""type"": ""Cell""}, {""token"": ""breast cancer MCF - 7 cells"", ""start_span"": 161, ""end_span"": 188, ""type"": ""Cell""}]"	train
Betulin ( 10 microg / mL) induces apoptotic cell death, as evidenced by morphological characteristics such as membrane phosphatidylserine translocation, nuclear condensation / fragmentation, and apoptotic body formation.	Betulin,0,7,Chemical	cell,44,48,Cell	membrane,110,118,Cellular_component	phosphatidylserine,119,137,Amino_acid	nuclear,153,160,Cellular_component	apoptotic body,195,209,Cellular_component	"[{""token"": ""Betulin"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Chemical""}, {""token"": ""cell"", ""start_span"": 44, ""end_span"": 48, ""type"": ""Cell""}, {""token"": ""membrane"", ""start_span"": 110, ""end_span"": 118, ""type"": ""Cellular_component""}, {""token"": ""phosphatidylserine"", ""start_span"": 119, ""end_span"": 137, ""type"": ""Amino_acid""}, {""token"": ""nuclear"", ""start_span"": 153, ""end_span"": 160, ""type"": ""Cellular_component""}, {""token"": ""apoptotic body"", ""start_span"": 195, ""end_span"": 209, ""type"": ""Cellular_component""}]"	train
SAHA enhanced acetylation of histone H3 in Bim promoter region, while E1A upregulated Egr - 1, which was directly involved in Bim transactivation.	SAHA,0,4,Chemical	histone H3,29,39,Gene_or_gene_product	Bim,43,46,Gene_or_gene_product	E1A,70,73,Gene_or_gene_product	Egr - 1,86,93,Gene_or_gene_product	Bim,126,129,Gene_or_gene_product	"[{""token"": ""SAHA"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Chemical""}, {""token"": ""histone H3"", ""start_span"": 29, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bim"", ""start_span"": 43, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""E1A"", ""start_span"": 70, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""Egr - 1"", ""start_span"": 86, ""end_span"": 93, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bim"", ""start_span"": 126, ""end_span"": 129, ""type"": ""Gene_or_gene_product""}]"	train
Brick1 ( Brk1) is the less - studied component of the Wave / Scar pathway involved in the branched nucleation of actin fibers.	Brick1,0,6,Gene_or_gene_product	Brk1,9,13,Gene_or_gene_product	Wave,54,58,Gene_or_gene_product	Scar,61,65,Gene_or_gene_product	actin,113,118,Gene_or_gene_product	fibers,119,125,Cellular_component	"[{""token"": ""Brick1"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Gene_or_gene_product""}, {""token"": ""Brk1"", ""start_span"": 9, ""end_span"": 13, ""type"": ""Gene_or_gene_product""}, {""token"": ""Wave"", ""start_span"": 54, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""Scar"", ""start_span"": 61, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""actin"", ""start_span"": 113, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}, {""token"": ""fibers"", ""start_span"": 119, ""end_span"": 125, ""type"": ""Cellular_component""}]"	train
ADAM - 9 is expressed in human melanoma at the tumor - stroma border where direct or indirect interactions between tumor cells and fibroblasts occur.	ADAM - 9,0,8,Gene_or_gene_product	human,25,30,Organism	melanoma,31,39,Cancer	tumor - stroma border,47,68,Tissue	tumor cells,115,126,Cell	fibroblasts,131,142,Cell	"[{""token"": ""ADAM - 9"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 25, ""end_span"": 30, ""type"": ""Organism""}, {""token"": ""melanoma"", ""start_span"": 31, ""end_span"": 39, ""type"": ""Cancer""}, {""token"": ""tumor - stroma border"", ""start_span"": 47, ""end_span"": 68, ""type"": ""Tissue""}, {""token"": ""tumor cells"", ""start_span"": 115, ""end_span"": 126, ""type"": ""Cell""}, {""token"": ""fibroblasts"", ""start_span"": 131, ""end_span"": 142, ""type"": ""Cell""}]"	train
To analyze the role of ADAM - 9 for the interaction between melanoma cells and stromal fibroblasts, we produced the recombinant disintegrin - like and cysteine - rich domain of ADAM - 9 ( DC - 9).	ADAM - 9,23,31,Gene_or_gene_product	melanoma cells,60,74,Cell	stromal fibroblasts,79,98,Cell	disintegrin,128,139,Gene_or_gene_product	cysteine,151,159,Amino_acid	ADAM - 9,177,185,Gene_or_gene_product	"[{""token"": ""ADAM - 9"", ""start_span"": 23, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""melanoma cells"", ""start_span"": 60, ""end_span"": 74, ""type"": ""Cell""}, {""token"": ""stromal fibroblasts"", ""start_span"": 79, ""end_span"": 98, ""type"": ""Cell""}, {""token"": ""disintegrin"", ""start_span"": 128, ""end_span"": 139, ""type"": ""Gene_or_gene_product""}, {""token"": ""cysteine"", ""start_span"": 151, ""end_span"": 159, ""type"": ""Amino_acid""}, {""token"": ""ADAM - 9"", ""start_span"": 177, ""end_span"": 185, ""type"": ""Gene_or_gene_product""}]"	train
In summary, these results suggest that ADAM - 9 expression plays an important role in mediating cell - cell contacts between fibroblasts and melanoma cells and that these interactions contribute to proteolytic activities required during invasion of melanoma cells.	ADAM - 9,39,47,Gene_or_gene_product	cell,96,100,Cell	cell,103,107,Cell	fibroblasts,125,136,Cell	melanoma cells,141,155,Cell	melanoma cells,249,263,Cell	"[{""token"": ""ADAM - 9"", ""start_span"": 39, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 96, ""end_span"": 100, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 103, ""end_span"": 107, ""type"": ""Cell""}, {""token"": ""fibroblasts"", ""start_span"": 125, ""end_span"": 136, ""type"": ""Cell""}, {""token"": ""melanoma cells"", ""start_span"": 141, ""end_span"": 155, ""type"": ""Cell""}, {""token"": ""melanoma cells"", ""start_span"": 249, ""end_span"": 263, ""type"": ""Cell""}]"	train
Patients having low sVAP - 1 levels had significantly poorer prognosis relative to patients having elevated sVAP - 1 in all or stages I - III gastric cancer patients, respectively.	Patients,0,8,Organism	sVAP - 1,20,28,Gene_or_gene_product	patients,83,91,Organism	sVAP - 1,108,116,Gene_or_gene_product	gastric cancer,142,156,Cancer	patients,157,165,Organism	"[{""token"": ""Patients"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Organism""}, {""token"": ""sVAP - 1"", ""start_span"": 20, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 83, ""end_span"": 91, ""type"": ""Organism""}, {""token"": ""sVAP - 1"", ""start_span"": 108, ""end_span"": 116, ""type"": ""Gene_or_gene_product""}, {""token"": ""gastric cancer"", ""start_span"": 142, ""end_span"": 156, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 157, ""end_span"": 165, ""type"": ""Organism""}]"	train
Using human neuroblastoma cell line, SK - N - MC, we found that treatment of these cells with FGF - 2 resulted in early induction of both Id - 1 mRNA and protein.	human,6,11,Organism	neuroblastoma cell line,12,35,Cell	SK - N - MC,37,48,Cell	cells,83,88,Cell	FGF - 2,94,101,Gene_or_gene_product	Id - 1,138,144,Gene_or_gene_product	"[{""token"": ""human"", ""start_span"": 6, ""end_span"": 11, ""type"": ""Organism""}, {""token"": ""neuroblastoma cell line"", ""start_span"": 12, ""end_span"": 35, ""type"": ""Cell""}, {""token"": ""SK - N - MC"", ""start_span"": 37, ""end_span"": 48, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 83, ""end_span"": 88, ""type"": ""Cell""}, {""token"": ""FGF - 2"", ""start_span"": 94, ""end_span"": 101, ""type"": ""Gene_or_gene_product""}, {""token"": ""Id - 1"", ""start_span"": 138, ""end_span"": 144, ""type"": ""Gene_or_gene_product""}]"	train
Epstein - Barr virus ( EBV) transforms B lymphocytes through the expression of the latent viral proteins EBNA and latent membrane protein ( LMP).	Epstein - Barr virus,0,20,Organism	EBV,23,26,Organism	B lymphocytes,39,52,Cell	EBNA,105,109,Gene_or_gene_product	latent membrane protein,114,137,Gene_or_gene_product	LMP,140,143,Gene_or_gene_product	"[{""token"": ""Epstein - Barr virus"", ""start_span"": 0, ""end_span"": 20, ""type"": ""Organism""}, {""token"": ""EBV"", ""start_span"": 23, ""end_span"": 26, ""type"": ""Organism""}, {""token"": ""B lymphocytes"", ""start_span"": 39, ""end_span"": 52, ""type"": ""Cell""}, {""token"": ""EBNA"", ""start_span"": 105, ""end_span"": 109, ""type"": ""Gene_or_gene_product""}, {""token"": ""latent membrane protein"", ""start_span"": 114, ""end_span"": 137, ""type"": ""Gene_or_gene_product""}, {""token"": ""LMP"", ""start_span"": 140, ""end_span"": 143, ""type"": ""Gene_or_gene_product""}]"	train
Knockdown of VEGFR - 2 attenuated the sunitinib - induced effects, including apoptosis and inhibition of signaling pathways such as the phosphorylation of Akt as well as mTOR, and Bcl - 2, which confirmed that these effects could be mediated by VEGFR - 2.	VEGFR - 2,13,22,Gene_or_gene_product	sunitinib,38,47,Chemical	Akt,155,158,Gene_or_gene_product	mTOR,170,174,Gene_or_gene_product	Bcl - 2,180,187,Gene_or_gene_product	VEGFR - 2,245,254,Gene_or_gene_product	"[{""token"": ""VEGFR - 2"", ""start_span"": 13, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""sunitinib"", ""start_span"": 38, ""end_span"": 47, ""type"": ""Chemical""}, {""token"": ""Akt"", ""start_span"": 155, ""end_span"": 158, ""type"": ""Gene_or_gene_product""}, {""token"": ""mTOR"", ""start_span"": 170, ""end_span"": 174, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bcl - 2"", ""start_span"": 180, ""end_span"": 187, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGFR - 2"", ""start_span"": 245, ""end_span"": 254, ""type"": ""Gene_or_gene_product""}]"	train
To analyze the contribution of VEGF - C to lymph node metastasis, its corresponding gene was stably introduced into HEC1A cells ( HEC1A / VEGF - C), which then produced more than 10 times the amount of VEGF - C.	VEGF - C,31,39,Gene_or_gene_product	lymph node,43,53,Multi	HEC1A cells,116,127,Cell	HEC1A,130,135,Cell	VEGF - C,138,146,Gene_or_gene_product	VEGF - C,202,210,Gene_or_gene_product	"[{""token"": ""VEGF - C"", ""start_span"": 31, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymph node"", ""start_span"": 43, ""end_span"": 53, ""type"": ""Multi""}, {""token"": ""HEC1A cells"", ""start_span"": 116, ""end_span"": 127, ""type"": ""Cell""}, {""token"": ""HEC1A"", ""start_span"": 130, ""end_span"": 135, ""type"": ""Cell""}, {""token"": ""VEGF - C"", ""start_span"": 138, ""end_span"": 146, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF - C"", ""start_span"": 202, ""end_span"": 210, ""type"": ""Gene_or_gene_product""}]"	train
Cooperative transformation by c - MYC and OSM required PI3K and AKT signaling, showing the importance of multiple signaling pathways downstream of the OSM receptor in defining the cellular response to cytokines.	c - MYC,30,37,Gene_or_gene_product	OSM,42,45,Gene_or_gene_product	PI3K,55,59,Gene_or_gene_product	AKT,64,67,Gene_or_gene_product	OSM receptor,151,163,Gene_or_gene_product	cellular,180,188,Cell	"[{""token"": ""c - MYC"", ""start_span"": 30, ""end_span"": 37, ""type"": ""Gene_or_gene_product""}, {""token"": ""OSM"", ""start_span"": 42, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""PI3K"", ""start_span"": 55, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""AKT"", ""start_span"": 64, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""OSM receptor"", ""start_span"": 151, ""end_span"": 163, ""type"": ""Gene_or_gene_product""}, {""token"": ""cellular"", ""start_span"": 180, ""end_span"": 188, ""type"": ""Cell""}]"	train
The NBD peptide suppressed metastasis and tongue tumor growth in GSAS / N5 - inoculated mice, and was accompanied by the downregulation of the NF - kappaB - regulated metastasis - related molecules in engrafted tongue tumors.	NBD peptide,4,15,Chemical	tongue tumor,42,54,Cancer	GSAS / N5,65,74,Cell	mice,88,92,Organism	NF - kappaB,143,154,Gene_or_gene_product	tongue tumors,211,224,Cancer	"[{""token"": ""NBD peptide"", ""start_span"": 4, ""end_span"": 15, ""type"": ""Chemical""}, {""token"": ""tongue tumor"", ""start_span"": 42, ""end_span"": 54, ""type"": ""Cancer""}, {""token"": ""GSAS / N5"", ""start_span"": 65, ""end_span"": 74, ""type"": ""Cell""}, {""token"": ""mice"", ""start_span"": 88, ""end_span"": 92, ""type"": ""Organism""}, {""token"": ""NF - kappaB"", ""start_span"": 143, ""end_span"": 154, ""type"": ""Gene_or_gene_product""}, {""token"": ""tongue tumors"", ""start_span"": 211, ""end_span"": 224, ""type"": ""Cancer""}]"	train
In addition to altering metastasis, beta - catenin levels control tumor differentiation and regulate both MAPK / Erk and PI3K / Akt signaling.	beta - catenin,36,50,Gene_or_gene_product	tumor,66,71,Cancer	MAPK,106,110,Gene_or_gene_product	Erk,113,116,Gene_or_gene_product	PI3K,121,125,Gene_or_gene_product	Akt,128,131,Gene_or_gene_product	"[{""token"": ""beta - catenin"", ""start_span"": 36, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 66, ""end_span"": 71, ""type"": ""Cancer""}, {""token"": ""MAPK"", ""start_span"": 106, ""end_span"": 110, ""type"": ""Gene_or_gene_product""}, {""token"": ""Erk"", ""start_span"": 113, ""end_span"": 116, ""type"": ""Gene_or_gene_product""}, {""token"": ""PI3K"", ""start_span"": 121, ""end_span"": 125, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 128, ""end_span"": 131, ""type"": ""Gene_or_gene_product""}]"	train
Mitochondrial apoptosis and FAK signaling disruption by a novel histone deacetylase inhibitor, HTPB, in antitumor and antimetastatic mouse models.	Mitochondrial,0,13,Cellular_component	FAK,28,31,Gene_or_gene_product	histone deacetylase,64,83,Gene_or_gene_product	HTPB,95,99,Chemical	antitumor,104,113,Cancer	mouse,133,138,Organism	"[{""token"": ""Mitochondrial"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Cellular_component""}, {""token"": ""FAK"", ""start_span"": 28, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""histone deacetylase"", ""start_span"": 64, ""end_span"": 83, ""type"": ""Gene_or_gene_product""}, {""token"": ""HTPB"", ""start_span"": 95, ""end_span"": 99, ""type"": ""Chemical""}, {""token"": ""antitumor"", ""start_span"": 104, ""end_span"": 113, ""type"": ""Cancer""}, {""token"": ""mouse"", ""start_span"": 133, ""end_span"": 138, ""type"": ""Organism""}]"	train
Moreover, HTPB inhibited activity of MMP2 and MMP9, reduced integrin - beta1 / focal adhesion complex formation and decreased pericellular poly - fibronectin assemblies.	HTPB,10,14,Chemical	MMP2,37,41,Gene_or_gene_product	MMP9,46,50,Gene_or_gene_product	integrin - beta1,60,76,Gene_or_gene_product	focal adhesion complex,79,101,Gene_or_gene_product	fibronectin,146,157,Gene_or_gene_product	"[{""token"": ""HTPB"", ""start_span"": 10, ""end_span"": 14, ""type"": ""Chemical""}, {""token"": ""MMP2"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP9"", ""start_span"": 46, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""integrin - beta1"", ""start_span"": 60, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}, {""token"": ""focal adhesion complex"", ""start_span"": 79, ""end_span"": 101, ""type"": ""Gene_or_gene_product""}, {""token"": ""fibronectin"", ""start_span"": 146, ""end_span"": 157, ""type"": ""Gene_or_gene_product""}]"	train
On the contrary, there was intense staining for HER2 on the basolateral membrane of epithelial cells of intestinal metaplasia ( 22 / 24; 91. 7%) and carcinoma in situ ( 9 / 10; 90%), the lesions that displayed a significantly high proliferation index.	HER2,48,52,Gene_or_gene_product	basolateral membrane,60,80,Cellular_component	epithelial cells,84,100,Cell	intestinal metaplasia,104,125,Cancer	carcinoma,149,158,Cancer	lesions,187,194,Pathological_formation	"[{""token"": ""HER2"", ""start_span"": 48, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""basolateral membrane"", ""start_span"": 60, ""end_span"": 80, ""type"": ""Cellular_component""}, {""token"": ""epithelial cells"", ""start_span"": 84, ""end_span"": 100, ""type"": ""Cell""}, {""token"": ""intestinal metaplasia"", ""start_span"": 104, ""end_span"": 125, ""type"": ""Cancer""}, {""token"": ""carcinoma"", ""start_span"": 149, ""end_span"": 158, ""type"": ""Cancer""}, {""token"": ""lesions"", ""start_span"": 187, ""end_span"": 194, ""type"": ""Pathological_formation""}]"	train
Plasminogen activator ( PA) content of excised tumors was determined by SDS - PAGE, and major PA was found to be urokinase ( UK) type.	Plasminogen activator,0,21,Gene_or_gene_product	PA,24,26,Gene_or_gene_product	tumors,47,53,Cancer	PA,78,80,Gene_or_gene_product	urokinase,113,122,Gene_or_gene_product	UK,125,127,Gene_or_gene_product	"[{""token"": ""Plasminogen activator"", ""start_span"": 0, ""end_span"": 21, ""type"": ""Gene_or_gene_product""}, {""token"": ""PA"", ""start_span"": 24, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 47, ""end_span"": 53, ""type"": ""Cancer""}, {""token"": ""PA"", ""start_span"": 78, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""urokinase"", ""start_span"": 113, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}, {""token"": ""UK"", ""start_span"": 125, ""end_span"": 127, ""type"": ""Gene_or_gene_product""}]"	train
When tumor cells possessed a high level of UK, laminin and type IV collagen, components of the basement membrane, disappeared from tumor tissues.	tumor cells,5,16,Cell	UK,43,45,Gene_or_gene_product	laminin,47,54,Gene_or_gene_product	type IV collagen,59,75,Gene_or_gene_product	basement membrane,95,112,Cellular_component	tumor tissues,131,144,Tissue	"[{""token"": ""tumor cells"", ""start_span"": 5, ""end_span"": 16, ""type"": ""Cell""}, {""token"": ""UK"", ""start_span"": 43, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""laminin"", ""start_span"": 47, ""end_span"": 54, ""type"": ""Gene_or_gene_product""}, {""token"": ""type IV collagen"", ""start_span"": 59, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}, {""token"": ""basement membrane"", ""start_span"": 95, ""end_span"": 112, ""type"": ""Cellular_component""}, {""token"": ""tumor tissues"", ""start_span"": 131, ""end_span"": 144, ""type"": ""Tissue""}]"	train
Clinically, patients with advanced cancer are usually in a hypercoagulable state with elevated fibrinogen, and fibrin deposition around tumor mass is a serious problem in cancer chemotherapy.	patients,12,20,Organism	advanced cancer,26,41,Cancer	fibrinogen,95,105,Gene_or_gene_product	fibrin,111,117,Gene_or_gene_product	tumor,136,141,Cancer	cancer,171,177,Cancer	"[{""token"": ""patients"", ""start_span"": 12, ""end_span"": 20, ""type"": ""Organism""}, {""token"": ""advanced cancer"", ""start_span"": 26, ""end_span"": 41, ""type"": ""Cancer""}, {""token"": ""fibrinogen"", ""start_span"": 95, ""end_span"": 105, ""type"": ""Gene_or_gene_product""}, {""token"": ""fibrin"", ""start_span"": 111, ""end_span"": 117, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 136, ""end_span"": 141, ""type"": ""Cancer""}, {""token"": ""cancer"", ""start_span"": 171, ""end_span"": 177, ""type"": ""Cancer""}]"	train
This enhanced glycolysis was partly sensitive to rutamycin and partly sensitive to ouabain, suggesting that the detergent released the control of the ATPase of the mitochondria and of the plasma membrane Na + K + - ATPase.	rutamycin,49,58,Chemical	ouabain,83,90,Chemical	ATPase,150,156,Gene_or_gene_product	mitochondria,164,176,Cellular_component	plasma membrane,188,203,Cellular_component	Na + K + - ATPase,204,221,Gene_or_gene_product	"[{""token"": ""rutamycin"", ""start_span"": 49, ""end_span"": 58, ""type"": ""Chemical""}, {""token"": ""ouabain"", ""start_span"": 83, ""end_span"": 90, ""type"": ""Chemical""}, {""token"": ""ATPase"", ""start_span"": 150, ""end_span"": 156, ""type"": ""Gene_or_gene_product""}, {""token"": ""mitochondria"", ""start_span"": 164, ""end_span"": 176, ""type"": ""Cellular_component""}, {""token"": ""plasma membrane"", ""start_span"": 188, ""end_span"": 203, ""type"": ""Cellular_component""}, {""token"": ""Na + K + - ATPase"", ""start_span"": 204, ""end_span"": 221, ""type"": ""Gene_or_gene_product""}]"	train
In down modulated growing cells, PDBu caused almost complete inhibition of EGF binding, whereas in down modulated stationary cells, minimal inhibition of EGF binding by PDBu was observed.	cells,26,31,Cell	PDBu,33,37,Chemical	EGF,75,78,Gene_or_gene_product	cells,125,130,Cell	EGF,154,157,Gene_or_gene_product	PDBu,169,173,Chemical	"[{""token"": ""cells"", ""start_span"": 26, ""end_span"": 31, ""type"": ""Cell""}, {""token"": ""PDBu"", ""start_span"": 33, ""end_span"": 37, ""type"": ""Chemical""}, {""token"": ""EGF"", ""start_span"": 75, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 125, ""end_span"": 130, ""type"": ""Cell""}, {""token"": ""EGF"", ""start_span"": 154, ""end_span"": 157, ""type"": ""Gene_or_gene_product""}, {""token"": ""PDBu"", ""start_span"": 169, ""end_span"": 173, ""type"": ""Chemical""}]"	train
Rat - 1 cells which had been transformed with the activated Ha - ras - 1 gene from human EJ bladder carcinoma cells were fused with diploid embryonic rat fibroblasts.	Rat - 1 cells,0,13,Cell	Ha - ras - 1,60,72,Gene_or_gene_product	human,83,88,Organism	EJ bladder carcinoma cells,89,115,Cell	rat,150,153,Organism	fibroblasts,154,165,Cell	"[{""token"": ""Rat - 1 cells"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Cell""}, {""token"": ""Ha - ras - 1"", ""start_span"": 60, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 83, ""end_span"": 88, ""type"": ""Organism""}, {""token"": ""EJ bladder carcinoma cells"", ""start_span"": 89, ""end_span"": 115, ""type"": ""Cell""}, {""token"": ""rat"", ""start_span"": 150, ""end_span"": 153, ""type"": ""Organism""}, {""token"": ""fibroblasts"", ""start_span"": 154, ""end_span"": 165, ""type"": ""Cell""}]"	train
DNA of the non - tumorigenic cell hybrids transformed Rat - 1 cells to anchorage - independent proliferation as expected for the transforming human Ha - ras gene present in the donor DNA.	DNA,0,3,Cellular_component	cell hybrids,29,41,Cell	Rat - 1 cells,54,67,Cell	human,142,147,Organism	Ha - ras,148,156,Gene_or_gene_product	DNA,183,186,Cellular_component	"[{""token"": ""DNA"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Cellular_component""}, {""token"": ""cell hybrids"", ""start_span"": 29, ""end_span"": 41, ""type"": ""Cell""}, {""token"": ""Rat - 1 cells"", ""start_span"": 54, ""end_span"": 67, ""type"": ""Cell""}, {""token"": ""human"", ""start_span"": 142, ""end_span"": 147, ""type"": ""Organism""}, {""token"": ""Ha - ras"", ""start_span"": 148, ""end_span"": 156, ""type"": ""Gene_or_gene_product""}, {""token"": ""DNA"", ""start_span"": 183, ""end_span"": 186, ""type"": ""Cellular_component""}]"	train
"Their genomes are relatively simple, containing the genes gag, pol, env, and a 3 ' region termed "" X. "" This 3 ' region may be responsible for the transforming potential of the viruses."	gag,58,61,Gene_or_gene_product	pol,63,66,Gene_or_gene_product	env,68,71,Gene_or_gene_product	3 ' region,79,89,Cellular_component	X,99,100,Cellular_component	3 ' region,109,119,Cellular_component	"[{""token"": ""gag"", ""start_span"": 58, ""end_span"": 61, ""type"": ""Gene_or_gene_product""}, {""token"": ""pol"", ""start_span"": 63, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""env"", ""start_span"": 68, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""3 ' region"", ""start_span"": 79, ""end_span"": 89, ""type"": ""Cellular_component""}, {""token"": ""X"", ""start_span"": 99, ""end_span"": 100, ""type"": ""Cellular_component""}, {""token"": ""3 ' region"", ""start_span"": 109, ""end_span"": 119, ""type"": ""Cellular_component""}]"	train
Experiments using the tsA 58 allele of the SV 40 - A gene have demonstrated that the SV 40 large T - antigen is strictly required both for immortalization and induction anchorage independence of cells.	tsA 58,22,28,Gene_or_gene_product	SV 40,43,48,Organism	A,51,52,Gene_or_gene_product	SV 40,85,90,Organism	large T - antigen,91,108,Gene_or_gene_product	cells,195,200,Cell	"[{""token"": ""tsA 58"", ""start_span"": 22, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""SV 40"", ""start_span"": 43, ""end_span"": 48, ""type"": ""Organism""}, {""token"": ""A"", ""start_span"": 51, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""SV 40"", ""start_span"": 85, ""end_span"": 90, ""type"": ""Organism""}, {""token"": ""large T - antigen"", ""start_span"": 91, ""end_span"": 108, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 195, ""end_span"": 200, ""type"": ""Cell""}]"	train
In DNA from the T - cells not expressing DR alpha mRNA, all of the potential HpaII sites within the BglII fragment appeared to be methylated.	DNA,3,6,Cellular_component	T - cells,16,25,Cell	DR alpha,41,49,Gene_or_gene_product	HpaII,77,82,Gene_or_gene_product	BglII,100,105,Gene_or_gene_product	fragment,106,114,Cellular_component	"[{""token"": ""DNA"", ""start_span"": 3, ""end_span"": 6, ""type"": ""Cellular_component""}, {""token"": ""T - cells"", ""start_span"": 16, ""end_span"": 25, ""type"": ""Cell""}, {""token"": ""DR alpha"", ""start_span"": 41, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""HpaII"", ""start_span"": 77, ""end_span"": 82, ""type"": ""Gene_or_gene_product""}, {""token"": ""BglII"", ""start_span"": 100, ""end_span"": 105, ""type"": ""Gene_or_gene_product""}, {""token"": ""fragment"", ""start_span"": 106, ""end_span"": 114, ""type"": ""Cellular_component""}]"	train
Treatment of these T - cells with 5 - azacytidine resulted in the induction of DR surface antigen expression, the appearance of DR alpha mRNA, and the partial demethylation of the DR alpha DNA sequences.	T - cells,19,28,Cell	5 - azacytidine,34,49,Chemical	DR surface antigen,79,97,Gene_or_gene_product	DR alpha,128,136,Gene_or_gene_product	DR alpha,180,188,Gene_or_gene_product	DNA,189,192,Cellular_component	"[{""token"": ""T - cells"", ""start_span"": 19, ""end_span"": 28, ""type"": ""Cell""}, {""token"": ""5 - azacytidine"", ""start_span"": 34, ""end_span"": 49, ""type"": ""Chemical""}, {""token"": ""DR surface antigen"", ""start_span"": 79, ""end_span"": 97, ""type"": ""Gene_or_gene_product""}, {""token"": ""DR alpha"", ""start_span"": 128, ""end_span"": 136, ""type"": ""Gene_or_gene_product""}, {""token"": ""DR alpha"", ""start_span"": 180, ""end_span"": 188, ""type"": ""Gene_or_gene_product""}, {""token"": ""DNA"", ""start_span"": 189, ""end_span"": 192, ""type"": ""Cellular_component""}]"	train
Uncultured peripheral blood T - cells from human T - cell leukemia - lymphoma virus - infected individuals expressed DR antigens at a low level, and the DR alpha locus was partially unmethylated.	peripheral blood T - cells,11,37,Cell	human T - cell leukemia - lymphoma virus,43,83,Organism	individuals,95,106,Organism	DR antigens,117,128,Gene_or_gene_product	DR alpha,153,161,Gene_or_gene_product	locus,162,167,Cellular_component	"[{""token"": ""peripheral blood T - cells"", ""start_span"": 11, ""end_span"": 37, ""type"": ""Cell""}, {""token"": ""human T - cell leukemia - lymphoma virus"", ""start_span"": 43, ""end_span"": 83, ""type"": ""Organism""}, {""token"": ""individuals"", ""start_span"": 95, ""end_span"": 106, ""type"": ""Organism""}, {""token"": ""DR antigens"", ""start_span"": 117, ""end_span"": 128, ""type"": ""Gene_or_gene_product""}, {""token"": ""DR alpha"", ""start_span"": 153, ""end_span"": 161, ""type"": ""Gene_or_gene_product""}, {""token"": ""locus"", ""start_span"": 162, ""end_span"": 167, ""type"": ""Cellular_component""}]"	train
The parameters considered are the number of platelets and their aggregability, prothrombin and partial thromboplastin times, plasma fibrinogen concentration and tumor cell procoagulant activity.	platelets,44,53,Cell	prothrombin,79,90,Gene_or_gene_product	thromboplastin,103,117,Gene_or_gene_product	plasma,125,131,Organism_substance	fibrinogen,132,142,Gene_or_gene_product	tumor cell,161,171,Cell	"[{""token"": ""platelets"", ""start_span"": 44, ""end_span"": 53, ""type"": ""Cell""}, {""token"": ""prothrombin"", ""start_span"": 79, ""end_span"": 90, ""type"": ""Gene_or_gene_product""}, {""token"": ""thromboplastin"", ""start_span"": 103, ""end_span"": 117, ""type"": ""Gene_or_gene_product""}, {""token"": ""plasma"", ""start_span"": 125, ""end_span"": 131, ""type"": ""Organism_substance""}, {""token"": ""fibrinogen"", ""start_span"": 132, ""end_span"": 142, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor cell"", ""start_span"": 161, ""end_span"": 171, ""type"": ""Cell""}]"	train
The inhibition of cultured myoblast differentiation by the simian virus 40 large T antigen occurs after myogenin expression and Rb up - regulation and is not exerted by transformation - competent cytoplasmic mutants.	myoblast,27,35,Cell	simian virus 40,59,74,Organism	large T antigen,75,90,Gene_or_gene_product	myogenin,104,112,Gene_or_gene_product	Rb,128,130,Gene_or_gene_product	cytoplasmic,196,207,Organism_substance	"[{""token"": ""myoblast"", ""start_span"": 27, ""end_span"": 35, ""type"": ""Cell""}, {""token"": ""simian virus 40"", ""start_span"": 59, ""end_span"": 74, ""type"": ""Organism""}, {""token"": ""large T antigen"", ""start_span"": 75, ""end_span"": 90, ""type"": ""Gene_or_gene_product""}, {""token"": ""myogenin"", ""start_span"": 104, ""end_span"": 112, ""type"": ""Gene_or_gene_product""}, {""token"": ""Rb"", ""start_span"": 128, ""end_span"": 130, ""type"": ""Gene_or_gene_product""}, {""token"": ""cytoplasmic"", ""start_span"": 196, ""end_span"": 207, ""type"": ""Organism_substance""}]"	train
The inhibiting mutants, including the Rb binding site mutant, were able to promote a higher state of Rb phosphorylation than that observed in either normal cells or cytoplasmic - SVLT transformants.	Rb,38,40,Gene_or_gene_product	Rb,101,103,Gene_or_gene_product	cells,156,161,Cell	cytoplasmic,165,176,Organism_substance	SVLT,179,183,Gene_or_gene_product	transformants,184,197,Cell	"[{""token"": ""Rb"", ""start_span"": 38, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""Rb"", ""start_span"": 101, ""end_span"": 103, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 156, ""end_span"": 161, ""type"": ""Cell""}, {""token"": ""cytoplasmic"", ""start_span"": 165, ""end_span"": 176, ""type"": ""Organism_substance""}, {""token"": ""SVLT"", ""start_span"": 179, ""end_span"": 183, ""type"": ""Gene_or_gene_product""}, {""token"": ""transformants"", ""start_span"": 184, ""end_span"": 197, ""type"": ""Cell""}]"	train
Intraperitoneal injections of 2G7 starting 1 d after intraperitoneal inoculation of tumor cells suppressed intraabdominal tumor and lung metastases, whereas the nonneutralizing anti - TGF - beta 12H5 IgG2a had no effect.	Intraperitoneal,0,15,Immaterial_anatomical_entity	intraperitoneal,53,68,Immaterial_anatomical_entity	tumor cells,84,95,Cell	intraabdominal tumor,107,127,Cancer	lung,132,136,Organ	TGF - beta,184,194,Gene_or_gene_product	"[{""token"": ""Intraperitoneal"", ""start_span"": 0, ""end_span"": 15, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""intraperitoneal"", ""start_span"": 53, ""end_span"": 68, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""tumor cells"", ""start_span"": 84, ""end_span"": 95, ""type"": ""Cell""}, {""token"": ""intraabdominal tumor"", ""start_span"": 107, ""end_span"": 127, ""type"": ""Cancer""}, {""token"": ""lung"", ""start_span"": 132, ""end_span"": 136, ""type"": ""Organ""}, {""token"": ""TGF - beta"", ""start_span"": 184, ""end_span"": 194, ""type"": ""Gene_or_gene_product""}]"	train
Both the erbA IRES and the erbA / myb IRES virus constructs transformed erythroid cells after infection of bone marrow or blastoderm cultures.	erbA,9,13,Gene_or_gene_product	erbA,27,31,Gene_or_gene_product	myb,34,37,Gene_or_gene_product	erythroid cells,72,87,Cell	bone marrow,107,118,Multi	blastoderm cultures,122,141,Cell	"[{""token"": ""erbA"", ""start_span"": 9, ""end_span"": 13, ""type"": ""Gene_or_gene_product""}, {""token"": ""erbA"", ""start_span"": 27, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""myb"", ""start_span"": 34, ""end_span"": 37, ""type"": ""Gene_or_gene_product""}, {""token"": ""erythroid cells"", ""start_span"": 72, ""end_span"": 87, ""type"": ""Cell""}, {""token"": ""bone marrow"", ""start_span"": 107, ""end_span"": 118, ""type"": ""Multi""}, {""token"": ""blastoderm cultures"", ""start_span"": 122, ""end_span"": 141, ""type"": ""Cell""}]"	train
Assessment of starved HUVECs at 14 days demonstrated sixfold more cells for AdCMV. VEGF165 - infected HUVECs ( 20 pfu per cell) than for either infected or uninfected control cells.	HUVECs,22,28,Cell	cells,66,71,Cell	VEGF165,83,90,Gene_or_gene_product	HUVECs,102,108,Cell	cell,122,126,Cell	cells,175,180,Cell	"[{""token"": ""HUVECs"", ""start_span"": 22, ""end_span"": 28, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 66, ""end_span"": 71, ""type"": ""Cell""}, {""token"": ""VEGF165"", ""start_span"": 83, ""end_span"": 90, ""type"": ""Gene_or_gene_product""}, {""token"": ""HUVECs"", ""start_span"": 102, ""end_span"": 108, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 122, ""end_span"": 126, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 175, ""end_span"": 180, ""type"": ""Cell""}]"	train
When plated in 2% serum on dishes precoated with reconstituted basement membrane ( Matrigel), HUVECs infected with AdCMV. VEGF165 ( 20 pfu per cell) differentiated into capillary - like structures.	serum,18,23,Organism_substance	basement membrane,63,80,Cellular_component	HUVECs,94,100,Cell	VEGF165,122,129,Gene_or_gene_product	cell,143,147,Cell	capillary - like structures,169,196,Tissue	"[{""token"": ""serum"", ""start_span"": 18, ""end_span"": 23, ""type"": ""Organism_substance""}, {""token"": ""basement membrane"", ""start_span"": 63, ""end_span"": 80, ""type"": ""Cellular_component""}, {""token"": ""HUVECs"", ""start_span"": 94, ""end_span"": 100, ""type"": ""Cell""}, {""token"": ""VEGF165"", ""start_span"": 122, ""end_span"": 129, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 143, ""end_span"": 147, ""type"": ""Cell""}, {""token"": ""capillary - like structures"", ""start_span"": 169, ""end_span"": 196, ""type"": ""Tissue""}]"	train
When the macro - molecular synthesis inhibitor cycloheximide ( CHX) or actinomycin D ( Act D) was present for 26 hours in the absence of GM - CSF and FBS, apoptosis was inhibited.	cycloheximide,47,60,Chemical	CHX,63,66,Chemical	actinomycin D,71,84,Chemical	Act D,87,92,Chemical	GM - CSF,137,145,Gene_or_gene_product	FBS,150,153,Organism_substance	"[{""token"": ""cycloheximide"", ""start_span"": 47, ""end_span"": 60, ""type"": ""Chemical""}, {""token"": ""CHX"", ""start_span"": 63, ""end_span"": 66, ""type"": ""Chemical""}, {""token"": ""actinomycin D"", ""start_span"": 71, ""end_span"": 84, ""type"": ""Chemical""}, {""token"": ""Act D"", ""start_span"": 87, ""end_span"": 92, ""type"": ""Chemical""}, {""token"": ""GM - CSF"", ""start_span"": 137, ""end_span"": 145, ""type"": ""Gene_or_gene_product""}, {""token"": ""FBS"", ""start_span"": 150, ""end_span"": 153, ""type"": ""Organism_substance""}]"	train
Tetracyclines are antimicrobial agents that can suppress MP activity in a variety of tissues, including gingiva, bone, and cartilage.	Tetracyclines,0,13,Chemical	MP,57,59,Gene_or_gene_product	tissues,85,92,Tissue	gingiva,104,111,Multi	bone,113,117,Tissue	cartilage,123,132,Tissue	"[{""token"": ""Tetracyclines"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Chemical""}, {""token"": ""MP"", ""start_span"": 57, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""tissues"", ""start_span"": 85, ""end_span"": 92, ""type"": ""Tissue""}, {""token"": ""gingiva"", ""start_span"": 104, ""end_span"": 111, ""type"": ""Multi""}, {""token"": ""bone"", ""start_span"": 113, ""end_span"": 117, ""type"": ""Tissue""}, {""token"": ""cartilage"", ""start_span"": 123, ""end_span"": 132, ""type"": ""Tissue""}]"	train
These TGF - beta - resistant cells also exhibited progressively increasing levels of expression of the c - fos and and myc mRNA, and increased resistance to the cytotoxicity of Adriamycin and melphalan.	TGF - beta,6,16,Gene_or_gene_product	cells,29,34,Cell	c - fos,103,110,Gene_or_gene_product	myc,119,122,Gene_or_gene_product	Adriamycin,177,187,Chemical	melphalan,192,201,Chemical	"[{""token"": ""TGF - beta"", ""start_span"": 6, ""end_span"": 16, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 29, ""end_span"": 34, ""type"": ""Cell""}, {""token"": ""c - fos"", ""start_span"": 103, ""end_span"": 110, ""type"": ""Gene_or_gene_product""}, {""token"": ""myc"", ""start_span"": 119, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}, {""token"": ""Adriamycin"", ""start_span"": 177, ""end_span"": 187, ""type"": ""Chemical""}, {""token"": ""melphalan"", ""start_span"": 192, ""end_span"": 201, ""type"": ""Chemical""}]"	train
Two small RNAs ( 0. 9 and 0. 75 kb), named Marek ' s disease virus ( MDV) small RNAs ( MSRs) and a 10 - kb RNA, all of which map antisense to the MDV ICP4 homolog gene, have been readily detected in MDCC - MSB1 MDV - transformed T - lymphoblastoid cells.	MSRs,87,91,Gene_or_gene_product	MDV,146,149,Organism	ICP4 homolog,150,162,Gene_or_gene_product	MDCC - MSB1,199,210,Cell	MDV,211,214,Organism	T - lymphoblastoid cells,229,253,Cell	"[{""token"": ""MSRs"", ""start_span"": 87, ""end_span"": 91, ""type"": ""Gene_or_gene_product""}, {""token"": ""MDV"", ""start_span"": 146, ""end_span"": 149, ""type"": ""Organism""}, {""token"": ""ICP4 homolog"", ""start_span"": 150, ""end_span"": 162, ""type"": ""Gene_or_gene_product""}, {""token"": ""MDCC - MSB1"", ""start_span"": 199, ""end_span"": 210, ""type"": ""Cell""}, {""token"": ""MDV"", ""start_span"": 211, ""end_span"": 214, ""type"": ""Organism""}, {""token"": ""T - lymphoblastoid cells"", ""start_span"": 229, ""end_span"": 253, ""type"": ""Cell""}]"	train
Importantly, a striking increase in the expression of specific PTPases, LAR and PTP1B, was observed in 3 independently neu transformed cell lines and their derived tumors.	PTPases,63,70,Gene_or_gene_product	LAR,72,75,Gene_or_gene_product	PTP1B,80,85,Gene_or_gene_product	neu,119,122,Gene_or_gene_product	cell lines,135,145,Cell	tumors,164,170,Cancer	"[{""token"": ""PTPases"", ""start_span"": 63, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""LAR"", ""start_span"": 72, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}, {""token"": ""PTP1B"", ""start_span"": 80, ""end_span"": 85, ""type"": ""Gene_or_gene_product""}, {""token"": ""neu"", ""start_span"": 119, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell lines"", ""start_span"": 135, ""end_span"": 145, ""type"": ""Cell""}, {""token"": ""tumors"", ""start_span"": 164, ""end_span"": 170, ""type"": ""Cancer""}]"	train
Thus, our results provide the first evidence that, in human breast carcinoma cells and in rat mammary carcinomas that have an induced increase in neu expression, a consistent and substantial increase in the expression of specific PTPases occurs.	human,54,59,Organism	breast carcinoma cells,60,82,Cell	rat,90,93,Organism	mammary carcinomas,94,112,Cancer	neu,146,149,Gene_or_gene_product	PTPases,230,237,Gene_or_gene_product	"[{""token"": ""human"", ""start_span"": 54, ""end_span"": 59, ""type"": ""Organism""}, {""token"": ""breast carcinoma cells"", ""start_span"": 60, ""end_span"": 82, ""type"": ""Cell""}, {""token"": ""rat"", ""start_span"": 90, ""end_span"": 93, ""type"": ""Organism""}, {""token"": ""mammary carcinomas"", ""start_span"": 94, ""end_span"": 112, ""type"": ""Cancer""}, {""token"": ""neu"", ""start_span"": 146, ""end_span"": 149, ""type"": ""Gene_or_gene_product""}, {""token"": ""PTPases"", ""start_span"": 230, ""end_span"": 237, ""type"": ""Gene_or_gene_product""}]"	train
In vivo effects of insulin on tumor and skeletal muscle glucose metabolism in patients with lymphoma.	insulin,19,26,Gene_or_gene_product	tumor,30,35,Cancer	skeletal muscle,40,55,Tissue	glucose,56,63,Chemical	patients,78,86,Organism	lymphoma,92,100,Cancer	"[{""token"": ""insulin"", ""start_span"": 19, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 30, ""end_span"": 35, ""type"": ""Cancer""}, {""token"": ""skeletal muscle"", ""start_span"": 40, ""end_span"": 55, ""type"": ""Tissue""}, {""token"": ""glucose"", ""start_span"": 56, ""end_span"": 63, ""type"": ""Chemical""}, {""token"": ""patients"", ""start_span"": 78, ""end_span"": 86, ""type"": ""Organism""}, {""token"": ""lymphoma"", ""start_span"": 92, ""end_span"": 100, ""type"": ""Cancer""}]"	train
Whole body glucose use was 55% lower in patients than in control subjects ( 17 + / - 3 mumol / kg / minute versus 38 + / - 3 mumol / kg / minute, P = 0. 002), consistent with insulin resistance in cancer.	body,6,10,Organism_subdivision	glucose,11,18,Chemical	patients,40,48,Organism	control subjects,57,73,Organism	insulin,175,182,Gene_or_gene_product	cancer,197,203,Cancer	"[{""token"": ""body"", ""start_span"": 6, ""end_span"": 10, ""type"": ""Organism_subdivision""}, {""token"": ""glucose"", ""start_span"": 11, ""end_span"": 18, ""type"": ""Chemical""}, {""token"": ""patients"", ""start_span"": 40, ""end_span"": 48, ""type"": ""Organism""}, {""token"": ""control subjects"", ""start_span"": 57, ""end_span"": 73, ""type"": ""Organism""}, {""token"": ""insulin"", ""start_span"": 175, ""end_span"": 182, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancer"", ""start_span"": 197, ""end_span"": 203, ""type"": ""Cancer""}]"	train
In spite of uncertainties regarding the mechanisms of carcinogenesis, several vitamins such as beta - carotene and vitamins A, C, and E, which can reduce the risk of cancer, have been identified, using animal and in vitro models of carcinogenesis.	vitamins,78,86,Chemical	beta - carotene,95,110,Chemical	vitamins A,115,125,Chemical	C,127,128,Chemical	E,134,135,Chemical	cancer,166,172,Cancer	"[{""token"": ""vitamins"", ""start_span"": 78, ""end_span"": 86, ""type"": ""Chemical""}, {""token"": ""beta - carotene"", ""start_span"": 95, ""end_span"": 110, ""type"": ""Chemical""}, {""token"": ""vitamins A"", ""start_span"": 115, ""end_span"": 125, ""type"": ""Chemical""}, {""token"": ""C"", ""start_span"": 127, ""end_span"": 128, ""type"": ""Chemical""}, {""token"": ""E"", ""start_span"": 134, ""end_span"": 135, ""type"": ""Chemical""}, {""token"": ""cancer"", ""start_span"": 166, ""end_span"": 172, ""type"": ""Cancer""}]"	train
The fact that some vitamins induce cell differentiation and / or growth inhibition in tumor cells in culture suggests that the use of these vitamins in cancer prevention has a cellular basis.	vitamins,19,27,Chemical	cell,35,39,Cell	tumor cells,86,97,Cell	vitamins,140,148,Chemical	cancer,152,158,Cancer	cellular,176,184,Cell	"[{""token"": ""vitamins"", ""start_span"": 19, ""end_span"": 27, ""type"": ""Chemical""}, {""token"": ""cell"", ""start_span"": 35, ""end_span"": 39, ""type"": ""Cell""}, {""token"": ""tumor cells"", ""start_span"": 86, ""end_span"": 97, ""type"": ""Cell""}, {""token"": ""vitamins"", ""start_span"": 140, ""end_span"": 148, ""type"": ""Chemical""}, {""token"": ""cancer"", ""start_span"": 152, ""end_span"": 158, ""type"": ""Cancer""}, {""token"": ""cellular"", ""start_span"": 176, ""end_span"": 184, ""type"": ""Cell""}]"	train
Some vitamins like beta - carotene, retinoic acid, alpha - tocopheryl succinate, and vitamin D also regulate the expressions of certain oncogenes and cellular genes.	vitamins,5,13,Chemical	beta - carotene,19,34,Chemical	retinoic acid,36,49,Chemical	alpha - tocopheryl succinate,51,79,Chemical	vitamin D,85,94,Chemical	cellular,150,158,Cell	"[{""token"": ""vitamins"", ""start_span"": 5, ""end_span"": 13, ""type"": ""Chemical""}, {""token"": ""beta - carotene"", ""start_span"": 19, ""end_span"": 34, ""type"": ""Chemical""}, {""token"": ""retinoic acid"", ""start_span"": 36, ""end_span"": 49, ""type"": ""Chemical""}, {""token"": ""alpha - tocopheryl succinate"", ""start_span"": 51, ""end_span"": 79, ""type"": ""Chemical""}, {""token"": ""vitamin D"", ""start_span"": 85, ""end_span"": 94, ""type"": ""Chemical""}, {""token"": ""cellular"", ""start_span"": 150, ""end_span"": 158, ""type"": ""Cell""}]"	train
More recent data have demonstrated the existence of two human nm23 gene homologues, nm23 - H1 and nm23 - H2, and have shown that deletion of nm23 - H1 alleles occurs in some colon carcinomas associated with poor prognosis.	human,56,61,Organism	nm23,62,66,Gene_or_gene_product	nm23 - H1,84,93,Gene_or_gene_product	nm23 - H2,98,107,Gene_or_gene_product	nm23 - H1,141,150,Gene_or_gene_product	colon carcinomas,174,190,Cancer	"[{""token"": ""human"", ""start_span"": 56, ""end_span"": 61, ""type"": ""Organism""}, {""token"": ""nm23"", ""start_span"": 62, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""nm23 - H1"", ""start_span"": 84, ""end_span"": 93, ""type"": ""Gene_or_gene_product""}, {""token"": ""nm23 - H2"", ""start_span"": 98, ""end_span"": 107, ""type"": ""Gene_or_gene_product""}, {""token"": ""nm23 - H1"", ""start_span"": 141, ""end_span"": 150, ""type"": ""Gene_or_gene_product""}, {""token"": ""colon carcinomas"", ""start_span"": 174, ""end_span"": 190, ""type"": ""Cancer""}]"	train
To assess the lymphoid tumorigenic potential of bcl - 2, mice of five independent strains expressing a bcl - 2 transgene in B and / or T cells were monitored for disease up to 12 months of age.	lymphoid,14,22,Cell	bcl - 2,48,55,Gene_or_gene_product	mice,57,61,Organism	bcl - 2,103,110,Gene_or_gene_product	B,124,125,Cell	T cells,135,142,Cell	"[{""token"": ""lymphoid"", ""start_span"": 14, ""end_span"": 22, ""type"": ""Cell""}, {""token"": ""bcl - 2"", ""start_span"": 48, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""mice"", ""start_span"": 57, ""end_span"": 61, ""type"": ""Organism""}, {""token"": ""bcl - 2"", ""start_span"": 103, ""end_span"": 110, ""type"": ""Gene_or_gene_product""}, {""token"": ""B"", ""start_span"": 124, ""end_span"": 125, ""type"": ""Cell""}, {""token"": ""T cells"", ""start_span"": 135, ""end_span"": 142, ""type"": ""Cell""}]"	train
Gangliocytic paraganglioma ( GPG) with local lymph node metastasis was found in the pancreas of a 74 - yr - old female who presented with diarrhea, steatorrhea, vomiting, nausea, and abdominal pain.	Gangliocytic paraganglioma,0,26,Cancer	GPG,29,32,Cancer	lymph node,45,55,Multi	pancreas,84,92,Organ	female,112,118,Organism	abdominal,183,192,Organism_subdivision	"[{""token"": ""Gangliocytic paraganglioma"", ""start_span"": 0, ""end_span"": 26, ""type"": ""Cancer""}, {""token"": ""GPG"", ""start_span"": 29, ""end_span"": 32, ""type"": ""Cancer""}, {""token"": ""lymph node"", ""start_span"": 45, ""end_span"": 55, ""type"": ""Multi""}, {""token"": ""pancreas"", ""start_span"": 84, ""end_span"": 92, ""type"": ""Organ""}, {""token"": ""female"", ""start_span"": 112, ""end_span"": 118, ""type"": ""Organism""}, {""token"": ""abdominal"", ""start_span"": 183, ""end_span"": 192, ""type"": ""Organism_subdivision""}]"	train
Stimulation of endothelial cell migration by vascular permeability factor / vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin.	endothelial cell,15,31,Cell	vascular permeability factor,45,73,Gene_or_gene_product	vascular endothelial growth factor,76,110,Gene_or_gene_product	alphavbeta3 integrin,156,176,Gene_or_gene_product	osteopontin,178,189,Gene_or_gene_product	thrombin,195,203,Gene_or_gene_product	"[{""token"": ""endothelial cell"", ""start_span"": 15, ""end_span"": 31, ""type"": ""Cell""}, {""token"": ""vascular permeability factor"", ""start_span"": 45, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 76, ""end_span"": 110, ""type"": ""Gene_or_gene_product""}, {""token"": ""alphavbeta3 integrin"", ""start_span"": 156, ""end_span"": 176, ""type"": ""Gene_or_gene_product""}, {""token"": ""osteopontin"", ""start_span"": 178, ""end_span"": 189, ""type"": ""Gene_or_gene_product""}, {""token"": ""thrombin"", ""start_span"": 195, ""end_span"": 203, ""type"": ""Gene_or_gene_product""}]"	train
We have identified several mechanisms by which the angiogenic cytokine vascular permeability factor / vascular endothelial growth factor ( VPF / VEGF) likely regulates endothelial cells ( EC) migration.	vascular permeability factor,71,99,Gene_or_gene_product	vascular endothelial growth factor,102,136,Gene_or_gene_product	VPF,139,142,Gene_or_gene_product	VEGF,145,149,Gene_or_gene_product	endothelial cells,168,185,Cell	EC,188,190,Cell	"[{""token"": ""vascular permeability factor"", ""start_span"": 71, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 102, ""end_span"": 136, ""type"": ""Gene_or_gene_product""}, {""token"": ""VPF"", ""start_span"": 139, ""end_span"": 142, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 145, ""end_span"": 149, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cells"", ""start_span"": 168, ""end_span"": 185, ""type"": ""Cell""}, {""token"": ""EC"", ""start_span"": 188, ""end_span"": 190, ""type"": ""Cell""}]"	train
Upon retroviral transduction of the mouse c - myc gene, Rat 6 cells showed mildly altered morphology and formed microcolonies in soft agar; furthermore, they could be transformed by BP and MNNG to form large colonies in agar ( Hsiao et al. ( 1992) Mol. Carcinogenesis, 5, 140 - 154).	retroviral,5,15,Organism	mouse,36,41,Organism	c - myc,42,49,Gene_or_gene_product	Rat 6 cells,56,67,Cell	BP,182,184,Chemical	MNNG,189,193,Chemical	"[{""token"": ""retroviral"", ""start_span"": 5, ""end_span"": 15, ""type"": ""Organism""}, {""token"": ""mouse"", ""start_span"": 36, ""end_span"": 41, ""type"": ""Organism""}, {""token"": ""c - myc"", ""start_span"": 42, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""Rat 6 cells"", ""start_span"": 56, ""end_span"": 67, ""type"": ""Cell""}, {""token"": ""BP"", ""start_span"": 182, ""end_span"": 184, ""type"": ""Chemical""}, {""token"": ""MNNG"", ""start_span"": 189, ""end_span"": 193, ""type"": ""Chemical""}]"	train
E1A proteins stimulate DNA synthesis and cell proliferation; however, they also cause rapid cell death by p53 - dependent and p53 - independent apoptosis.	E1A,0,3,Gene_or_gene_product	DNA,23,26,Cellular_component	cell,41,45,Cell	cell,92,96,Cell	p53,106,109,Gene_or_gene_product	p53,126,129,Gene_or_gene_product	"[{""token"": ""E1A"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""DNA"", ""start_span"": 23, ""end_span"": 26, ""type"": ""Cellular_component""}, {""token"": ""cell"", ""start_span"": 41, ""end_span"": 45, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 92, ""end_span"": 96, ""type"": ""Cell""}, {""token"": ""p53"", ""start_span"": 106, ""end_span"": 109, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 126, ""end_span"": 129, ""type"": ""Gene_or_gene_product""}]"	train
Apoptosis is a regulated form of cell death that may be triggered by natural killer ( NK) or cytotoxic T cells, which effect target cell lysis by cytolytic effector and related proteins through complex intracellular signals.	cell,33,37,Cell	natural killer,69,83,Cell	NK,86,88,Cell	cytotoxic T cells,93,110,Cell	cell,132,136,Cell	intracellular,202,215,Immaterial_anatomical_entity	"[{""token"": ""cell"", ""start_span"": 33, ""end_span"": 37, ""type"": ""Cell""}, {""token"": ""natural killer"", ""start_span"": 69, ""end_span"": 83, ""type"": ""Cell""}, {""token"": ""NK"", ""start_span"": 86, ""end_span"": 88, ""type"": ""Cell""}, {""token"": ""cytotoxic T cells"", ""start_span"": 93, ""end_span"": 110, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 132, ""end_span"": 136, ""type"": ""Cell""}, {""token"": ""intracellular"", ""start_span"": 202, ""end_span"": 215, ""type"": ""Immaterial_anatomical_entity""}]"	train
CONCLUSION: In MEN II A patients undergoing prophylactic thyroidectomy, baseline but not stimulated calcitonin levels already correlate with the histologic tumor stage at the stage of clinically occult C - cell hyperplasia or medullary microcarcinoma.	MEN II A,15,23,Cancer	patients,24,32,Organism	calcitonin,100,110,Gene_or_gene_product	tumor,156,161,Cancer	C - cell,202,210,Cell	medullary microcarcinoma,226,250,Cancer	"[{""token"": ""MEN II A"", ""start_span"": 15, ""end_span"": 23, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 24, ""end_span"": 32, ""type"": ""Organism""}, {""token"": ""calcitonin"", ""start_span"": 100, ""end_span"": 110, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 156, ""end_span"": 161, ""type"": ""Cancer""}, {""token"": ""C - cell"", ""start_span"": 202, ""end_span"": 210, ""type"": ""Cell""}, {""token"": ""medullary microcarcinoma"", ""start_span"": 226, ""end_span"": 250, ""type"": ""Cancer""}]"	train
When a confluent monolayer of human umbilical vein endothelial cell line, ECV304, was denuded, ECV304 at the wound edge expressed Ets - 1.	monolayer,17,26,Cell	human umbilical vein endothelial cell line,30,72,Cell	ECV304,74,80,Cell	ECV304,95,101,Cell	wound edge,109,119,Pathological_formation	Ets - 1,130,137,Gene_or_gene_product	"[{""token"": ""monolayer"", ""start_span"": 17, ""end_span"": 26, ""type"": ""Cell""}, {""token"": ""human umbilical vein endothelial cell line"", ""start_span"": 30, ""end_span"": 72, ""type"": ""Cell""}, {""token"": ""ECV304"", ""start_span"": 74, ""end_span"": 80, ""type"": ""Cell""}, {""token"": ""ECV304"", ""start_span"": 95, ""end_span"": 101, ""type"": ""Cell""}, {""token"": ""wound edge"", ""start_span"": 109, ""end_span"": 119, ""type"": ""Pathological_formation""}, {""token"": ""Ets - 1"", ""start_span"": 130, ""end_span"": 137, ""type"": ""Gene_or_gene_product""}]"	train
Their resistance to the anti - invasive action of TGFbeta was explained by the failure of TGFbeta to upregulate TIMPs and PAI - I, in contrast to the TGFbeta - induced upregulation noted in parental HTR8 cells.	TGFbeta,50,57,Gene_or_gene_product	TGFbeta,90,97,Gene_or_gene_product	TIMPs,112,117,Gene_or_gene_product	PAI - I,122,129,Gene_or_gene_product	TGFbeta,150,157,Gene_or_gene_product	HTR8 cells,199,209,Cell	"[{""token"": ""TGFbeta"", ""start_span"": 50, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""TGFbeta"", ""start_span"": 90, ""end_span"": 97, ""type"": ""Gene_or_gene_product""}, {""token"": ""TIMPs"", ""start_span"": 112, ""end_span"": 117, ""type"": ""Gene_or_gene_product""}, {""token"": ""PAI - I"", ""start_span"": 122, ""end_span"": 129, ""type"": ""Gene_or_gene_product""}, {""token"": ""TGFbeta"", ""start_span"": 150, ""end_span"": 157, ""type"": ""Gene_or_gene_product""}, {""token"": ""HTR8 cells"", ""start_span"": 199, ""end_span"": 209, ""type"": ""Cell""}]"	train
Our study indicates that 1) Ca2 + entry in pulmonary endothelial cells through SOCs produces cell shape change that is dependent on site - specific rearrangement of the microfilamentous cytoskeleton and 2) Trp1 may be a component of pulmonary endothelial SOCs.	Ca2 +,28,33,Chemical	pulmonary endothelial cells,43,70,Cell	cell,93,97,Cell	microfilamentous cytoskeleton,169,198,Cellular_component	Trp1,206,210,Gene_or_gene_product	pulmonary endothelial,233,254,Cell	"[{""token"": ""Ca2 +"", ""start_span"": 28, ""end_span"": 33, ""type"": ""Chemical""}, {""token"": ""pulmonary endothelial cells"", ""start_span"": 43, ""end_span"": 70, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 93, ""end_span"": 97, ""type"": ""Cell""}, {""token"": ""microfilamentous cytoskeleton"", ""start_span"": 169, ""end_span"": 198, ""type"": ""Cellular_component""}, {""token"": ""Trp1"", ""start_span"": 206, ""end_span"": 210, ""type"": ""Gene_or_gene_product""}, {""token"": ""pulmonary endothelial"", ""start_span"": 233, ""end_span"": 254, ""type"": ""Cell""}]"	train
Tumors of the retinal pigment epithelium metastasize to inguinal lymph nodes and spleen in tyrosinase - related protein 1 / SV40 T antigen transgenic mice.	Tumors,0,6,Cancer	retinal pigment epithelium,14,40,Tissue	lymph nodes,65,76,Multi	spleen,81,87,Organ	tyrosinase - related protein 1,91,121,Gene_or_gene_product	SV40 T antigen,124,138,Gene_or_gene_product	"[{""token"": ""Tumors"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Cancer""}, {""token"": ""retinal pigment epithelium"", ""start_span"": 14, ""end_span"": 40, ""type"": ""Tissue""}, {""token"": ""lymph nodes"", ""start_span"": 65, ""end_span"": 76, ""type"": ""Multi""}, {""token"": ""spleen"", ""start_span"": 81, ""end_span"": 87, ""type"": ""Organ""}, {""token"": ""tyrosinase - related protein 1"", ""start_span"": 91, ""end_span"": 121, ""type"": ""Gene_or_gene_product""}, {""token"": ""SV40 T antigen"", ""start_span"": 124, ""end_span"": 138, ""type"": ""Gene_or_gene_product""}]"	train
In spleen, tyrosinase, TRP - 1 and SV40 Tag were expressed and tyrosinase was enzymatically active.	spleen,3,9,Organ	tyrosinase,11,21,Gene_or_gene_product	TRP - 1,23,30,Gene_or_gene_product	SV40,35,39,Organism	Tag,40,43,Gene_or_gene_product	tyrosinase,63,73,Gene_or_gene_product	"[{""token"": ""spleen"", ""start_span"": 3, ""end_span"": 9, ""type"": ""Organ""}, {""token"": ""tyrosinase"", ""start_span"": 11, ""end_span"": 21, ""type"": ""Gene_or_gene_product""}, {""token"": ""TRP - 1"", ""start_span"": 23, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""SV40"", ""start_span"": 35, ""end_span"": 39, ""type"": ""Organism""}, {""token"": ""Tag"", ""start_span"": 40, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""tyrosinase"", ""start_span"": 63, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}]"	train
In conclusion, the metastasis from TRP - 1 / Tag RPE tumors towards spleen and lymph nodes serves as potential tool to investigate biology and metastasis of tumors derived from the pigment epithelium.	TRP - 1,35,42,Gene_or_gene_product	Tag,45,48,Gene_or_gene_product	spleen,68,74,Organ	lymph nodes,79,90,Multi	tumors,157,163,Cancer	pigment epithelium,181,199,Tissue	"[{""token"": ""TRP - 1"", ""start_span"": 35, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""Tag"", ""start_span"": 45, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""spleen"", ""start_span"": 68, ""end_span"": 74, ""type"": ""Organ""}, {""token"": ""lymph nodes"", ""start_span"": 79, ""end_span"": 90, ""type"": ""Multi""}, {""token"": ""tumors"", ""start_span"": 157, ""end_span"": 163, ""type"": ""Cancer""}, {""token"": ""pigment epithelium"", ""start_span"": 181, ""end_span"": 199, ""type"": ""Tissue""}]"	train
Inhibition of NO synthase by L - NAME might induce an anti - tumour effect by limiting nutrients and oxygen to reach tumour tissue or affecting vascular growth.	NO synthase,14,25,Gene_or_gene_product	L - NAME,29,37,Chemical	tumour,61,67,Cancer	oxygen,101,107,Chemical	tumour tissue,117,130,Tissue	vascular,144,152,Multi	"[{""token"": ""NO synthase"", ""start_span"": 14, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""L - NAME"", ""start_span"": 29, ""end_span"": 37, ""type"": ""Chemical""}, {""token"": ""tumour"", ""start_span"": 61, ""end_span"": 67, ""type"": ""Cancer""}, {""token"": ""oxygen"", ""start_span"": 101, ""end_span"": 107, ""type"": ""Chemical""}, {""token"": ""tumour tissue"", ""start_span"": 117, ""end_span"": 130, ""type"": ""Tissue""}, {""token"": ""vascular"", ""start_span"": 144, ""end_span"": 152, ""type"": ""Multi""}]"	valid
In addition, although VEGF receptors were higher in tumors than normal kidney, there was a significant up - regulation of only flt - 1 ( P = 0. 003) but not KDR ( P = 0. 12) or flt - 4 ( P = 0. 09).	VEGF receptors,22,36,Gene_or_gene_product	tumors,52,58,Cancer	kidney,71,77,Organ	flt - 1,127,134,Gene_or_gene_product	KDR,157,160,Gene_or_gene_product	flt - 4,177,184,Gene_or_gene_product	"[{""token"": ""VEGF receptors"", ""start_span"": 22, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 52, ""end_span"": 58, ""type"": ""Cancer""}, {""token"": ""kidney"", ""start_span"": 71, ""end_span"": 77, ""type"": ""Organ""}, {""token"": ""flt - 1"", ""start_span"": 127, ""end_span"": 134, ""type"": ""Gene_or_gene_product""}, {""token"": ""KDR"", ""start_span"": 157, ""end_span"": 160, ""type"": ""Gene_or_gene_product""}, {""token"": ""flt - 4"", ""start_span"": 177, ""end_span"": 184, ""type"": ""Gene_or_gene_product""}]"	valid
A significant increase was observed in flt - 1 ( P less than 0. 001), KDR ( P = 0. 02), and flt - 4 ( P = 0. 01) but not VEGF - B ( P = 0. 82) or VEGF - C ( P = 0. 52) expression in clear cell compared with chromophil ( papillary) carcinomas.	flt - 1,39,46,Gene_or_gene_product	KDR,70,73,Gene_or_gene_product	flt - 4,92,99,Gene_or_gene_product	VEGF - B,121,129,Gene_or_gene_product	VEGF - C,146,154,Gene_or_gene_product	clear cell,182,192,Cell	"[{""token"": ""flt - 1"", ""start_span"": 39, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""KDR"", ""start_span"": 70, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""flt - 4"", ""start_span"": 92, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF - B"", ""start_span"": 121, ""end_span"": 129, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF - C"", ""start_span"": 146, ""end_span"": 154, ""type"": ""Gene_or_gene_product""}, {""token"": ""clear cell"", ""start_span"": 182, ""end_span"": 192, ""type"": ""Cell""}]"	valid
PURPOSE: To evaluate alterations in the retinal vasculature overlying pigment epithelial detachments ( PED) in exudative age - related macular degeneration ( ARMD) using indocyanine green and fluorescein angiography.	retinal vasculature,40,59,Multi	pigment epithelial detachments,70,100,Pathological_formation	PED,103,106,Pathological_formation	macular,135,142,Tissue	indocyanine green,170,187,Chemical	fluorescein,192,203,Chemical	"[{""token"": ""retinal vasculature"", ""start_span"": 40, ""end_span"": 59, ""type"": ""Multi""}, {""token"": ""pigment epithelial detachments"", ""start_span"": 70, ""end_span"": 100, ""type"": ""Pathological_formation""}, {""token"": ""PED"", ""start_span"": 103, ""end_span"": 106, ""type"": ""Pathological_formation""}, {""token"": ""macular"", ""start_span"": 135, ""end_span"": 142, ""type"": ""Tissue""}, {""token"": ""indocyanine green"", ""start_span"": 170, ""end_span"": 187, ""type"": ""Chemical""}, {""token"": ""fluorescein"", ""start_span"": 192, ""end_span"": 203, ""type"": ""Chemical""}]"	valid
Control RM - 9 cells and RM - 9 cells stably transfected with IL - 12 gene ( RM - 9 - IL12) were inoculated subcutaneously in 4 - to 6 - week - old male C57BL / J6 mice.	RM - 9 cells,8,20,Cell	RM - 9 cells,25,37,Cell	IL - 12,62,69,Gene_or_gene_product	IL12,86,90,Gene_or_gene_product	subcutaneously,108,122,Immaterial_anatomical_entity	C57BL / J6 mice,153,168,Organism	"[{""token"": ""RM - 9 cells"", ""start_span"": 8, ""end_span"": 20, ""type"": ""Cell""}, {""token"": ""RM - 9 cells"", ""start_span"": 25, ""end_span"": 37, ""type"": ""Cell""}, {""token"": ""IL - 12"", ""start_span"": 62, ""end_span"": 69, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL12"", ""start_span"": 86, ""end_span"": 90, ""type"": ""Gene_or_gene_product""}, {""token"": ""subcutaneously"", ""start_span"": 108, ""end_span"": 122, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""C57BL / J6 mice"", ""start_span"": 153, ""end_span"": 168, ""type"": ""Organism""}]"	valid
Adaptor protein Crk is required for ephrin - B1 - induced membrane ruffling and focal complex assembly of human aortic endothelial cells.	Crk,16,19,Gene_or_gene_product	ephrin - B1,36,47,Gene_or_gene_product	membrane,58,66,Cellular_component	focal complex,80,93,Cellular_component	human,106,111,Organism	aortic endothelial cells,112,136,Cell	"[{""token"": ""Crk"", ""start_span"": 16, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""ephrin - B1"", ""start_span"": 36, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""membrane"", ""start_span"": 58, ""end_span"": 66, ""type"": ""Cellular_component""}, {""token"": ""focal complex"", ""start_span"": 80, ""end_span"": 93, ""type"": ""Cellular_component""}, {""token"": ""human"", ""start_span"": 106, ""end_span"": 111, ""type"": ""Organism""}, {""token"": ""aortic endothelial cells"", ""start_span"": 112, ""end_span"": 136, ""type"": ""Cell""}]"	valid
We investigated the mechanism by which ephrin - B1 promotes membrane ruffling in human aortic endothelial cells, because membrane ruffling heralds cell body migration.	ephrin - B1,39,50,Gene_or_gene_product	membrane,60,68,Cellular_component	human,81,86,Organism	aortic endothelial cells,87,111,Cell	membrane,121,129,Cellular_component	cell body,147,156,Cell	"[{""token"": ""ephrin - B1"", ""start_span"": 39, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""membrane"", ""start_span"": 60, ""end_span"": 68, ""type"": ""Cellular_component""}, {""token"": ""human"", ""start_span"": 81, ""end_span"": 86, ""type"": ""Organism""}, {""token"": ""aortic endothelial cells"", ""start_span"": 87, ""end_span"": 111, ""type"": ""Cell""}, {""token"": ""membrane"", ""start_span"": 121, ""end_span"": 129, ""type"": ""Cellular_component""}, {""token"": ""cell body"", ""start_span"": 147, ""end_span"": 156, ""type"": ""Cell""}]"	valid
Serum deprivation - induced apoptosis of BHK ( + TF) cells was characterized by apoptotic blebs, nuclei with chromatin - condensed bodies, DNA degradation, and activation of caspase 3.	Serum,0,5,Organism_substance	blebs,90,95,Cellular_component	nuclei,97,103,Cellular_component	chromatin,109,118,Cellular_component	DNA,139,142,Cellular_component	caspase 3,174,183,Gene_or_gene_product	"[{""token"": ""Serum"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Organism_substance""}, {""token"": ""blebs"", ""start_span"": 90, ""end_span"": 95, ""type"": ""Cellular_component""}, {""token"": ""nuclei"", ""start_span"": 97, ""end_span"": 103, ""type"": ""Cellular_component""}, {""token"": ""chromatin"", ""start_span"": 109, ""end_span"": 118, ""type"": ""Cellular_component""}, {""token"": ""DNA"", ""start_span"": 139, ""end_span"": 142, ""type"": ""Cellular_component""}, {""token"": ""caspase 3"", ""start_span"": 174, ""end_span"": 183, ""type"": ""Gene_or_gene_product""}]"	valid
This study aimed to explore the correlation between the expression of VEGF - C in TAMs and lymphatic metastasis in human oral squamous - cell carcinoma ( OSCC).	VEGF - C,70,78,Gene_or_gene_product	TAMs,82,86,Cell	lymphatic,91,100,Organ	human,115,120,Organism	oral squamous - cell carcinoma,121,151,Cancer	OSCC,154,158,Cancer	"[{""token"": ""VEGF - C"", ""start_span"": 70, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""TAMs"", ""start_span"": 82, ""end_span"": 86, ""type"": ""Cell""}, {""token"": ""lymphatic"", ""start_span"": 91, ""end_span"": 100, ""type"": ""Organ""}, {""token"": ""human"", ""start_span"": 115, ""end_span"": 120, ""type"": ""Organism""}, {""token"": ""oral squamous - cell carcinoma"", ""start_span"": 121, ""end_span"": 151, ""type"": ""Cancer""}, {""token"": ""OSCC"", ""start_span"": 154, ""end_span"": 158, ""type"": ""Cancer""}]"	valid
An earlier study showed that thrombospondin is expressed in benign prostatic hyperplasia ( BPH) and high - grade prostatic intraepithelial neoplasia ( PIN) but is absent in prostate cancer.	thrombospondin,29,43,Gene_or_gene_product	benign prostatic hyperplasia,60,88,Pathological_formation	BPH,91,94,Pathological_formation	prostatic intraepithelial neoplasia,113,148,Pathological_formation	PIN,151,154,Pathological_formation	prostate cancer,173,188,Cancer	"[{""token"": ""thrombospondin"", ""start_span"": 29, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""benign prostatic hyperplasia"", ""start_span"": 60, ""end_span"": 88, ""type"": ""Pathological_formation""}, {""token"": ""BPH"", ""start_span"": 91, ""end_span"": 94, ""type"": ""Pathological_formation""}, {""token"": ""prostatic intraepithelial neoplasia"", ""start_span"": 113, ""end_span"": 148, ""type"": ""Pathological_formation""}, {""token"": ""PIN"", ""start_span"": 151, ""end_span"": 154, ""type"": ""Pathological_formation""}, {""token"": ""prostate cancer"", ""start_span"": 173, ""end_span"": 188, ""type"": ""Cancer""}]"	valid
These data complement work that shows that HPV16 E7 also interacts with p600, and that this interaction correlates with the ability of HPV16 E7 to transform cells.	HPV16,43,48,Organism	E7,49,51,Gene_or_gene_product	p600,72,76,Gene_or_gene_product	HPV16,135,140,Organism	E7,141,143,Gene_or_gene_product	cells,157,162,Cell	"[{""token"": ""HPV16"", ""start_span"": 43, ""end_span"": 48, ""type"": ""Organism""}, {""token"": ""E7"", ""start_span"": 49, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""p600"", ""start_span"": 72, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}, {""token"": ""HPV16"", ""start_span"": 135, ""end_span"": 140, ""type"": ""Organism""}, {""token"": ""E7"", ""start_span"": 141, ""end_span"": 143, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 157, ""end_span"": 162, ""type"": ""Cell""}]"	valid
Constitutive expression of a transfected Hox 1. 4 gene under the control of a simian virus 40 promotor leads to differentiated cell morphology similar to that of the RA - induced phenotype and restores the growth - inhibitory effects of RA in N - ras - transformed cells.	simian virus 40,78,93,Organism	cell,127,131,Cell	RA,166,168,Chemical	RA,237,239,Chemical	N - ras,243,250,Gene_or_gene_product	cells,265,270,Cell	"[{""token"": ""simian virus 40"", ""start_span"": 78, ""end_span"": 93, ""type"": ""Organism""}, {""token"": ""cell"", ""start_span"": 127, ""end_span"": 131, ""type"": ""Cell""}, {""token"": ""RA"", ""start_span"": 166, ""end_span"": 168, ""type"": ""Chemical""}, {""token"": ""RA"", ""start_span"": 237, ""end_span"": 239, ""type"": ""Chemical""}, {""token"": ""N - ras"", ""start_span"": 243, ""end_span"": 250, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 265, ""end_span"": 270, ""type"": ""Cell""}]"	valid
In vitro and in vivo studies with losartan, small interfering RNA specific for calcineurin and FK506 demonstrated that Ang II - mediated sFlt - 1 release was via Ang II type 1 receptor activation and calcineurin signaling, respectively.	losartan,34,42,Chemical	calcineurin,79,90,Gene_or_gene_product	FK506,95,100,Chemical	Ang II,119,125,Gene_or_gene_product	sFlt - 1,137,145,Gene_or_gene_product	Ang II type 1 receptor,162,184,Gene_or_gene_product	"[{""token"": ""losartan"", ""start_span"": 34, ""end_span"": 42, ""type"": ""Chemical""}, {""token"": ""calcineurin"", ""start_span"": 79, ""end_span"": 90, ""type"": ""Gene_or_gene_product""}, {""token"": ""FK506"", ""start_span"": 95, ""end_span"": 100, ""type"": ""Chemical""}, {""token"": ""Ang II"", ""start_span"": 119, ""end_span"": 125, ""type"": ""Gene_or_gene_product""}, {""token"": ""sFlt - 1"", ""start_span"": 137, ""end_span"": 145, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ang II type 1 receptor"", ""start_span"": 162, ""end_span"": 184, ""type"": ""Gene_or_gene_product""}]"	valid
In addition, magnolol activated phosphatase and tensin homolog deleted on chromosome 10 ( PTEN) and inactivated Akt by decreasing levels of phosphorylated PTEN and phosphorylated Akt.	magnolol,13,21,Chemical	phosphatase and tensin homolog deleted on chromosome 10,32,87,Gene_or_gene_product	PTEN,90,94,Gene_or_gene_product	Akt,112,115,Gene_or_gene_product	PTEN,155,159,Gene_or_gene_product	Akt,179,182,Gene_or_gene_product	"[{""token"": ""magnolol"", ""start_span"": 13, ""end_span"": 21, ""type"": ""Chemical""}, {""token"": ""phosphatase and tensin homolog deleted on chromosome 10"", ""start_span"": 32, ""end_span"": 87, ""type"": ""Gene_or_gene_product""}, {""token"": ""PTEN"", ""start_span"": 90, ""end_span"": 94, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 112, ""end_span"": 115, ""type"": ""Gene_or_gene_product""}, {""token"": ""PTEN"", ""start_span"": 155, ""end_span"": 159, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 179, ""end_span"": 182, ""type"": ""Gene_or_gene_product""}]"	valid
Furthermore, inhibition of PARP activity, but not of caspase activity, completely prevented magnolol - induced necrosis, suggesting the notion that it might be caused by depletion of intracellular ATP levels due to PARP activation.	PARP,27,31,Gene_or_gene_product	caspase,53,60,Gene_or_gene_product	magnolol,92,100,Chemical	intracellular,183,196,Immaterial_anatomical_entity	ATP,197,200,Chemical	PARP,215,219,Gene_or_gene_product	"[{""token"": ""PARP"", ""start_span"": 27, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""caspase"", ""start_span"": 53, ""end_span"": 60, ""type"": ""Gene_or_gene_product""}, {""token"": ""magnolol"", ""start_span"": 92, ""end_span"": 100, ""type"": ""Chemical""}, {""token"": ""intracellular"", ""start_span"": 183, ""end_span"": 196, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""ATP"", ""start_span"": 197, ""end_span"": 200, ""type"": ""Chemical""}, {""token"": ""PARP"", ""start_span"": 215, ""end_span"": 219, ""type"": ""Gene_or_gene_product""}]"	valid
The cell type specific glycosylation protects Sp1 and HIF1alpha from proteosome degradation and plays an important and novel role in the regulation of VEGF in DCN transfected MCE cells.	cell,4,8,Cell	Sp1,46,49,Gene_or_gene_product	HIF1alpha,54,63,Gene_or_gene_product	VEGF,151,155,Gene_or_gene_product	DCN,159,162,Gene_or_gene_product	MCE cells,175,184,Cell	"[{""token"": ""cell"", ""start_span"": 4, ""end_span"": 8, ""type"": ""Cell""}, {""token"": ""Sp1"", ""start_span"": 46, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""HIF1alpha"", ""start_span"": 54, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 151, ""end_span"": 155, ""type"": ""Gene_or_gene_product""}, {""token"": ""DCN"", ""start_span"": 159, ""end_span"": 162, ""type"": ""Gene_or_gene_product""}, {""token"": ""MCE cells"", ""start_span"": 175, ""end_span"": 184, ""type"": ""Cell""}]"	valid
In this study, we investigated the effects of spironolactone on the prevention of corneal allograft rejection in a MHC class I / II mismatch rat corneal transplant model.	spironolactone,46,60,Chemical	corneal allograft,82,99,Multi	MHC class I,115,126,Gene_or_gene_product	II,129,131,Gene_or_gene_product	rat,141,144,Organism	corneal,145,152,Multi	"[{""token"": ""spironolactone"", ""start_span"": 46, ""end_span"": 60, ""type"": ""Chemical""}, {""token"": ""corneal allograft"", ""start_span"": 82, ""end_span"": 99, ""type"": ""Multi""}, {""token"": ""MHC class I"", ""start_span"": 115, ""end_span"": 126, ""type"": ""Gene_or_gene_product""}, {""token"": ""II"", ""start_span"": 129, ""end_span"": 131, ""type"": ""Gene_or_gene_product""}, {""token"": ""rat"", ""start_span"": 141, ""end_span"": 144, ""type"": ""Organism""}, {""token"": ""corneal"", ""start_span"": 145, ""end_span"": 152, ""type"": ""Multi""}]"	valid
METHODS: Immunohistochemical staining with D2 - 40 and CD34 was performed on formalin - fixed, paraffin - embedded tissue sections of 254 invasive breast tumors of 247 patients with node negative and node positive early breast cancer.	D2 - 40,43,50,Gene_or_gene_product	CD34,55,59,Gene_or_gene_product	tissue sections,115,130,Tissue	breast tumors,147,160,Cancer	patients,168,176,Organism	breast cancer,220,233,Cancer	"[{""token"": ""D2 - 40"", ""start_span"": 43, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD34"", ""start_span"": 55, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""tissue sections"", ""start_span"": 115, ""end_span"": 130, ""type"": ""Tissue""}, {""token"": ""breast tumors"", ""start_span"": 147, ""end_span"": 160, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 168, ""end_span"": 176, ""type"": ""Organism""}, {""token"": ""breast cancer"", ""start_span"": 220, ""end_span"": 233, ""type"": ""Cancer""}]"	valid
LVI was correctly identified by D2 - 40 ( D2 - 40 +) in 70 out of 254 tumors ( 28%) as compared to 40 tumors ( 16%) by routine HE staining ( HE +).	D2 - 40,32,39,Gene_or_gene_product	D2 - 40,42,49,Gene_or_gene_product	tumors,70,76,Cancer	tumors,102,108,Cancer	HE,127,129,Chemical	HE,141,143,Chemical	"[{""token"": ""D2 - 40"", ""start_span"": 32, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""D2 - 40"", ""start_span"": 42, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 70, ""end_span"": 76, ""type"": ""Cancer""}, {""token"": ""tumors"", ""start_span"": 102, ""end_span"": 108, ""type"": ""Cancer""}, {""token"": ""HE"", ""start_span"": 127, ""end_span"": 129, ""type"": ""Chemical""}, {""token"": ""HE"", ""start_span"": 141, ""end_span"": 143, ""type"": ""Chemical""}]"	valid
We conditionally activated N - myc in SH - EP neuroblastoma cells subjected to the trophic stress of serum or nutrient deprivation while changing the expression of Bcl - 2, survivin and FLIP ( L), antiapoptotic molecules often overexpressed in poor prognosis neuroblastomas.	N - myc,27,34,Gene_or_gene_product	SH - EP neuroblastoma cells,38,65,Cell	serum,101,106,Organism_substance	Bcl - 2,164,171,Gene_or_gene_product	survivin,173,181,Gene_or_gene_product	neuroblastomas,259,273,Cancer	"[{""token"": ""N - myc"", ""start_span"": 27, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""SH - EP neuroblastoma cells"", ""start_span"": 38, ""end_span"": 65, ""type"": ""Cell""}, {""token"": ""serum"", ""start_span"": 101, ""end_span"": 106, ""type"": ""Organism_substance""}, {""token"": ""Bcl - 2"", ""start_span"": 164, ""end_span"": 171, ""type"": ""Gene_or_gene_product""}, {""token"": ""survivin"", ""start_span"": 173, ""end_span"": 181, ""type"": ""Gene_or_gene_product""}, {""token"": ""neuroblastomas"", ""start_span"": 259, ""end_span"": 273, ""type"": ""Cancer""}]"	valid
Endosialin / TEM 1 / CD248 is a pericyte marker of embryonic and tumor neovascularization.	Endosialin,0,10,Gene_or_gene_product	TEM 1,13,18,Gene_or_gene_product	CD248,21,26,Gene_or_gene_product	pericyte,32,40,Cell	embryonic,51,60,Developing_anatomical_structure	tumor,65,70,Cancer	"[{""token"": ""Endosialin"", ""start_span"": 0, ""end_span"": 10, ""type"": ""Gene_or_gene_product""}, {""token"": ""TEM 1"", ""start_span"": 13, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD248"", ""start_span"": 21, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""pericyte"", ""start_span"": 32, ""end_span"": 40, ""type"": ""Cell""}, {""token"": ""embryonic"", ""start_span"": 51, ""end_span"": 60, ""type"": ""Developing_anatomical_structure""}, {""token"": ""tumor"", ""start_span"": 65, ""end_span"": 70, ""type"": ""Cancer""}]"	valid
OBJECTIVE: We transfected ovarian cancer cells and administered recombinant plasmid encoding hPNAS - 4 to nude mice bearing ovarian cancer, aiming to evaluate the effect of hPNAS - 4 against ovarian cancer in vitro and in vivo.	ovarian cancer cells,26,46,Cell	hPNAS - 4,93,102,Gene_or_gene_product	nude mice,106,115,Organism	ovarian cancer,124,138,Cancer	hPNAS - 4,173,182,Gene_or_gene_product	ovarian cancer,191,205,Cancer	"[{""token"": ""ovarian cancer cells"", ""start_span"": 26, ""end_span"": 46, ""type"": ""Cell""}, {""token"": ""hPNAS - 4"", ""start_span"": 93, ""end_span"": 102, ""type"": ""Gene_or_gene_product""}, {""token"": ""nude mice"", ""start_span"": 106, ""end_span"": 115, ""type"": ""Organism""}, {""token"": ""ovarian cancer"", ""start_span"": 124, ""end_span"": 138, ""type"": ""Cancer""}, {""token"": ""hPNAS - 4"", ""start_span"": 173, ""end_span"": 182, ""type"": ""Gene_or_gene_product""}, {""token"": ""ovarian cancer"", ""start_span"": 191, ""end_span"": 205, ""type"": ""Cancer""}]"	valid
The present findings indicate that vandetanib therapy effectively counteracted the aggressive feature of tumor growth resulting from VEGF over - expressing tumor cells and suggest that such tumors may be particularly well suited for anti - VEGF interventions.	vandetanib,35,45,Chemical	tumor,105,110,Cancer	VEGF,133,137,Gene_or_gene_product	tumor cells,156,167,Cell	tumors,190,196,Cancer	VEGF,240,244,Gene_or_gene_product	"[{""token"": ""vandetanib"", ""start_span"": 35, ""end_span"": 45, ""type"": ""Chemical""}, {""token"": ""tumor"", ""start_span"": 105, ""end_span"": 110, ""type"": ""Cancer""}, {""token"": ""VEGF"", ""start_span"": 133, ""end_span"": 137, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor cells"", ""start_span"": 156, ""end_span"": 167, ""type"": ""Cell""}, {""token"": ""tumors"", ""start_span"": 190, ""end_span"": 196, ""type"": ""Cancer""}, {""token"": ""VEGF"", ""start_span"": 240, ""end_span"": 244, ""type"": ""Gene_or_gene_product""}]"	valid
Induction of TSP - 1 mRNA by TGF - beta was attenuated by c - Ski in vitro, and expression of TSP - 1 mRNA was decreased in tumors expressing c - Ski in vivo.	TSP - 1,13,20,Gene_or_gene_product	TGF - beta,29,39,Gene_or_gene_product	c - Ski,58,65,Gene_or_gene_product	TSP - 1,94,101,Gene_or_gene_product	tumors,124,130,Cancer	c - Ski,142,149,Gene_or_gene_product	"[{""token"": ""TSP - 1"", ""start_span"": 13, ""end_span"": 20, ""type"": ""Gene_or_gene_product""}, {""token"": ""TGF - beta"", ""start_span"": 29, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - Ski"", ""start_span"": 58, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""TSP - 1"", ""start_span"": 94, ""end_span"": 101, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 124, ""end_span"": 130, ""type"": ""Cancer""}, {""token"": ""c - Ski"", ""start_span"": 142, ""end_span"": 149, ""type"": ""Gene_or_gene_product""}]"	valid
Down syndrome critical region gene 1 ( DSCR - 1) short variant ( DSCR - 1s) is an inhibitor of calcineurin / NFAT signaling encoded by exons 4 - 7 of DSCR1.	Down syndrome critical region gene 1,0,36,Gene_or_gene_product	DSCR - 1,39,47,Gene_or_gene_product	DSCR - 1s,65,74,Gene_or_gene_product	calcineurin,95,106,Gene_or_gene_product	NFAT,109,113,Gene_or_gene_product	DSCR1,150,155,Gene_or_gene_product	"[{""token"": ""Down syndrome critical region gene 1"", ""start_span"": 0, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""DSCR - 1"", ""start_span"": 39, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""DSCR - 1s"", ""start_span"": 65, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""calcineurin"", ""start_span"": 95, ""end_span"": 106, ""type"": ""Gene_or_gene_product""}, {""token"": ""NFAT"", ""start_span"": 109, ""end_span"": 113, ""type"": ""Gene_or_gene_product""}, {""token"": ""DSCR1"", ""start_span"": 150, ""end_span"": 155, ""type"": ""Gene_or_gene_product""}]"	valid
In a mouse model of endotoxemia, DSCR - 1s - deficient mice demonstrated increased sepsis mortality, whereas adenovirus - mediated DSCR - 1s overexpression protected against LPS - induced lethality.	mouse,5,10,Organism	DSCR - 1s,33,42,Gene_or_gene_product	mice,55,59,Organism	adenovirus,109,119,Organism	DSCR - 1s,131,140,Gene_or_gene_product	LPS,174,177,Chemical	"[{""token"": ""mouse"", ""start_span"": 5, ""end_span"": 10, ""type"": ""Organism""}, {""token"": ""DSCR - 1s"", ""start_span"": 33, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""mice"", ""start_span"": 55, ""end_span"": 59, ""type"": ""Organism""}, {""token"": ""adenovirus"", ""start_span"": 109, ""end_span"": 119, ""type"": ""Organism""}, {""token"": ""DSCR - 1s"", ""start_span"": 131, ""end_span"": 140, ""type"": ""Gene_or_gene_product""}, {""token"": ""LPS"", ""start_span"": 174, ""end_span"": 177, ""type"": ""Chemical""}]"	valid
Via this binding, nicked beta2GPI attenuates the antiangiogenic functions of AS4. 5 in the proliferation of arterial / venous endothelial cells, in the extracellular matrix invasion and the tube formation of venous endothelial cells, and in vivo angiogenesis.	nicked beta2GPI,18,33,Gene_or_gene_product	arterial,108,116,Cell	venous endothelial cells,119,143,Cell	extracellular matrix,152,172,Cellular_component	tube,190,194,Tissue	venous endothelial cells,208,232,Cell	"[{""token"": ""nicked beta2GPI"", ""start_span"": 18, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""arterial"", ""start_span"": 108, ""end_span"": 116, ""type"": ""Cell""}, {""token"": ""venous endothelial cells"", ""start_span"": 119, ""end_span"": 143, ""type"": ""Cell""}, {""token"": ""extracellular matrix"", ""start_span"": 152, ""end_span"": 172, ""type"": ""Cellular_component""}, {""token"": ""tube"", ""start_span"": 190, ""end_span"": 194, ""type"": ""Tissue""}, {""token"": ""venous endothelial cells"", ""start_span"": 208, ""end_span"": 232, ""type"": ""Cell""}]"	valid
Our previous studies have shown that the neurotransmitter dopamine could inhibit VEGF - induced phosphorylation of VEGF receptor 2 ( VEGFR - 2), endothelial cell proliferation, migration, microvascular permeability, and thus, angiogenesis.	dopamine,58,66,Chemical	VEGF,81,85,Gene_or_gene_product	VEGF receptor 2,115,130,Gene_or_gene_product	VEGFR - 2,133,142,Gene_or_gene_product	endothelial cell,145,161,Cell	microvascular,188,201,Tissue	"[{""token"": ""dopamine"", ""start_span"": 58, ""end_span"": 66, ""type"": ""Chemical""}, {""token"": ""VEGF"", ""start_span"": 81, ""end_span"": 85, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF receptor 2"", ""start_span"": 115, ""end_span"": 130, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGFR - 2"", ""start_span"": 133, ""end_span"": 142, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cell"", ""start_span"": 145, ""end_span"": 161, ""type"": ""Cell""}, {""token"": ""microvascular"", ""start_span"": 188, ""end_span"": 201, ""type"": ""Tissue""}]"	valid
In this study we separated weakly acidic phenolic components from other neutral, acidic and basic components of tobacco smoke condensate ( TSC) and observed that phenolic fraction of TSC significantly increased the number of colonies of promotion - sensitive JB6 Cl41 cells that showed anchorage - independent growth on soft agar in response to BPDE ( an ultimate carcinogen produced by metabolic activation of the PAH benzo [ a] pyrene).	tobacco smoke condensate,112,136,Chemical	TSC,139,142,Chemical	phenolic fraction,162,179,Chemical	TSC,183,186,Chemical	JB6 Cl41 cells,259,273,Cell	BPDE,345,349,Chemical	"[{""token"": ""tobacco smoke condensate"", ""start_span"": 112, ""end_span"": 136, ""type"": ""Chemical""}, {""token"": ""TSC"", ""start_span"": 139, ""end_span"": 142, ""type"": ""Chemical""}, {""token"": ""phenolic fraction"", ""start_span"": 162, ""end_span"": 179, ""type"": ""Chemical""}, {""token"": ""TSC"", ""start_span"": 183, ""end_span"": 186, ""type"": ""Chemical""}, {""token"": ""JB6 Cl41 cells"", ""start_span"": 259, ""end_span"": 273, ""type"": ""Cell""}, {""token"": ""BPDE"", ""start_span"": 345, ""end_span"": 349, ""type"": ""Chemical""}]"	valid
In order to understand the underlying mechanism by which TSC phenolic fraction potentiates BPDE - induced tumorigenicity, we examined its effect on the activation of two transcription factors AP - 1 and NF - kappaB which are known to be influenced by established tumor promoter TPA.	TSC phenolic fraction,57,78,Chemical	BPDE,91,95,Chemical	AP - 1,192,198,Gene_or_gene_product	NF - kappaB,203,214,Gene_or_gene_product	tumor,263,268,Cancer	TPA,278,281,Chemical	"[{""token"": ""TSC phenolic fraction"", ""start_span"": 57, ""end_span"": 78, ""type"": ""Chemical""}, {""token"": ""BPDE"", ""start_span"": 91, ""end_span"": 95, ""type"": ""Chemical""}, {""token"": ""AP - 1"", ""start_span"": 192, ""end_span"": 198, ""type"": ""Gene_or_gene_product""}, {""token"": ""NF - kappaB"", ""start_span"": 203, ""end_span"": 214, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 263, ""end_span"": 268, ""type"": ""Cancer""}, {""token"": ""TPA"", ""start_span"": 278, ""end_span"": 281, ""type"": ""Chemical""}]"	valid
Attenuation of NF - kappaB activation by TSC phenolic fraction was associated with significant decrease of intracellular PKC substrate phosphorylation in BPDE treated cells.	NF - kappaB,15,26,Gene_or_gene_product	TSC phenolic fraction,41,62,Chemical	intracellular,107,120,Immaterial_anatomical_entity	PKC,121,124,Gene_or_gene_product	BPDE,154,158,Chemical	cells,167,172,Cell	"[{""token"": ""NF - kappaB"", ""start_span"": 15, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""TSC phenolic fraction"", ""start_span"": 41, ""end_span"": 62, ""type"": ""Chemical""}, {""token"": ""intracellular"", ""start_span"": 107, ""end_span"": 120, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""PKC"", ""start_span"": 121, ""end_span"": 124, ""type"": ""Gene_or_gene_product""}, {""token"": ""BPDE"", ""start_span"": 154, ""end_span"": 158, ""type"": ""Chemical""}, {""token"": ""cells"", ""start_span"": 167, ""end_span"": 172, ""type"": ""Cell""}]"	valid
However, although beta ( 2) M and MHC class I are expressed on normal hematopoietic cells, which is a potential safety concern, the monoclonal antibodies were selective to tumor cells and did not damage normal cells in vitro or in human - like mouse models.	MHC class I,34,45,Gene_or_gene_product	hematopoietic cells,70,89,Cell	tumor cells,172,183,Cell	cells,210,215,Cell	human,231,236,Organism	mouse,244,249,Organism	"[{""token"": ""MHC class I"", ""start_span"": 34, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""hematopoietic cells"", ""start_span"": 70, ""end_span"": 89, ""type"": ""Cell""}, {""token"": ""tumor cells"", ""start_span"": 172, ""end_span"": 183, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 210, ""end_span"": 215, ""type"": ""Cell""}, {""token"": ""human"", ""start_span"": 231, ""end_span"": 236, ""type"": ""Organism""}, {""token"": ""mouse"", ""start_span"": 244, ""end_span"": 249, ""type"": ""Organism""}]"	valid
Mutations in colonic adenomas, and the frequent losses on 4q described in gastric cancer prompt speculation about the role of CDC4 / FBXW7 in gastric carcinogenesis.	colonic adenomas,13,29,Cancer	4q,58,60,Cellular_component	gastric cancer,74,88,Cancer	CDC4,126,130,Gene_or_gene_product	FBXW7,133,138,Gene_or_gene_product	gastric,142,149,Organ	"[{""token"": ""colonic adenomas"", ""start_span"": 13, ""end_span"": 29, ""type"": ""Cancer""}, {""token"": ""4q"", ""start_span"": 58, ""end_span"": 60, ""type"": ""Cellular_component""}, {""token"": ""gastric cancer"", ""start_span"": 74, ""end_span"": 88, ""type"": ""Cancer""}, {""token"": ""CDC4"", ""start_span"": 126, ""end_span"": 130, ""type"": ""Gene_or_gene_product""}, {""token"": ""FBXW7"", ""start_span"": 133, ""end_span"": 138, ""type"": ""Gene_or_gene_product""}, {""token"": ""gastric"", ""start_span"": 142, ""end_span"": 149, ""type"": ""Organ""}]"	valid
In addition, our in vivo studies indicated that the lenti - BI - 1 - infected cells formed obvious tumours, while no tumours were formed by the control cells after subcutaneously injected into nude mice.	BI - 1,60,66,Gene_or_gene_product	cells,78,83,Cell	tumours,99,106,Cancer	tumours,117,124,Cancer	control cells,144,157,Cell	nude mice,193,202,Organism	"[{""token"": ""BI - 1"", ""start_span"": 60, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 78, ""end_span"": 83, ""type"": ""Cell""}, {""token"": ""tumours"", ""start_span"": 99, ""end_span"": 106, ""type"": ""Cancer""}, {""token"": ""tumours"", ""start_span"": 117, ""end_span"": 124, ""type"": ""Cancer""}, {""token"": ""control cells"", ""start_span"": 144, ""end_span"": 157, ""type"": ""Cell""}, {""token"": ""nude mice"", ""start_span"": 193, ""end_span"": 202, ""type"": ""Organism""}]"	valid
Anti - metastasis effects of gallic acid on gastric cancer cells involves inhibition of NF - kappaB activity and downregulation of PI3K / AKT / small GTPase signals.	gallic acid,29,40,Chemical	gastric cancer cells,44,64,Cell	NF - kappaB,88,99,Gene_or_gene_product	PI3K,131,135,Gene_or_gene_product	AKT,138,141,Gene_or_gene_product	small GTPase,144,156,Gene_or_gene_product	"[{""token"": ""gallic acid"", ""start_span"": 29, ""end_span"": 40, ""type"": ""Chemical""}, {""token"": ""gastric cancer cells"", ""start_span"": 44, ""end_span"": 64, ""type"": ""Cell""}, {""token"": ""NF - kappaB"", ""start_span"": 88, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}, {""token"": ""PI3K"", ""start_span"": 131, ""end_span"": 135, ""type"": ""Gene_or_gene_product""}, {""token"": ""AKT"", ""start_span"": 138, ""end_span"": 141, ""type"": ""Gene_or_gene_product""}, {""token"": ""small GTPase"", ""start_span"": 144, ""end_span"": 156, ""type"": ""Gene_or_gene_product""}]"	valid
In the current investigation, we show that p - XSC, but not an equivalent dose of SM, alters molecular targets and induces apoptosis in androgen - responsive LNCaP and androgen - independent LNCaP C4 - 2 human prostate cancer cells.	p - XSC,43,50,Chemical	SM,82,84,Chemical	androgen,136,144,Chemical	LNCaP,158,163,Cell	androgen,168,176,Chemical	LNCaP C4 - 2 human prostate cancer cells,191,231,Cell	"[{""token"": ""p - XSC"", ""start_span"": 43, ""end_span"": 50, ""type"": ""Chemical""}, {""token"": ""SM"", ""start_span"": 82, ""end_span"": 84, ""type"": ""Chemical""}, {""token"": ""androgen"", ""start_span"": 136, ""end_span"": 144, ""type"": ""Chemical""}, {""token"": ""LNCaP"", ""start_span"": 158, ""end_span"": 163, ""type"": ""Cell""}, {""token"": ""androgen"", ""start_span"": 168, ""end_span"": 176, ""type"": ""Chemical""}, {""token"": ""LNCaP C4 - 2 human prostate cancer cells"", ""start_span"": 191, ""end_span"": 231, ""type"": ""Cell""}]"	valid
The present study revealed that androgen increases glucose utilization for de novo lipogenesis in LNCaP cells through the activation of HK2 ( hexokinase 2) and activation of the cardiac isoform of PFKFB2 ( 6 - phosphofructo - 2 - kinase / fructose - 2, 6 - bisphosphatase).	androgen,32,40,Chemical	glucose,51,58,Chemical	LNCaP cells,98,109,Cell	HK2,136,139,Gene_or_gene_product	cardiac,178,185,Organ	PFKFB2,197,203,Gene_or_gene_product	"[{""token"": ""androgen"", ""start_span"": 32, ""end_span"": 40, ""type"": ""Chemical""}, {""token"": ""glucose"", ""start_span"": 51, ""end_span"": 58, ""type"": ""Chemical""}, {""token"": ""LNCaP cells"", ""start_span"": 98, ""end_span"": 109, ""type"": ""Cell""}, {""token"": ""HK2"", ""start_span"": 136, ""end_span"": 139, ""type"": ""Gene_or_gene_product""}, {""token"": ""cardiac"", ""start_span"": 178, ""end_span"": 185, ""type"": ""Organ""}, {""token"": ""PFKFB2"", ""start_span"": 197, ""end_span"": 203, ""type"": ""Gene_or_gene_product""}]"	valid
Activation of PKA ( cAMP - dependent protein kinase) by androgen increased phosphorylation of CREB [ CRE ( cAMP - response element) - binding protein], which in turn bound to CRE on the promoter of the HK2 gene resulting in transcriptional activation of the HK2 gene.	PKA,14,17,Gene_or_gene_product	cAMP - dependent protein kinase,20,51,Gene_or_gene_product	androgen,56,64,Chemical	CREB,94,98,Gene_or_gene_product	HK2,202,205,Gene_or_gene_product	HK2,258,261,Gene_or_gene_product	"[{""token"": ""PKA"", ""start_span"": 14, ""end_span"": 17, ""type"": ""Gene_or_gene_product""}, {""token"": ""cAMP - dependent protein kinase"", ""start_span"": 20, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""androgen"", ""start_span"": 56, ""end_span"": 64, ""type"": ""Chemical""}, {""token"": ""CREB"", ""start_span"": 94, ""end_span"": 98, ""type"": ""Gene_or_gene_product""}, {""token"": ""HK2"", ""start_span"": 202, ""end_span"": 205, ""type"": ""Gene_or_gene_product""}, {""token"": ""HK2"", ""start_span"": 258, ""end_span"": 261, ""type"": ""Gene_or_gene_product""}]"	valid
Diallyl trisulfide ( DATS) inhibits mouse colon tumor in mouse CT - 26 cells allograft model in vivo.	Diallyl trisulfide,0,18,Chemical	DATS,21,25,Chemical	mouse,36,41,Organism	colon tumor,42,53,Cancer	mouse,57,62,Organism	CT - 26 cells,63,76,Cell	"[{""token"": ""Diallyl trisulfide"", ""start_span"": 0, ""end_span"": 18, ""type"": ""Chemical""}, {""token"": ""DATS"", ""start_span"": 21, ""end_span"": 25, ""type"": ""Chemical""}, {""token"": ""mouse"", ""start_span"": 36, ""end_span"": 41, ""type"": ""Organism""}, {""token"": ""colon tumor"", ""start_span"": 42, ""end_span"": 53, ""type"": ""Cancer""}, {""token"": ""mouse"", ""start_span"": 57, ""end_span"": 62, ""type"": ""Organism""}, {""token"": ""CT - 26 cells"", ""start_span"": 63, ""end_span"": 76, ""type"": ""Cell""}]"	valid
Our study reveals a novel link between HMGA2 and the regulation of human telomerase reverse transcriptase ( hTERT), the catalytic subunit of telomerase, which offers critical insight into how HMGA2 contributes to tumorigenesis.	HMGA2,39,44,Gene_or_gene_product	human,67,72,Organism	telomerase reverse transcriptase,73,105,Gene_or_gene_product	hTERT,108,113,Gene_or_gene_product	telomerase,141,151,Gene_or_gene_product	HMGA2,192,197,Gene_or_gene_product	"[{""token"": ""HMGA2"", ""start_span"": 39, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 67, ""end_span"": 72, ""type"": ""Organism""}, {""token"": ""telomerase reverse transcriptase"", ""start_span"": 73, ""end_span"": 105, ""type"": ""Gene_or_gene_product""}, {""token"": ""hTERT"", ""start_span"": 108, ""end_span"": 113, ""type"": ""Gene_or_gene_product""}, {""token"": ""telomerase"", ""start_span"": 141, ""end_span"": 151, ""type"": ""Gene_or_gene_product""}, {""token"": ""HMGA2"", ""start_span"": 192, ""end_span"": 197, ""type"": ""Gene_or_gene_product""}]"	valid
Treatment with suberoylanilide hydroxamide ( SAHA), a histone deacetylase ( HDAC) inhibitor, causes dose - dependent hTERT reporter activation, mimicking HMGA2 overexpression.	suberoylanilide hydroxamide,15,42,Chemical	SAHA,45,49,Chemical	histone deacetylase,54,73,Gene_or_gene_product	HDAC,76,80,Gene_or_gene_product	hTERT,117,122,Gene_or_gene_product	HMGA2,154,159,Gene_or_gene_product	"[{""token"": ""suberoylanilide hydroxamide"", ""start_span"": 15, ""end_span"": 42, ""type"": ""Chemical""}, {""token"": ""SAHA"", ""start_span"": 45, ""end_span"": 49, ""type"": ""Chemical""}, {""token"": ""histone deacetylase"", ""start_span"": 54, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""HDAC"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""hTERT"", ""start_span"": 117, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}, {""token"": ""HMGA2"", ""start_span"": 154, ""end_span"": 159, ""type"": ""Gene_or_gene_product""}]"	valid
We examined the paired tumour and normal - tissue specimens of 86 CRC patients for the occurrence of aberrations in the mutation cluster region ( MCR) of the APC gene and exon 3 of the beta - catenin gene by polymerase chain reaction - single - strand conformation polymorphism ( PCR - SSCP) and / or PCR - direct sequencing.	tumour,23,29,Cancer	tissue specimens,43,59,Tissue	CRC,66,69,Cancer	patients,70,78,Organism	APC,158,161,Gene_or_gene_product	beta - catenin,185,199,Gene_or_gene_product	"[{""token"": ""tumour"", ""start_span"": 23, ""end_span"": 29, ""type"": ""Cancer""}, {""token"": ""tissue specimens"", ""start_span"": 43, ""end_span"": 59, ""type"": ""Tissue""}, {""token"": ""CRC"", ""start_span"": 66, ""end_span"": 69, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 70, ""end_span"": 78, ""type"": ""Organism""}, {""token"": ""APC"", ""start_span"": 158, ""end_span"": 161, ""type"": ""Gene_or_gene_product""}, {""token"": ""beta - catenin"", ""start_span"": 185, ""end_span"": 199, ""type"": ""Gene_or_gene_product""}]"	valid
Although the number of mutations in the APC and beta - catenin genes in our CRC cases was very low, the study confirms the role of epigenetic gene silencing of the pivotal molecular gladiator, APC, of the Wnt pathway in the development of CRC in the Kashmiri population.	APC,40,43,Gene_or_gene_product	beta - catenin,48,62,Gene_or_gene_product	CRC,76,79,Cancer	APC,193,196,Gene_or_gene_product	Wnt,205,208,Gene_or_gene_product	CRC,239,242,Cancer	"[{""token"": ""APC"", ""start_span"": 40, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""beta - catenin"", ""start_span"": 48, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""CRC"", ""start_span"": 76, ""end_span"": 79, ""type"": ""Cancer""}, {""token"": ""APC"", ""start_span"": 193, ""end_span"": 196, ""type"": ""Gene_or_gene_product""}, {""token"": ""Wnt"", ""start_span"": 205, ""end_span"": 208, ""type"": ""Gene_or_gene_product""}, {""token"": ""CRC"", ""start_span"": 239, ""end_span"": 242, ""type"": ""Cancer""}]"	valid
In addition, AglRhz induced activation of caspase - 3 and poly ( ADP - ribose) polymerase ( PARP), and DNA fragmentation in HT - 29 cells, leads to induction of apoptosis as well as suppression of tumorigenicity of HT - 29 cells.	AglRhz,13,19,Chemical	caspase - 3,42,53,Gene_or_gene_product	PARP,92,96,Gene_or_gene_product	DNA,103,106,Cellular_component	HT - 29 cells,124,137,Cell	HT - 29 cells,215,228,Cell	"[{""token"": ""AglRhz"", ""start_span"": 13, ""end_span"": 19, ""type"": ""Chemical""}, {""token"": ""caspase - 3"", ""start_span"": 42, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""PARP"", ""start_span"": 92, ""end_span"": 96, ""type"": ""Gene_or_gene_product""}, {""token"": ""DNA"", ""start_span"": 103, ""end_span"": 106, ""type"": ""Cellular_component""}, {""token"": ""HT - 29 cells"", ""start_span"": 124, ""end_span"": 137, ""type"": ""Cell""}, {""token"": ""HT - 29 cells"", ""start_span"": 215, ""end_span"": 228, ""type"": ""Cell""}]"	valid
Surgical specimens from 20 cases of OSCC with lymph node metastasis, 20 cases of OSCC without lymph node metastasis, and 10 cases of normal mucosa were examined by immunohistochemistry.	specimens,9,18,Multi	OSCC,36,40,Cancer	lymph node,46,56,Multi	OSCC,81,85,Cancer	lymph node,94,104,Multi	mucosa,140,146,Multi	"[{""token"": ""specimens"", ""start_span"": 9, ""end_span"": 18, ""type"": ""Multi""}, {""token"": ""OSCC"", ""start_span"": 36, ""end_span"": 40, ""type"": ""Cancer""}, {""token"": ""lymph node"", ""start_span"": 46, ""end_span"": 56, ""type"": ""Multi""}, {""token"": ""OSCC"", ""start_span"": 81, ""end_span"": 85, ""type"": ""Cancer""}, {""token"": ""lymph node"", ""start_span"": 94, ""end_span"": 104, ""type"": ""Multi""}, {""token"": ""mucosa"", ""start_span"": 140, ""end_span"": 146, ""type"": ""Multi""}]"	valid
Here we characterized the effects of mutant CK1delta variants with impaired kinase activity on SV40 - induced cell transformation in vitro, and on SV40 - induced mammary carcinogenesis in vivo in a transgenic / bi - transgenic mouse model.	CK1delta,44,52,Gene_or_gene_product	SV40,95,99,Organism	cell,110,114,Cell	SV40,147,151,Organism	mammary,162,169,Organ	transgenic / bi - transgenic mouse,198,232,Organism	"[{""token"": ""CK1delta"", ""start_span"": 44, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""SV40"", ""start_span"": 95, ""end_span"": 99, ""type"": ""Organism""}, {""token"": ""cell"", ""start_span"": 110, ""end_span"": 114, ""type"": ""Cell""}, {""token"": ""SV40"", ""start_span"": 147, ""end_span"": 151, ""type"": ""Organism""}, {""token"": ""mammary"", ""start_span"": 162, ""end_span"": 169, ""type"": ""Organ""}, {""token"": ""transgenic / bi - transgenic mouse"", ""start_span"": 198, ""end_span"": 232, ""type"": ""Organism""}]"	valid
Both WAP - T mice as well as WAP - mutCK1delta / WAP - T bi - transgenic mice developed breast cancer.	WAP - T,5,12,Gene_or_gene_product	mice,13,17,Organism	WAP,29,32,Gene_or_gene_product	mutCK1delta,35,46,Gene_or_gene_product	WAP - T,49,56,Gene_or_gene_product	breast cancer,88,101,Cancer	"[{""token"": ""WAP - T"", ""start_span"": 5, ""end_span"": 12, ""type"": ""Gene_or_gene_product""}, {""token"": ""mice"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Organism""}, {""token"": ""WAP"", ""start_span"": 29, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""mutCK1delta"", ""start_span"": 35, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""WAP - T"", ""start_span"": 49, ""end_span"": 56, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast cancer"", ""start_span"": 88, ""end_span"": 101, ""type"": ""Cancer""}]"	valid
Thirty uterine cervix specimens sampled following conization or total hysterectomy were studied using histology, histoenzymology ( vessel phosphatase alkaline activity), and immunohistochemistry ( demonstration of laminin and type IV collagen in epithelium and vessel basement membranes).	uterine cervix specimens,7,31,Multi	vessel,131,137,Multi	laminin,214,221,Gene_or_gene_product	type IV collagen,226,242,Gene_or_gene_product	epithelium,246,256,Tissue	vessel basement membranes,261,286,Cellular_component	"[{""token"": ""uterine cervix specimens"", ""start_span"": 7, ""end_span"": 31, ""type"": ""Multi""}, {""token"": ""vessel"", ""start_span"": 131, ""end_span"": 137, ""type"": ""Multi""}, {""token"": ""laminin"", ""start_span"": 214, ""end_span"": 221, ""type"": ""Gene_or_gene_product""}, {""token"": ""type IV collagen"", ""start_span"": 226, ""end_span"": 242, ""type"": ""Gene_or_gene_product""}, {""token"": ""epithelium"", ""start_span"": 246, ""end_span"": 256, ""type"": ""Tissue""}, {""token"": ""vessel basement membranes"", ""start_span"": 261, ""end_span"": 286, ""type"": ""Cellular_component""}]"	valid
Our current data suggest that gamma rays worked as an initiator of carcinogenesis in normal human cells, giving rise to chromosome aberrations and immortality, and the Ha - ras oncogene played a role in the progression of the immortally transformed cell population to a neoplastic one showing enhanced colony formation in soft agar and tumorigenicity in nude mice.	human,92,97,Organism	cells,98,103,Cell	chromosome,120,130,Cellular_component	Ha - ras,168,176,Gene_or_gene_product	cell,249,253,Cell	nude mice,354,363,Organism	"[{""token"": ""human"", ""start_span"": 92, ""end_span"": 97, ""type"": ""Organism""}, {""token"": ""cells"", ""start_span"": 98, ""end_span"": 103, ""type"": ""Cell""}, {""token"": ""chromosome"", ""start_span"": 120, ""end_span"": 130, ""type"": ""Cellular_component""}, {""token"": ""Ha - ras"", ""start_span"": 168, ""end_span"": 176, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 249, ""end_span"": 253, ""type"": ""Cell""}, {""token"": ""nude mice"", ""start_span"": 354, ""end_span"": 363, ""type"": ""Organism""}]"	valid
The proliferative response of bovine retinal capillary endothelial cells to EGF is dependent upon attaching the cells to a matrix of fibronectin.	bovine,30,36,Organism	retinal capillary endothelial cells,37,72,Cell	EGF,76,79,Gene_or_gene_product	cells,112,117,Cell	matrix,123,129,Cellular_component	fibronectin,133,144,Gene_or_gene_product	"[{""token"": ""bovine"", ""start_span"": 30, ""end_span"": 36, ""type"": ""Organism""}, {""token"": ""retinal capillary endothelial cells"", ""start_span"": 37, ""end_span"": 72, ""type"": ""Cell""}, {""token"": ""EGF"", ""start_span"": 76, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 112, ""end_span"": 117, ""type"": ""Cell""}, {""token"": ""matrix"", ""start_span"": 123, ""end_span"": 129, ""type"": ""Cellular_component""}, {""token"": ""fibronectin"", ""start_span"": 133, ""end_span"": 144, ""type"": ""Gene_or_gene_product""}]"	valid
Each consists of repetitive cycles of interaction with adjacent extracellular matrix components by mediating cellular adhesion, matrix dissolution, and cellular motility to achieve metastasis of cancer cells or neovascularization of tumors.	extracellular matrix components,64,95,Cellular_component	cellular,109,117,Cell	matrix,128,134,Cellular_component	cellular,152,160,Cell	cancer cells,195,207,Cell	tumors,233,239,Cancer	"[{""token"": ""extracellular matrix components"", ""start_span"": 64, ""end_span"": 95, ""type"": ""Cellular_component""}, {""token"": ""cellular"", ""start_span"": 109, ""end_span"": 117, ""type"": ""Cell""}, {""token"": ""matrix"", ""start_span"": 128, ""end_span"": 134, ""type"": ""Cellular_component""}, {""token"": ""cellular"", ""start_span"": 152, ""end_span"": 160, ""type"": ""Cell""}, {""token"": ""cancer cells"", ""start_span"": 195, ""end_span"": 207, ""type"": ""Cell""}, {""token"": ""tumors"", ""start_span"": 233, ""end_span"": 239, ""type"": ""Cancer""}]"	valid
Emodin, at a 40 - microM concentration, which repressed tyrosine kinase of p185neu, efficiently inhibited both anchorage - dependent and anchorage - independent growth of HER - 2 / neu - overexpressing breast cancer cells.	Emodin,0,6,Chemical	tyrosine,56,64,Amino_acid	p185neu,75,82,Gene_or_gene_product	HER - 2,171,178,Gene_or_gene_product	neu,181,184,Gene_or_gene_product	breast cancer cells,202,221,Cell	"[{""token"": ""Emodin"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Chemical""}, {""token"": ""tyrosine"", ""start_span"": 56, ""end_span"": 64, ""type"": ""Amino_acid""}, {""token"": ""p185neu"", ""start_span"": 75, ""end_span"": 82, ""type"": ""Gene_or_gene_product""}, {""token"": ""HER - 2"", ""start_span"": 171, ""end_span"": 178, ""type"": ""Gene_or_gene_product""}, {""token"": ""neu"", ""start_span"": 181, ""end_span"": 184, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast cancer cells"", ""start_span"": 202, ""end_span"": 221, ""type"": ""Cell""}]"	valid
Here we examined expression of type IV collagenases in parental LTA and NIH 3T3 cells ( with and without ras) and four metastatic LTA x NIH 3T3 hybrids ( also with and without ras).	type IV collagenases,31,51,Gene_or_gene_product	LTA,64,67,Cell	NIH 3T3 cells,72,85,Cell	ras,105,108,Gene_or_gene_product	LTA x NIH 3T3 hybrids,130,151,Cell	ras,176,179,Gene_or_gene_product	"[{""token"": ""type IV collagenases"", ""start_span"": 31, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""LTA"", ""start_span"": 64, ""end_span"": 67, ""type"": ""Cell""}, {""token"": ""NIH 3T3 cells"", ""start_span"": 72, ""end_span"": 85, ""type"": ""Cell""}, {""token"": ""ras"", ""start_span"": 105, ""end_span"": 108, ""type"": ""Gene_or_gene_product""}, {""token"": ""LTA x NIH 3T3 hybrids"", ""start_span"": 130, ""end_span"": 151, ""type"": ""Cell""}, {""token"": ""ras"", ""start_span"": 176, ""end_span"": 179, ""type"": ""Gene_or_gene_product""}]"	valid
Parental NIH 3T3 - derived cells had both 72 kDa and 92 kDa gelatinase activities, and LTA - derived cells had either aberrantly sized approximately 90 kDa activity alone or neither enzyme activity.	NIH 3T3 - derived cells,9,32,Cell	72 kDa,42,48,Gene_or_gene_product	92 kDa gelatinase,53,70,Gene_or_gene_product	LTA,87,90,Cell	cells,101,106,Cell	90 kDa,149,155,Gene_or_gene_product	"[{""token"": ""NIH 3T3 - derived cells"", ""start_span"": 9, ""end_span"": 32, ""type"": ""Cell""}, {""token"": ""72 kDa"", ""start_span"": 42, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""92 kDa gelatinase"", ""start_span"": 53, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""LTA"", ""start_span"": 87, ""end_span"": 90, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 101, ""end_span"": 106, ""type"": ""Cell""}, {""token"": ""90 kDa"", ""start_span"": 149, ""end_span"": 155, ""type"": ""Gene_or_gene_product""}]"	valid
The ST3 and BM - 40 / SPARC transcripts were overexpressed in primary colorectal cancers and their liver metastases compared to non - neoplastic mucosa.	ST3,4,7,Gene_or_gene_product	BM - 40,12,19,Gene_or_gene_product	SPARC,22,27,Gene_or_gene_product	colorectal cancers,70,88,Cancer	liver,99,104,Organ	mucosa,145,151,Multi	"[{""token"": ""ST3"", ""start_span"": 4, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""BM - 40"", ""start_span"": 12, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""SPARC"", ""start_span"": 22, ""end_span"": 27, ""type"": ""Gene_or_gene_product""}, {""token"": ""colorectal cancers"", ""start_span"": 70, ""end_span"": 88, ""type"": ""Cancer""}, {""token"": ""liver"", ""start_span"": 99, ""end_span"": 104, ""type"": ""Organ""}, {""token"": ""mucosa"", ""start_span"": 145, ""end_span"": 151, ""type"": ""Multi""}]"	valid
However, it is completely absent from cells transformed by the oncogene v - myc or v - src and from cells derived from a methylcholanthrene - induced fibrosarcoma.	cells,38,43,Cell	v - myc,72,79,Gene_or_gene_product	v - src,83,90,Gene_or_gene_product	cells,100,105,Cell	methylcholanthrene,121,139,Chemical	fibrosarcoma,150,162,Cancer	"[{""token"": ""cells"", ""start_span"": 38, ""end_span"": 43, ""type"": ""Cell""}, {""token"": ""v - myc"", ""start_span"": 72, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""v - src"", ""start_span"": 83, ""end_span"": 90, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 100, ""end_span"": 105, ""type"": ""Cell""}, {""token"": ""methylcholanthrene"", ""start_span"": 121, ""end_span"": 139, ""type"": ""Chemical""}, {""token"": ""fibrosarcoma"", ""start_span"": 150, ""end_span"": 162, ""type"": ""Cancer""}]"	valid
Molecular mechanisms of pituitary tumorigenesis were studied using Polymerase chain reaction - single stranded conformational polymorphism with DNA sequencing to identify potential mutations in the ras protooncogenes and the tumor suppressor gene p53 in invasive pituitary adenomas and carcinomas.	pituitary,24,33,Organ	ras,73,76,Gene_or_gene_product	tumor,225,230,Cancer	p53,247,250,Gene_or_gene_product	invasive pituitary adenomas,254,281,Cancer	carcinomas,286,296,Cancer	"[{""token"": ""pituitary"", ""start_span"": 24, ""end_span"": 33, ""type"": ""Organ""}, {""token"": ""ras"", ""start_span"": 73, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 225, ""end_span"": 230, ""type"": ""Cancer""}, {""token"": ""p53"", ""start_span"": 247, ""end_span"": 250, ""type"": ""Gene_or_gene_product""}, {""token"": ""invasive pituitary adenomas"", ""start_span"": 254, ""end_span"": 281, ""type"": ""Cancer""}, {""token"": ""carcinomas"", ""start_span"": 286, ""end_span"": 296, ""type"": ""Cancer""}]"	valid
This transporter was expressed on the cell membrane and in the cytoplasm of the tumor cells, but exhibited marked intratumoral and intertumoral variability in the proportions of positive cells and the intensity of staining.	cell membrane,38,51,Cellular_component	cytoplasm,63,72,Organism_substance	tumor cells,80,91,Cell	intratumoral,114,126,Cancer	intertumoral,131,143,Cancer	cells,187,192,Cell	"[{""token"": ""cell membrane"", ""start_span"": 38, ""end_span"": 51, ""type"": ""Cellular_component""}, {""token"": ""cytoplasm"", ""start_span"": 63, ""end_span"": 72, ""type"": ""Organism_substance""}, {""token"": ""tumor cells"", ""start_span"": 80, ""end_span"": 91, ""type"": ""Cell""}, {""token"": ""intratumoral"", ""start_span"": 114, ""end_span"": 126, ""type"": ""Cancer""}, {""token"": ""intertumoral"", ""start_span"": 131, ""end_span"": 143, ""type"": ""Cancer""}, {""token"": ""cells"", ""start_span"": 187, ""end_span"": 192, ""type"": ""Cell""}]"	valid
The 5T4 antigen is a transmembrane glycoprotein with a 310 amino acid extracellular domain and a 44 amino acid cytoplasmic domain.	5T4,4,7,Gene_or_gene_product	transmembrane,21,34,Cellular_component	amino acid,59,69,Amino_acid	extracellular,70,83,Immaterial_anatomical_entity	amino acid,100,110,Amino_acid	cytoplasmic,111,122,Organism_substance	"[{""token"": ""5T4"", ""start_span"": 4, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""transmembrane"", ""start_span"": 21, ""end_span"": 34, ""type"": ""Cellular_component""}, {""token"": ""amino acid"", ""start_span"": 59, ""end_span"": 69, ""type"": ""Amino_acid""}, {""token"": ""extracellular"", ""start_span"": 70, ""end_span"": 83, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""amino acid"", ""start_span"": 100, ""end_span"": 110, ""type"": ""Amino_acid""}, {""token"": ""cytoplasmic"", ""start_span"": 111, ""end_span"": 122, ""type"": ""Organism_substance""}]"	valid
Thus, in 5T4 - transfected CL - S1 murine mammary cells, 5T4 expression is associated with dendritic morphology, accompanied by abrogation of actin / cadherin - containing contacts and increased motility.	5T4,9,12,Gene_or_gene_product	CL - S1 murine mammary cells,27,55,Cell	5T4,57,60,Gene_or_gene_product	dendritic,91,100,Cell	actin,142,147,Gene_or_gene_product	cadherin,150,158,Gene_or_gene_product	"[{""token"": ""5T4"", ""start_span"": 9, ""end_span"": 12, ""type"": ""Gene_or_gene_product""}, {""token"": ""CL - S1 murine mammary cells"", ""start_span"": 27, ""end_span"": 55, ""type"": ""Cell""}, {""token"": ""5T4"", ""start_span"": 57, ""end_span"": 60, ""type"": ""Gene_or_gene_product""}, {""token"": ""dendritic"", ""start_span"": 91, ""end_span"": 100, ""type"": ""Cell""}, {""token"": ""actin"", ""start_span"": 142, ""end_span"": 147, ""type"": ""Gene_or_gene_product""}, {""token"": ""cadherin"", ""start_span"": 150, ""end_span"": 158, ""type"": ""Gene_or_gene_product""}]"	valid
The effects of 5T4 expression on morphology and motility are separable since cells transfected with a truncated form of 5T4 cDNA in which the cytoplasmic domain is deleted reveal that the latter is necessary to abrogate actin / cadherin - containing contacts but does not influence the effects on motility.	5T4,15,18,Gene_or_gene_product	cells,77,82,Cell	5T4,120,123,Gene_or_gene_product	cytoplasmic,142,153,Organism_substance	actin,220,225,Gene_or_gene_product	cadherin,228,236,Gene_or_gene_product	"[{""token"": ""5T4"", ""start_span"": 15, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 77, ""end_span"": 82, ""type"": ""Cell""}, {""token"": ""5T4"", ""start_span"": 120, ""end_span"": 123, ""type"": ""Gene_or_gene_product""}, {""token"": ""cytoplasmic"", ""start_span"": 142, ""end_span"": 153, ""type"": ""Organism_substance""}, {""token"": ""actin"", ""start_span"": 220, ""end_span"": 225, ""type"": ""Gene_or_gene_product""}, {""token"": ""cadherin"", ""start_span"": 228, ""end_span"": 236, ""type"": ""Gene_or_gene_product""}]"	valid
Direct involvement of BRCA1 in the development of breast and ovarian cancer is suggested by the finding that the BRCA1 promoter region CpG island is methylated in a proportion of breast and ovarian cancers.	BRCA1,22,27,Gene_or_gene_product	breast,50,56,Cancer	ovarian cancer,61,75,Cancer	BRCA1,113,118,Gene_or_gene_product	breast,179,185,Cancer	ovarian cancers,190,205,Cancer	"[{""token"": ""BRCA1"", ""start_span"": 22, ""end_span"": 27, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast"", ""start_span"": 50, ""end_span"": 56, ""type"": ""Cancer""}, {""token"": ""ovarian cancer"", ""start_span"": 61, ""end_span"": 75, ""type"": ""Cancer""}, {""token"": ""BRCA1"", ""start_span"": 113, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast"", ""start_span"": 179, ""end_span"": 185, ""type"": ""Cancer""}, {""token"": ""ovarian cancers"", ""start_span"": 190, ""end_span"": 205, ""type"": ""Cancer""}]"	test
Activation of MybER both prevented the growth arrest induced by interleukin - 6 ( IL - 6) and rapidly restored c - myc expression in nearly terminal differentiated cells that had been exposed to IL - 6 for 3 days.	MybER,14,19,Gene_or_gene_product	interleukin - 6,64,79,Gene_or_gene_product	IL - 6,82,88,Gene_or_gene_product	c - myc,111,118,Gene_or_gene_product	cells,164,169,Cell	IL - 6,195,201,Gene_or_gene_product	"[{""token"": ""MybER"", ""start_span"": 14, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""interleukin - 6"", ""start_span"": 64, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 6"", ""start_span"": 82, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - myc"", ""start_span"": 111, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 164, ""end_span"": 169, ""type"": ""Cell""}, {""token"": ""IL - 6"", ""start_span"": 195, ""end_span"": 201, ""type"": ""Gene_or_gene_product""}]"	test
In this work, we show that an 11 - amino acid peptide derived from the second immunoglobulin - like domain of Flt - 1 functions as an angiogenic inhibitor in chick chorioallantoic membrane and inhibited VEGF - induced vascular permeability in Miles ' assay without binding to VEGF directly.	Flt - 1,110,117,Gene_or_gene_product	chick,158,163,Organism	chorioallantoic membrane,164,188,Multi	VEGF,203,207,Gene_or_gene_product	vascular,218,226,Multi	VEGF,276,280,Gene_or_gene_product	"[{""token"": ""Flt - 1"", ""start_span"": 110, ""end_span"": 117, ""type"": ""Gene_or_gene_product""}, {""token"": ""chick"", ""start_span"": 158, ""end_span"": 163, ""type"": ""Organism""}, {""token"": ""chorioallantoic membrane"", ""start_span"": 164, ""end_span"": 188, ""type"": ""Multi""}, {""token"": ""VEGF"", ""start_span"": 203, ""end_span"": 207, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular"", ""start_span"": 218, ""end_span"": 226, ""type"": ""Multi""}, {""token"": ""VEGF"", ""start_span"": 276, ""end_span"": 280, ""type"": ""Gene_or_gene_product""}]"	test
The authors detected both nm23 - H1 and nm23 - H2 mRNA levels in 47 tissues samples of patients with carcinoma of buccal mucosa ( CBM) by quantitative reverse transcription PCR amplification.	nm23 - H1,26,35,Gene_or_gene_product	nm23 - H2,40,49,Gene_or_gene_product	tissues samples,68,83,Tissue	patients,87,95,Organism	carcinoma of buccal mucosa,101,127,Cancer	CBM,130,133,Cancer	"[{""token"": ""nm23 - H1"", ""start_span"": 26, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""nm23 - H2"", ""start_span"": 40, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""tissues samples"", ""start_span"": 68, ""end_span"": 83, ""type"": ""Tissue""}, {""token"": ""patients"", ""start_span"": 87, ""end_span"": 95, ""type"": ""Organism""}, {""token"": ""carcinoma of buccal mucosa"", ""start_span"": 101, ""end_span"": 127, ""type"": ""Cancer""}, {""token"": ""CBM"", ""start_span"": 130, ""end_span"": 133, ""type"": ""Cancer""}]"	test
Both PLD1 - and PLD2 - mediated cell cycle distributions in stable cell lines revealed an increased fraction of cells in the S phase compared with control cells.	PLD1,5,9,Gene_or_gene_product	PLD2,16,20,Gene_or_gene_product	cell,32,36,Cell	cell lines,67,77,Cell	cells,112,117,Cell	cells,155,160,Cell	"[{""token"": ""PLD1"", ""start_span"": 5, ""end_span"": 9, ""type"": ""Gene_or_gene_product""}, {""token"": ""PLD2"", ""start_span"": 16, ""end_span"": 20, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 32, ""end_span"": 36, ""type"": ""Cell""}, {""token"": ""cell lines"", ""start_span"": 67, ""end_span"": 77, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 112, ""end_span"": 117, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 155, ""end_span"": 160, ""type"": ""Cell""}]"	test
Interestingly, the level of cyclin D3 protein, known as an activator of G ( 1) to S phase transition in the cell cycle, was aberrantly high in cells overexpressing PLD1 and PLD2 compared with control cells.	cyclin D3,28,37,Gene_or_gene_product	cell,108,112,Cell	cells,143,148,Cell	PLD1,164,168,Gene_or_gene_product	PLD2,173,177,Gene_or_gene_product	cells,200,205,Cell	"[{""token"": ""cyclin D3"", ""start_span"": 28, ""end_span"": 37, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 108, ""end_span"": 112, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 143, ""end_span"": 148, ""type"": ""Cell""}, {""token"": ""PLD1"", ""start_span"": 164, ""end_span"": 168, ""type"": ""Gene_or_gene_product""}, {""token"": ""PLD2"", ""start_span"": 173, ""end_span"": 177, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 200, ""end_span"": 205, ""type"": ""Cell""}]"	test
Interestingly, FRTL - 5 - RhoA QL cells express less Tg and TTF - 1 than wild - type FRTL - 5 ( FRTL - 5 - vector) or FRTL - 5 - RhoA N19, suggesting a loss at the differentiation stage.	RhoA,26,30,Gene_or_gene_product	Tg,53,55,Gene_or_gene_product	TTF - 1,60,67,Gene_or_gene_product	FRTL - 5,85,93,Cell	FRTL - 5,96,104,Cell	RhoA,129,133,Gene_or_gene_product	"[{""token"": ""RhoA"", ""start_span"": 26, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""Tg"", ""start_span"": 53, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""TTF - 1"", ""start_span"": 60, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""FRTL - 5"", ""start_span"": 85, ""end_span"": 93, ""type"": ""Cell""}, {""token"": ""FRTL - 5"", ""start_span"": 96, ""end_span"": 104, ""type"": ""Cell""}, {""token"": ""RhoA"", ""start_span"": 129, ""end_span"": 133, ""type"": ""Gene_or_gene_product""}]"	test
In this report we studied the effects of SFLLR, an agonist of the activated thrombin receptor and thrombin receptor peptide and non peptide antagonists on angiogenesis in the chick chorioallantoic membrane ( CAM) system.	SFLLR,41,46,Gene_or_gene_product	thrombin receptor,76,93,Gene_or_gene_product	thrombin receptor,98,115,Gene_or_gene_product	chick,175,180,Organism	chorioallantoic membrane,181,205,Multi	CAM,208,211,Multi	"[{""token"": ""SFLLR"", ""start_span"": 41, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""thrombin receptor"", ""start_span"": 76, ""end_span"": 93, ""type"": ""Gene_or_gene_product""}, {""token"": ""thrombin receptor"", ""start_span"": 98, ""end_span"": 115, ""type"": ""Gene_or_gene_product""}, {""token"": ""chick"", ""start_span"": 175, ""end_span"": 180, ""type"": ""Organism""}, {""token"": ""chorioallantoic membrane"", ""start_span"": 181, ""end_span"": 205, ""type"": ""Multi""}, {""token"": ""CAM"", ""start_span"": 208, ""end_span"": 211, ""type"": ""Multi""}]"	test
Thrombin and SFLLR activated progelatinase A ( MMP - 2) in the culture medium of human umbilical cord endothelial cells ( HUVECs).	Thrombin,0,8,Gene_or_gene_product	SFLLR,13,18,Gene_or_gene_product	progelatinase A,29,44,Gene_or_gene_product	MMP - 2,47,54,Gene_or_gene_product	human umbilical cord endothelial cells,81,119,Cell	HUVECs,122,128,Cell	"[{""token"": ""Thrombin"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""SFLLR"", ""start_span"": 13, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""progelatinase A"", ""start_span"": 29, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP - 2"", ""start_span"": 47, ""end_span"": 54, ""type"": ""Gene_or_gene_product""}, {""token"": ""human umbilical cord endothelial cells"", ""start_span"": 81, ""end_span"": 119, ""type"": ""Cell""}, {""token"": ""HUVECs"", ""start_span"": 122, ""end_span"": 128, ""type"": ""Cell""}]"	test
In contrast, there was no association between the expression of AP - 2alpha or AP - 2beta and the level of ErbB - 3, or between AP - 2alpha and AP - 2gamma double positivity and ErbB - 3 expression.	AP - 2alpha,64,75,Gene_or_gene_product	AP - 2beta,79,89,Gene_or_gene_product	ErbB - 3,107,115,Gene_or_gene_product	AP - 2alpha,128,139,Gene_or_gene_product	AP - 2gamma,144,155,Gene_or_gene_product	ErbB - 3,178,186,Gene_or_gene_product	"[{""token"": ""AP - 2alpha"", ""start_span"": 64, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}, {""token"": ""AP - 2beta"", ""start_span"": 79, ""end_span"": 89, ""type"": ""Gene_or_gene_product""}, {""token"": ""ErbB - 3"", ""start_span"": 107, ""end_span"": 115, ""type"": ""Gene_or_gene_product""}, {""token"": ""AP - 2alpha"", ""start_span"": 128, ""end_span"": 139, ""type"": ""Gene_or_gene_product""}, {""token"": ""AP - 2gamma"", ""start_span"": 144, ""end_span"": 155, ""type"": ""Gene_or_gene_product""}, {""token"": ""ErbB - 3"", ""start_span"": 178, ""end_span"": 186, ""type"": ""Gene_or_gene_product""}]"	test
Moreover, expression of a dominant negative AP - 2 protein, AP - 2delta ( deleted residues 31 - 117), not only repressed the ErbB - 3 promoter activity but also suppressed endogenous ErbB - 3 transcription in the ErbB - 3 overexpressing cell line MRC - 5VA.	AP - 2,44,50,Gene_or_gene_product	AP - 2delta,60,71,Gene_or_gene_product	ErbB - 3,125,133,Gene_or_gene_product	ErbB - 3,183,191,Gene_or_gene_product	ErbB - 3,213,221,Gene_or_gene_product	cell line MRC - 5VA,237,256,Cell	"[{""token"": ""AP - 2"", ""start_span"": 44, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""AP - 2delta"", ""start_span"": 60, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""ErbB - 3"", ""start_span"": 125, ""end_span"": 133, ""type"": ""Gene_or_gene_product""}, {""token"": ""ErbB - 3"", ""start_span"": 183, ""end_span"": 191, ""type"": ""Gene_or_gene_product""}, {""token"": ""ErbB - 3"", ""start_span"": 213, ""end_span"": 221, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell line MRC - 5VA"", ""start_span"": 237, ""end_span"": 256, ""type"": ""Cell""}]"	test
An intracellular complex containing NRP1 and KDR was immunoprecipitated from EC by anti - NRP1 antibodies only in the presence of VEGF165.	intracellular,3,16,Immaterial_anatomical_entity	NRP1,36,40,Gene_or_gene_product	KDR,45,48,Gene_or_gene_product	EC,77,79,Cell	anti - NRP1 antibodies,83,105,Gene_or_gene_product	VEGF165,130,137,Gene_or_gene_product	"[{""token"": ""intracellular"", ""start_span"": 3, ""end_span"": 16, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""NRP1"", ""start_span"": 36, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""KDR"", ""start_span"": 45, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""EC"", ""start_span"": 77, ""end_span"": 79, ""type"": ""Cell""}, {""token"": ""anti - NRP1 antibodies"", ""start_span"": 83, ""end_span"": 105, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF165"", ""start_span"": 130, ""end_span"": 137, ""type"": ""Gene_or_gene_product""}]"	test
These complexes are formed on the surface of EC and in a juxtacrine manner via association of tumor cell NRP1 and EC KDR.	surface,34,41,Cellular_component	EC,45,47,Cell	tumor cell,94,104,Cell	NRP1,105,109,Gene_or_gene_product	EC,114,116,Cell	KDR,117,120,Gene_or_gene_product	"[{""token"": ""surface"", ""start_span"": 34, ""end_span"": 41, ""type"": ""Cellular_component""}, {""token"": ""EC"", ""start_span"": 45, ""end_span"": 47, ""type"": ""Cell""}, {""token"": ""tumor cell"", ""start_span"": 94, ""end_span"": 104, ""type"": ""Cell""}, {""token"": ""NRP1"", ""start_span"": 105, ""end_span"": 109, ""type"": ""Gene_or_gene_product""}, {""token"": ""EC"", ""start_span"": 114, ""end_span"": 116, ""type"": ""Cell""}, {""token"": ""KDR"", ""start_span"": 117, ""end_span"": 120, ""type"": ""Gene_or_gene_product""}]"	test
Most of the tumor - suppressive properties of Pten are dependent on its lipid phosphatase activity, which inhibits the phosphatidylinositol - 3 ' - kinase ( PI3K) / Akt signaling pathway through dephosphorylation of phosphatidylinositol - ( 3, 4, 5) - triphosphate.	tumor,12,17,Cancer	Pten,46,50,Gene_or_gene_product	lipid,72,77,Chemical	phosphatidylinositol - 3 ' - kinase,119,154,Gene_or_gene_product	PI3K,157,161,Gene_or_gene_product	Akt,165,168,Gene_or_gene_product	"[{""token"": ""tumor"", ""start_span"": 12, ""end_span"": 17, ""type"": ""Cancer""}, {""token"": ""Pten"", ""start_span"": 46, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""lipid"", ""start_span"": 72, ""end_span"": 77, ""type"": ""Chemical""}, {""token"": ""phosphatidylinositol - 3 ' - kinase"", ""start_span"": 119, ""end_span"": 154, ""type"": ""Gene_or_gene_product""}, {""token"": ""PI3K"", ""start_span"": 157, ""end_span"": 161, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 165, ""end_span"": 168, ""type"": ""Gene_or_gene_product""}]"	test
We identify here hADA3, human homologue of the yeast transcriptional coactivator yADA3, as a novel E6 - interacting protein and a target of E6 - induced degradation.	hADA3,17,22,Gene_or_gene_product	human,24,29,Organism	yeast,47,52,Organism	yADA3,81,86,Gene_or_gene_product	E6,99,101,Gene_or_gene_product	E6,140,142,Gene_or_gene_product	"[{""token"": ""hADA3"", ""start_span"": 17, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 24, ""end_span"": 29, ""type"": ""Organism""}, {""token"": ""yeast"", ""start_span"": 47, ""end_span"": 52, ""type"": ""Organism""}, {""token"": ""yADA3"", ""start_span"": 81, ""end_span"": 86, ""type"": ""Gene_or_gene_product""}, {""token"": ""E6"", ""start_span"": 99, ""end_span"": 101, ""type"": ""Gene_or_gene_product""}, {""token"": ""E6"", ""start_span"": 140, ""end_span"": 142, ""type"": ""Gene_or_gene_product""}]"	test
Thyroid transcription factor - 1 ( TTF - 1) is expressed in lung adenocarcinomas and thyroid carcinomas but not in adenocarcinomas arising from other sites.	Thyroid transcription factor - 1,0,32,Gene_or_gene_product	TTF - 1,35,42,Gene_or_gene_product	lung adenocarcinomas,60,80,Cancer	thyroid carcinomas,85,103,Cancer	adenocarcinomas,115,130,Cancer	sites,150,155,Multi	"[{""token"": ""Thyroid transcription factor - 1"", ""start_span"": 0, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""TTF - 1"", ""start_span"": 35, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""lung adenocarcinomas"", ""start_span"": 60, ""end_span"": 80, ""type"": ""Cancer""}, {""token"": ""thyroid carcinomas"", ""start_span"": 85, ""end_span"": 103, ""type"": ""Cancer""}, {""token"": ""adenocarcinomas"", ""start_span"": 115, ""end_span"": 130, ""type"": ""Cancer""}, {""token"": ""sites"", ""start_span"": 150, ""end_span"": 155, ""type"": ""Multi""}]"	test
For patients with adenocarcinomas in the lung, TTF - 1 staining is now routinely used to distinguish a primary lung cancer from a lung metastasis.	patients,4,12,Organism	adenocarcinomas,18,33,Cancer	lung,41,45,Organ	TTF - 1,47,54,Gene_or_gene_product	lung cancer,111,122,Cancer	lung,130,134,Organ	"[{""token"": ""patients"", ""start_span"": 4, ""end_span"": 12, ""type"": ""Organism""}, {""token"": ""adenocarcinomas"", ""start_span"": 18, ""end_span"": 33, ""type"": ""Cancer""}, {""token"": ""lung"", ""start_span"": 41, ""end_span"": 45, ""type"": ""Organ""}, {""token"": ""TTF - 1"", ""start_span"": 47, ""end_span"": 54, ""type"": ""Gene_or_gene_product""}, {""token"": ""lung cancer"", ""start_span"": 111, ""end_span"": 122, ""type"": ""Cancer""}, {""token"": ""lung"", ""start_span"": 130, ""end_span"": 134, ""type"": ""Organ""}]"	test
When the metastatic lung carcinomas were subtyped, TTF - 1 staining was noted in 11 of 11 ( 100%) adenocarcinomas, in 6 of 7 ( 86%) small - cell carcinomas, in 15 of 19 ( 79%) large - cell carcinomas, and in none of 3 ( 0%) squamous cell carcinomas.	lung carcinomas,20,35,Cancer	TTF - 1,51,58,Gene_or_gene_product	adenocarcinomas,98,113,Cancer	small - cell carcinomas,132,155,Cancer	large - cell carcinomas,176,199,Cancer	squamous cell carcinomas,224,248,Cancer	"[{""token"": ""lung carcinomas"", ""start_span"": 20, ""end_span"": 35, ""type"": ""Cancer""}, {""token"": ""TTF - 1"", ""start_span"": 51, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""adenocarcinomas"", ""start_span"": 98, ""end_span"": 113, ""type"": ""Cancer""}, {""token"": ""small - cell carcinomas"", ""start_span"": 132, ""end_span"": 155, ""type"": ""Cancer""}, {""token"": ""large - cell carcinomas"", ""start_span"": 176, ""end_span"": 199, ""type"": ""Cancer""}, {""token"": ""squamous cell carcinomas"", ""start_span"": 224, ""end_span"": 248, ""type"": ""Cancer""}]"	test
TTF - 1 staining is very reliable in discerning whether a brain metastasis has arisen from a pulmonary or nonpulmonary site, particularly when dealing with adenocarcinomas and large - cell carcinomas.	TTF - 1,0,7,Gene_or_gene_product	brain,58,63,Organ	pulmonary,93,102,Multi	nonpulmonary site,106,123,Multi	adenocarcinomas,156,171,Cancer	large - cell carcinomas,176,199,Cancer	"[{""token"": ""TTF - 1"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""brain"", ""start_span"": 58, ""end_span"": 63, ""type"": ""Organ""}, {""token"": ""pulmonary"", ""start_span"": 93, ""end_span"": 102, ""type"": ""Multi""}, {""token"": ""nonpulmonary site"", ""start_span"": 106, ""end_span"": 123, ""type"": ""Multi""}, {""token"": ""adenocarcinomas"", ""start_span"": 156, ""end_span"": 171, ""type"": ""Cancer""}, {""token"": ""large - cell carcinomas"", ""start_span"": 176, ""end_span"": 199, ""type"": ""Cancer""}]"	test
In contrast, caspase - 3, Fas ligand, Fas / CD95, and PAI showed an inverse correlation to lymph node involvement.	caspase - 3,13,24,Gene_or_gene_product	Fas ligand,26,36,Gene_or_gene_product	Fas,38,41,Gene_or_gene_product	CD95,44,48,Gene_or_gene_product	PAI,54,57,Gene_or_gene_product	lymph node,91,101,Multi	"[{""token"": ""caspase - 3"", ""start_span"": 13, ""end_span"": 24, ""type"": ""Gene_or_gene_product""}, {""token"": ""Fas ligand"", ""start_span"": 26, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""Fas"", ""start_span"": 38, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD95"", ""start_span"": 44, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""PAI"", ""start_span"": 54, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymph node"", ""start_span"": 91, ""end_span"": 101, ""type"": ""Multi""}]"	test
In cell culture, the compound 317615 2HCl, a potent inhibitor of VEGF - stimulated HUVEC proliferation, was not very effective against MX - 1 breast cancer cells ( IC50 = 8. 1 microM) or SKOV - 3 ovarian carcinoma cells ( IC50 = 9. 5 microM).	cell,3,7,Cell	317615 2HCl,30,41,Chemical	VEGF,65,69,Gene_or_gene_product	HUVEC,83,88,Cell	MX - 1 breast cancer cells,135,161,Cell	SKOV - 3 ovarian carcinoma cells,187,219,Cell	"[{""token"": ""cell"", ""start_span"": 3, ""end_span"": 7, ""type"": ""Cell""}, {""token"": ""317615 2HCl"", ""start_span"": 30, ""end_span"": 41, ""type"": ""Chemical""}, {""token"": ""VEGF"", ""start_span"": 65, ""end_span"": 69, ""type"": ""Gene_or_gene_product""}, {""token"": ""HUVEC"", ""start_span"": 83, ""end_span"": 88, ""type"": ""Cell""}, {""token"": ""MX - 1 breast cancer cells"", ""start_span"": 135, ""end_span"": 161, ""type"": ""Cell""}, {""token"": ""SKOV - 3 ovarian carcinoma cells"", ""start_span"": 187, ""end_span"": 219, ""type"": ""Cell""}]"	test
Treatment of wild - type ( wt) p53 ALL cells ( EU - 3 cell line) with doxorubicin caused accumulation of p53, resulting in dramatic down - regulation of survivin, depletion of cells in G ( 2) / M, and apoptosis ( increased sub - G ( 1) compartment).	p53,31,34,Gene_or_gene_product	EU - 3 cell line,47,63,Cell	doxorubicin,70,81,Chemical	p53,105,108,Gene_or_gene_product	survivin,153,161,Gene_or_gene_product	cells,176,181,Cell	"[{""token"": ""p53"", ""start_span"": 31, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""EU - 3 cell line"", ""start_span"": 47, ""end_span"": 63, ""type"": ""Cell""}, {""token"": ""doxorubicin"", ""start_span"": 70, ""end_span"": 81, ""type"": ""Chemical""}, {""token"": ""p53"", ""start_span"": 105, ""end_span"": 108, ""type"": ""Gene_or_gene_product""}, {""token"": ""survivin"", ""start_span"": 153, ""end_span"": 161, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 176, ""end_span"": 181, ""type"": ""Cell""}]"	test
FGF2 - stimulated microvessel formation was inhibited by sequestration of FGF2 via addition of soluble FGF receptor ( FGFR) chimera protein or anti - FGF2 antibodies.	FGF2,0,4,Gene_or_gene_product	microvessel,18,29,Tissue	FGF2,74,78,Gene_or_gene_product	FGF receptor,103,115,Gene_or_gene_product	FGFR,118,122,Gene_or_gene_product	FGF2,150,154,Gene_or_gene_product	"[{""token"": ""FGF2"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""microvessel"", ""start_span"": 18, ""end_span"": 29, ""type"": ""Tissue""}, {""token"": ""FGF2"", ""start_span"": 74, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""FGF receptor"", ""start_span"": 103, ""end_span"": 115, ""type"": ""Gene_or_gene_product""}, {""token"": ""FGFR"", ""start_span"": 118, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}, {""token"": ""FGF2"", ""start_span"": 150, ""end_span"": 154, ""type"": ""Gene_or_gene_product""}]"	test
Furthermore, slow release administration by subcutaneous injection using an Alzet osmotic pump of a potent and bio - stable T140 analog, 4F - benzoyl - TN14003, gave a partial, but statistically significant ( P < / = 0. 05 ( t - test)) reduction in pulmonary metastasis of MDA - MB - 231 in SCID mice, even though no attempt was made to inhibit other important targets such as CCR7.	T140 analog,124,135,Chemical	4F - benzoyl - TN14003,137,159,Chemical	pulmonary,249,258,Organ	MDA - MB - 231,273,287,Cell	SCID mice,291,300,Organism	CCR7,377,381,Gene_or_gene_product	"[{""token"": ""T140 analog"", ""start_span"": 124, ""end_span"": 135, ""type"": ""Chemical""}, {""token"": ""4F - benzoyl - TN14003"", ""start_span"": 137, ""end_span"": 159, ""type"": ""Chemical""}, {""token"": ""pulmonary"", ""start_span"": 249, ""end_span"": 258, ""type"": ""Organ""}, {""token"": ""MDA - MB - 231"", ""start_span"": 273, ""end_span"": 287, ""type"": ""Cell""}, {""token"": ""SCID mice"", ""start_span"": 291, ""end_span"": 300, ""type"": ""Organism""}, {""token"": ""CCR7"", ""start_span"": 377, ""end_span"": 381, ""type"": ""Gene_or_gene_product""}]"	test
Hypoxia - inducible factor 1 ( HIF - 1) activates vascular endothelial growth factor ( VEGF) gene expression in hypoxic / ischemic tissue.	Hypoxia - inducible factor 1,0,28,Gene_or_gene_product	HIF - 1,31,38,Gene_or_gene_product	vascular endothelial growth factor,50,84,Gene_or_gene_product	VEGF,87,91,Gene_or_gene_product	hypoxic,112,119,Tissue	ischemic tissue,122,137,Tissue	"[{""token"": ""Hypoxia - inducible factor 1"", ""start_span"": 0, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""HIF - 1"", ""start_span"": 31, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 50, ""end_span"": 84, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 87, ""end_span"": 91, ""type"": ""Gene_or_gene_product""}, {""token"": ""hypoxic"", ""start_span"": 112, ""end_span"": 119, ""type"": ""Tissue""}, {""token"": ""ischemic tissue"", ""start_span"": 122, ""end_span"": 137, ""type"": ""Tissue""}]"	test
In epithelial cells, EphA2 and E - cadherin co - localize to sites of cell - cell contact, and it has been shown that E - cadherin regulates EphA2.	epithelial cells,3,19,Cell	EphA2,21,26,Gene_or_gene_product	E - cadherin,31,43,Gene_or_gene_product	cell - cell contact,70,89,Cellular_component	E - cadherin,118,130,Gene_or_gene_product	EphA2,141,146,Gene_or_gene_product	"[{""token"": ""epithelial cells"", ""start_span"": 3, ""end_span"": 19, ""type"": ""Cell""}, {""token"": ""EphA2"", ""start_span"": 21, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""E - cadherin"", ""start_span"": 31, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell - cell contact"", ""start_span"": 70, ""end_span"": 89, ""type"": ""Cellular_component""}, {""token"": ""E - cadherin"", ""start_span"": 118, ""end_span"": 130, ""type"": ""Gene_or_gene_product""}, {""token"": ""EphA2"", ""start_span"": 141, ""end_span"": 146, ""type"": ""Gene_or_gene_product""}]"	test
This study aimed to clarify the relationship between the expression of the EphA2 and E - cadherin proteins and clinicopathological characteristics, with reference to the expression levels of both EphA2 and E - cadherin, in patients with colorectal cancer.	EphA2,75,80,Gene_or_gene_product	E - cadherin,85,97,Gene_or_gene_product	EphA2,196,201,Gene_or_gene_product	E - cadherin,206,218,Gene_or_gene_product	patients,223,231,Organism	colorectal cancer,237,254,Cancer	"[{""token"": ""EphA2"", ""start_span"": 75, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""E - cadherin"", ""start_span"": 85, ""end_span"": 97, ""type"": ""Gene_or_gene_product""}, {""token"": ""EphA2"", ""start_span"": 196, ""end_span"": 201, ""type"": ""Gene_or_gene_product""}, {""token"": ""E - cadherin"", ""start_span"": 206, ""end_span"": 218, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 223, ""end_span"": 231, ""type"": ""Organism""}, {""token"": ""colorectal cancer"", ""start_span"": 237, ""end_span"": 254, ""type"": ""Cancer""}]"	test
We performed immunohistochemical staining of EphA2 and E - cadherin with EphA2 and E - cadherin monoclonal antibodies in samples from 194 primary lesions of colorectal cancer.	EphA2,45,50,Gene_or_gene_product	E - cadherin,55,67,Gene_or_gene_product	EphA2,73,78,Gene_or_gene_product	E - cadherin,83,95,Gene_or_gene_product	primary lesions,138,153,Cancer	colorectal cancer,157,174,Cancer	"[{""token"": ""EphA2"", ""start_span"": 45, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""E - cadherin"", ""start_span"": 55, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""EphA2"", ""start_span"": 73, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""E - cadherin"", ""start_span"": 83, ""end_span"": 95, ""type"": ""Gene_or_gene_product""}, {""token"": ""primary lesions"", ""start_span"": 138, ""end_span"": 153, ""type"": ""Cancer""}, {""token"": ""colorectal cancer"", ""start_span"": 157, ""end_span"": 174, ""type"": ""Cancer""}]"	test
Its Hsp90 inhibition results in multiple anti - tumor - specific effects, such as degradation of Hsp90 - client proteins involved in cell growth, survival, and specific transformation, inhibition of cancer cell growth, delay of cell cycle progression, induction of morphological and functional changes, and apoptosis.	Hsp90,4,9,Gene_or_gene_product	tumor,48,53,Cancer	Hsp90,97,102,Gene_or_gene_product	cell,133,137,Cell	cancer cell,199,210,Cell	cell,228,232,Cell	"[{""token"": ""Hsp90"", ""start_span"": 4, ""end_span"": 9, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 48, ""end_span"": 53, ""type"": ""Cancer""}, {""token"": ""Hsp90"", ""start_span"": 97, ""end_span"": 102, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 133, ""end_span"": 137, ""type"": ""Cell""}, {""token"": ""cancer cell"", ""start_span"": 199, ""end_span"": 210, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 228, ""end_span"": 232, ""type"": ""Cell""}]"	test
It is normally produced in bone, teeth, kidney and epithelial lining tissues and is found in plasma and breast milk.	bone,27,31,Tissue	teeth,33,38,Organ	kidney,40,46,Organ	epithelial lining tissues,51,76,Tissue	plasma,93,99,Organism_substance	breast milk,104,115,Organism_substance	"[{""token"": ""bone"", ""start_span"": 27, ""end_span"": 31, ""type"": ""Tissue""}, {""token"": ""teeth"", ""start_span"": 33, ""end_span"": 38, ""type"": ""Organ""}, {""token"": ""kidney"", ""start_span"": 40, ""end_span"": 46, ""type"": ""Organ""}, {""token"": ""epithelial lining tissues"", ""start_span"": 51, ""end_span"": 76, ""type"": ""Tissue""}, {""token"": ""plasma"", ""start_span"": 93, ""end_span"": 99, ""type"": ""Organism_substance""}, {""token"": ""breast milk"", ""start_span"": 104, ""end_span"": 115, ""type"": ""Organism_substance""}]"	test
Glucocorticoid receptor - induced MAPK phosphatase - 1 ( MPK - 1) expression inhibits paclitaxel - associated MAPK activation and contributes to breast cancer cell survival.	Glucocorticoid receptor,0,23,Gene_or_gene_product	MAPK phosphatase - 1,34,54,Gene_or_gene_product	MPK - 1,57,64,Gene_or_gene_product	paclitaxel,86,96,Chemical	MAPK,110,114,Gene_or_gene_product	breast cancer cell,145,163,Cell	"[{""token"": ""Glucocorticoid receptor"", ""start_span"": 0, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""MAPK phosphatase - 1"", ""start_span"": 34, ""end_span"": 54, ""type"": ""Gene_or_gene_product""}, {""token"": ""MPK - 1"", ""start_span"": 57, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""paclitaxel"", ""start_span"": 86, ""end_span"": 96, ""type"": ""Chemical""}, {""token"": ""MAPK"", ""start_span"": 110, ""end_span"": 114, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast cancer cell"", ""start_span"": 145, ""end_span"": 163, ""type"": ""Cell""}]"	test
Furthermore, induction of MKP - 1 correlated with the inhibition of extracellular signal - regulated kinase ( ERK1 / 2) and c - Jun N - terminal kinase ( JNK) activity, whereas p38 activity was minimally affected.	MKP - 1,26,33,Gene_or_gene_product	extracellular signal - regulated kinase,68,107,Gene_or_gene_product	ERK1 / 2,110,118,Gene_or_gene_product	c - Jun N - terminal kinase,124,151,Gene_or_gene_product	JNK,154,157,Gene_or_gene_product	p38,177,180,Gene_or_gene_product	"[{""token"": ""MKP - 1"", ""start_span"": 26, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""extracellular signal - regulated kinase"", ""start_span"": 68, ""end_span"": 107, ""type"": ""Gene_or_gene_product""}, {""token"": ""ERK1 / 2"", ""start_span"": 110, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - Jun N - terminal kinase"", ""start_span"": 124, ""end_span"": 151, ""type"": ""Gene_or_gene_product""}, {""token"": ""JNK"", ""start_span"": 154, ""end_span"": 157, ""type"": ""Gene_or_gene_product""}, {""token"": ""p38"", ""start_span"": 177, ""end_span"": 180, ""type"": ""Gene_or_gene_product""}]"	test
These findings demonstrate a requirement for VEGFR1 + haematopoietic progenitors in the regulation of metastasis, and suggest that expression patterns of fibronectin and VEGFR1 + VLA - 4 + clusters dictate organ - specific tumour spread.	VEGFR1,45,51,Gene_or_gene_product	fibronectin,154,165,Gene_or_gene_product	VEGFR1,170,176,Gene_or_gene_product	VLA - 4,179,186,Gene_or_gene_product	organ,206,211,Organ	tumour,223,229,Cancer	"[{""token"": ""VEGFR1"", ""start_span"": 45, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""fibronectin"", ""start_span"": 154, ""end_span"": 165, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGFR1"", ""start_span"": 170, ""end_span"": 176, ""type"": ""Gene_or_gene_product""}, {""token"": ""VLA - 4"", ""start_span"": 179, ""end_span"": 186, ""type"": ""Gene_or_gene_product""}, {""token"": ""organ"", ""start_span"": 206, ""end_span"": 211, ""type"": ""Organ""}, {""token"": ""tumour"", ""start_span"": 223, ""end_span"": 229, ""type"": ""Cancer""}]"	test
To this end, we generated endothelial cell lines stably expressing vGPCR or key KSHV latently expressed proteins ( vCyclin, vFlip, and LANA1).	endothelial cell lines,26,48,Cell	vGPCR,67,72,Gene_or_gene_product	KSHV,80,84,Organism	vCyclin,115,122,Gene_or_gene_product	vFlip,124,129,Gene_or_gene_product	LANA1,135,140,Gene_or_gene_product	"[{""token"": ""endothelial cell lines"", ""start_span"": 26, ""end_span"": 48, ""type"": ""Cell""}, {""token"": ""vGPCR"", ""start_span"": 67, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""KSHV"", ""start_span"": 80, ""end_span"": 84, ""type"": ""Organism""}, {""token"": ""vCyclin"", ""start_span"": 115, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}, {""token"": ""vFlip"", ""start_span"": 124, ""end_span"": 129, ""type"": ""Gene_or_gene_product""}, {""token"": ""LANA1"", ""start_span"": 135, ""end_span"": 140, ""type"": ""Gene_or_gene_product""}]"	test
The endothelial cell line expressing vGPCR was rendered sensitive to treatment with the nucleoside analogue ganciclovir by using a bicistronic construct coexpressing the herpes simplex virus 1 thymidine kinase.	endothelial cell line,4,25,Cell	vGPCR,37,42,Gene_or_gene_product	nucleoside,88,98,Chemical	ganciclovir,108,119,Chemical	herpes simplex virus 1,170,192,Organism	thymidine kinase,193,209,Gene_or_gene_product	"[{""token"": ""endothelial cell line"", ""start_span"": 4, ""end_span"": 25, ""type"": ""Cell""}, {""token"": ""vGPCR"", ""start_span"": 37, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""nucleoside"", ""start_span"": 88, ""end_span"": 98, ""type"": ""Chemical""}, {""token"": ""ganciclovir"", ""start_span"": 108, ""end_span"": 119, ""type"": ""Chemical""}, {""token"": ""herpes simplex virus 1"", ""start_span"": 170, ""end_span"": 192, ""type"": ""Organism""}, {""token"": ""thymidine kinase"", ""start_span"": 193, ""end_span"": 209, ""type"": ""Gene_or_gene_product""}]"	test
S. c. injection into nude mice with mixed - cell populations formed tumors that approximate the ratio of vGPCR - expressing and KSHV latent gene - expressing cells.	nude mice,21,30,Organism	mixed - cell populations,36,60,Cell	tumors,68,74,Cancer	vGPCR,105,110,Gene_or_gene_product	KSHV,128,132,Organism	cells,158,163,Cell	"[{""token"": ""nude mice"", ""start_span"": 21, ""end_span"": 30, ""type"": ""Organism""}, {""token"": ""mixed - cell populations"", ""start_span"": 36, ""end_span"": 60, ""type"": ""Cell""}, {""token"": ""tumors"", ""start_span"": 68, ""end_span"": 74, ""type"": ""Cancer""}, {""token"": ""vGPCR"", ""start_span"": 105, ""end_span"": 110, ""type"": ""Gene_or_gene_product""}, {""token"": ""KSHV"", ""start_span"": 128, ""end_span"": 132, ""type"": ""Organism""}, {""token"": ""cells"", ""start_span"": 158, ""end_span"": 163, ""type"": ""Cell""}]"	test
Surprisingly, despite the expression of KSHV latent genes in the vast majority of tumor cells, specifically targeting only the few vGPCR - expressing cells in established tumors resulted in tumor regression.	KSHV,40,44,Organism	tumor cells,82,93,Cell	vGPCR,131,136,Gene_or_gene_product	cells,150,155,Cell	tumors,171,177,Cancer	tumor,190,195,Cancer	"[{""token"": ""KSHV"", ""start_span"": 40, ""end_span"": 44, ""type"": ""Organism""}, {""token"": ""tumor cells"", ""start_span"": 82, ""end_span"": 93, ""type"": ""Cell""}, {""token"": ""vGPCR"", ""start_span"": 131, ""end_span"": 136, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 150, ""end_span"": 155, ""type"": ""Cell""}, {""token"": ""tumors"", ""start_span"": 171, ""end_span"": 177, ""type"": ""Cancer""}, {""token"": ""tumor"", ""start_span"": 190, ""end_span"": 195, ""type"": ""Cancer""}]"	test
Hepatitis B virus integration event in human chromosome 17p near the p53 gene identifies the region of the chromosome commonly deleted in virus - positive hepatocellular carcinomas.	Hepatitis B virus,0,17,Organism	human,39,44,Organism	chromosome 17p,45,59,Cellular_component	p53,69,72,Gene_or_gene_product	chromosome,107,117,Cellular_component	virus - positive hepatocellular carcinomas,138,180,Cancer	"[{""token"": ""Hepatitis B virus"", ""start_span"": 0, ""end_span"": 17, ""type"": ""Organism""}, {""token"": ""human"", ""start_span"": 39, ""end_span"": 44, ""type"": ""Organism""}, {""token"": ""chromosome 17p"", ""start_span"": 45, ""end_span"": 59, ""type"": ""Cellular_component""}, {""token"": ""p53"", ""start_span"": 69, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""chromosome"", ""start_span"": 107, ""end_span"": 117, ""type"": ""Cellular_component""}, {""token"": ""virus - positive hepatocellular carcinomas"", ""start_span"": 138, ""end_span"": 180, ""type"": ""Cancer""}]"	test
Hepatitis B virus ( HBV) is strongly associated with the development of HCC in people chronically infected with the virus, but the mechanism of viral involvement remains unclear.	Hepatitis B virus,0,17,Organism	HBV,20,23,Organism	HCC,72,75,Cancer	people,79,85,Organism	virus,116,121,Organism	viral,144,149,Organism	"[{""token"": ""Hepatitis B virus"", ""start_span"": 0, ""end_span"": 17, ""type"": ""Organism""}, {""token"": ""HBV"", ""start_span"": 20, ""end_span"": 23, ""type"": ""Organism""}, {""token"": ""HCC"", ""start_span"": 72, ""end_span"": 75, ""type"": ""Cancer""}, {""token"": ""people"", ""start_span"": 79, ""end_span"": 85, ""type"": ""Organism""}, {""token"": ""virus"", ""start_span"": 116, ""end_span"": 121, ""type"": ""Organism""}, {""token"": ""viral"", ""start_span"": 144, ""end_span"": 149, ""type"": ""Organism""}]"	test
The transmembrane peptidase prostate - specific membrane antigen ( PSMA) is universally upregulated in the vasculature of solid tumors, but its functional role in tumor angiogenesis has not been investigated.	transmembrane,4,17,Cellular_component	prostate - specific membrane antigen,28,64,Gene_or_gene_product	PSMA,67,71,Gene_or_gene_product	vasculature,107,118,Multi	solid tumors,122,134,Cancer	tumor,163,168,Cancer	"[{""token"": ""transmembrane"", ""start_span"": 4, ""end_span"": 17, ""type"": ""Cellular_component""}, {""token"": ""prostate - specific membrane antigen"", ""start_span"": 28, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""PSMA"", ""start_span"": 67, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""vasculature"", ""start_span"": 107, ""end_span"": 118, ""type"": ""Multi""}, {""token"": ""solid tumors"", ""start_span"": 122, ""end_span"": 134, ""type"": ""Cancer""}, {""token"": ""tumor"", ""start_span"": 163, ""end_span"": 168, ""type"": ""Cancer""}]"	test
PLGA - heparin microspheres released out bFGF in a more sustained manner with a smaller extent of initial burst than PLGA microspheres, indicating that surface immobilized heparin controlled the release rate of bFGF.	PLGA,0,4,Chemical	heparin,7,14,Chemical	bFGF,41,45,Gene_or_gene_product	PLGA,117,121,Chemical	heparin,172,179,Chemical	bFGF,211,215,Gene_or_gene_product	"[{""token"": ""PLGA"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Chemical""}, {""token"": ""heparin"", ""start_span"": 7, ""end_span"": 14, ""type"": ""Chemical""}, {""token"": ""bFGF"", ""start_span"": 41, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""PLGA"", ""start_span"": 117, ""end_span"": 121, ""type"": ""Chemical""}, {""token"": ""heparin"", ""start_span"": 172, ""end_span"": 179, ""type"": ""Chemical""}, {""token"": ""bFGF"", ""start_span"": 211, ""end_span"": 215, ""type"": ""Gene_or_gene_product""}]"	test
bFGF loaded PLGA - HP microspheres showed sustained release profiles of bFGF in vitro, demonstrating reversible and specific binding of bFGF to immobilized heparin.	bFGF,0,4,Gene_or_gene_product	PLGA,12,16,Chemical	HP,19,21,Chemical	bFGF,72,76,Gene_or_gene_product	bFGF,136,140,Gene_or_gene_product	heparin,156,163,Chemical	"[{""token"": ""bFGF"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""PLGA"", ""start_span"": 12, ""end_span"": 16, ""type"": ""Chemical""}, {""token"": ""HP"", ""start_span"": 19, ""end_span"": 21, ""type"": ""Chemical""}, {""token"": ""bFGF"", ""start_span"": 72, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}, {""token"": ""bFGF"", ""start_span"": 136, ""end_span"": 140, ""type"": ""Gene_or_gene_product""}, {""token"": ""heparin"", ""start_span"": 156, ""end_span"": 163, ""type"": ""Chemical""}]"	test
Lysophosphatidic acid ( LPA) levels are elevated in ascites from ovarian cancer patients, but its potential role in ovarian cancer metastasis has just begun to be revealed.	Lysophosphatidic acid,0,21,Chemical	LPA,24,27,Chemical	ascites,52,59,Organism_substance	ovarian cancer,65,79,Cancer	patients,80,88,Organism	ovarian cancer,116,130,Cancer	"[{""token"": ""Lysophosphatidic acid"", ""start_span"": 0, ""end_span"": 21, ""type"": ""Chemical""}, {""token"": ""LPA"", ""start_span"": 24, ""end_span"": 27, ""type"": ""Chemical""}, {""token"": ""ascites"", ""start_span"": 52, ""end_span"": 59, ""type"": ""Organism_substance""}, {""token"": ""ovarian cancer"", ""start_span"": 65, ""end_span"": 79, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 80, ""end_span"": 88, ""type"": ""Organism""}, {""token"": ""ovarian cancer"", ""start_span"": 116, ""end_span"": 130, ""type"": ""Cancer""}]"	test
"It summarizes strategies to destroy or prevent cancers by targeting their energy production factories, i. e., "" power plants. "" All nucleated animal / human cells have two types of power plants, i. e., systems that make the "" high energy "" compound ATP from ADP and P ( i)."	cancers,47,54,Cancer	animal,142,148,Organism	human,151,156,Organism	cells,157,162,Cell	ATP,249,252,Chemical	ADP,258,261,Chemical	"[{""token"": ""cancers"", ""start_span"": 47, ""end_span"": 54, ""type"": ""Cancer""}, {""token"": ""animal"", ""start_span"": 142, ""end_span"": 148, ""type"": ""Organism""}, {""token"": ""human"", ""start_span"": 151, ""end_span"": 156, ""type"": ""Organism""}, {""token"": ""cells"", ""start_span"": 157, ""end_span"": 162, ""type"": ""Cell""}, {""token"": ""ATP"", ""start_span"": 249, ""end_span"": 252, ""type"": ""Chemical""}, {""token"": ""ADP"", ""start_span"": 258, ""end_span"": 261, ""type"": ""Chemical""}]"	test
"One type is "" glycolysis, "" the other the "" mitochondria. "" In contrast to most normal cells where the mitochondria are the major ATP producers ( > 90%) in fueling growth, human cancers detected via Positron Emission Tomography ( PET) rely on both types of power plants."	mitochondria,44,56,Cellular_component	cells,87,92,Cell	mitochondria,103,115,Cellular_component	ATP,130,133,Chemical	human,172,177,Organism	cancers,178,185,Cancer	"[{""token"": ""mitochondria"", ""start_span"": 44, ""end_span"": 56, ""type"": ""Cellular_component""}, {""token"": ""cells"", ""start_span"": 87, ""end_span"": 92, ""type"": ""Cell""}, {""token"": ""mitochondria"", ""start_span"": 103, ""end_span"": 115, ""type"": ""Cellular_component""}, {""token"": ""ATP"", ""start_span"": 130, ""end_span"": 133, ""type"": ""Chemical""}, {""token"": ""human"", ""start_span"": 172, ""end_span"": 177, ""type"": ""Organism""}, {""token"": ""cancers"", ""start_span"": 178, ""end_span"": 185, ""type"": ""Cancer""}]"	test
The effect of swainsonine ( active compound of locoweed and a potential anticancer drug) on vascular development showed no differences in sinusoidal diameters at 7 weeks, but a decrease in capillary density was noted.	swainsonine,14,25,Chemical	locoweed,47,55,Organism	anticancer,72,82,Cancer	vascular,92,100,Multi	sinusoidal,138,148,Tissue	capillary,189,198,Tissue	"[{""token"": ""swainsonine"", ""start_span"": 14, ""end_span"": 25, ""type"": ""Chemical""}, {""token"": ""locoweed"", ""start_span"": 47, ""end_span"": 55, ""type"": ""Organism""}, {""token"": ""anticancer"", ""start_span"": 72, ""end_span"": 82, ""type"": ""Cancer""}, {""token"": ""vascular"", ""start_span"": 92, ""end_span"": 100, ""type"": ""Multi""}, {""token"": ""sinusoidal"", ""start_span"": 138, ""end_span"": 148, ""type"": ""Tissue""}, {""token"": ""capillary"", ""start_span"": 189, ""end_span"": 198, ""type"": ""Tissue""}]"	test
Together, these results suggest that Tip30 is an intrinsic and negative regulator of MEC proliferation partly through the inhibition of Wisp2 and Igf - 1 expression, and its absence in the mammary gland may predispose MECs to neoplastic transformation.	Tip30,37,42,Gene_or_gene_product	MEC,85,88,Cell	Wisp2,136,141,Gene_or_gene_product	Igf - 1,146,153,Gene_or_gene_product	mammary gland,189,202,Organ	MECs,218,222,Cell	"[{""token"": ""Tip30"", ""start_span"": 37, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""MEC"", ""start_span"": 85, ""end_span"": 88, ""type"": ""Cell""}, {""token"": ""Wisp2"", ""start_span"": 136, ""end_span"": 141, ""type"": ""Gene_or_gene_product""}, {""token"": ""Igf - 1"", ""start_span"": 146, ""end_span"": 153, ""type"": ""Gene_or_gene_product""}, {""token"": ""mammary gland"", ""start_span"": 189, ""end_span"": 202, ""type"": ""Organ""}, {""token"": ""MECs"", ""start_span"": 218, ""end_span"": 222, ""type"": ""Cell""}]"	test
Additionally, the synergistic apoptotic effects of MOG with As2O3 were detected in HL - 60 and primary AML cells, but not in normal cells, suggesting the selective toxicity of their combination to the malignant cells.	MOG,51,54,Chemical	As2O3,60,65,Chemical	HL - 60,83,90,Cell	primary AML cells,95,112,Cell	cells,132,137,Cell	malignant cells,201,216,Cell	"[{""token"": ""MOG"", ""start_span"": 51, ""end_span"": 54, ""type"": ""Chemical""}, {""token"": ""As2O3"", ""start_span"": 60, ""end_span"": 65, ""type"": ""Chemical""}, {""token"": ""HL - 60"", ""start_span"": 83, ""end_span"": 90, ""type"": ""Cell""}, {""token"": ""primary AML cells"", ""start_span"": 95, ""end_span"": 112, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 132, ""end_span"": 137, ""type"": ""Cell""}, {""token"": ""malignant cells"", ""start_span"": 201, ""end_span"": 216, ""type"": ""Cell""}]"	test
Treatment with 25 mg / kg cyclopamine significantly attenuated BrdU incorporation in tumor cells threefold ( P less than 0. 001), in tumor related endothelial cells threefold ( P = 0. 004), and delayed tumor growth by 4 days.	cyclopamine,26,37,Chemical	BrdU,63,67,Chemical	tumor cells,85,96,Cell	tumor,133,138,Cancer	endothelial cells,147,164,Cell	tumor,202,207,Cancer	"[{""token"": ""cyclopamine"", ""start_span"": 26, ""end_span"": 37, ""type"": ""Chemical""}, {""token"": ""BrdU"", ""start_span"": 63, ""end_span"": 67, ""type"": ""Chemical""}, {""token"": ""tumor cells"", ""start_span"": 85, ""end_span"": 96, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 133, ""end_span"": 138, ""type"": ""Cancer""}, {""token"": ""endothelial cells"", ""start_span"": 147, ""end_span"": 164, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 202, ""end_span"": 207, ""type"": ""Cancer""}]"	test
OBJECTIVE: In the present study, we attempted to identify EGFR and TGF - alpha expression and Ki - 67 index in carcinoma ex - pleomorphic adenoma ( Ca ex - PA) and PA.	EGFR,58,62,Gene_or_gene_product	TGF - alpha,67,78,Gene_or_gene_product	Ki - 67,94,101,Gene_or_gene_product	carcinoma ex - pleomorphic adenoma,111,145,Cancer	Ca ex - PA,148,158,Cancer	PA,164,166,Pathological_formation	"[{""token"": ""EGFR"", ""start_span"": 58, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""TGF - alpha"", ""start_span"": 67, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ki - 67"", ""start_span"": 94, ""end_span"": 101, ""type"": ""Gene_or_gene_product""}, {""token"": ""carcinoma ex - pleomorphic adenoma"", ""start_span"": 111, ""end_span"": 145, ""type"": ""Cancer""}, {""token"": ""Ca ex - PA"", ""start_span"": 148, ""end_span"": 158, ""type"": ""Cancer""}, {""token"": ""PA"", ""start_span"": 164, ""end_span"": 166, ""type"": ""Pathological_formation""}]"	test
In the immunohistochemical analysis of EGFR and TGF - alpha and Ki67 index, a significant increase was observed in Ca ex - PA, especially with adenocarcinoma, compared with PA and sialadenitis.	EGFR,39,43,Gene_or_gene_product	TGF - alpha,48,59,Gene_or_gene_product	Ki67,64,68,Gene_or_gene_product	Ca ex - PA,115,125,Cancer	adenocarcinoma,143,157,Cancer	PA,173,175,Pathological_formation	"[{""token"": ""EGFR"", ""start_span"": 39, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""TGF - alpha"", ""start_span"": 48, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ki67"", ""start_span"": 64, ""end_span"": 68, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ca ex - PA"", ""start_span"": 115, ""end_span"": 125, ""type"": ""Cancer""}, {""token"": ""adenocarcinoma"", ""start_span"": 143, ""end_span"": 157, ""type"": ""Cancer""}, {""token"": ""PA"", ""start_span"": 173, ""end_span"": 175, ""type"": ""Pathological_formation""}]"	test
The appearance of lipid - bloated subretinal MCs was drusen - like on funduscopy of senescent mice, and CX3CR1 - dependent MC accumulation was associated with an exacerbation of experimental CNV.	lipid,18,23,Chemical	subretinal MCs,34,48,Cell	drusen,53,59,Pathological_formation	mice,94,98,Organism	CX3CR1,104,110,Gene_or_gene_product	MC,123,125,Cell	"[{""token"": ""lipid"", ""start_span"": 18, ""end_span"": 23, ""type"": ""Chemical""}, {""token"": ""subretinal MCs"", ""start_span"": 34, ""end_span"": 48, ""type"": ""Cell""}, {""token"": ""drusen"", ""start_span"": 53, ""end_span"": 59, ""type"": ""Pathological_formation""}, {""token"": ""mice"", ""start_span"": 94, ""end_span"": 98, ""type"": ""Organism""}, {""token"": ""CX3CR1"", ""start_span"": 104, ""end_span"": 110, ""type"": ""Gene_or_gene_product""}, {""token"": ""MC"", ""start_span"": 123, ""end_span"": 125, ""type"": ""Cell""}]"	test
Conditional deletion of Smad1 and Smad5 in somatic cells of male and female gonads leads to metastatic tumor development in mice.	Smad1,24,29,Gene_or_gene_product	Smad5,34,39,Gene_or_gene_product	somatic cells,43,56,Cell	gonads,76,82,Organ	tumor,103,108,Cancer	mice,124,128,Organism	"[{""token"": ""Smad1"", ""start_span"": 24, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""Smad5"", ""start_span"": 34, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""somatic cells"", ""start_span"": 43, ""end_span"": 56, ""type"": ""Cell""}, {""token"": ""gonads"", ""start_span"": 76, ""end_span"": 82, ""type"": ""Organ""}, {""token"": ""tumor"", ""start_span"": 103, ""end_span"": 108, ""type"": ""Cancer""}, {""token"": ""mice"", ""start_span"": 124, ""end_span"": 128, ""type"": ""Organism""}]"	test
Using tissue - specific ablation in mice, we deleted the BR - SMADs from somatic cells of ovaries and testes.	tissue,6,12,Tissue	mice,36,40,Organism	BR - SMADs,57,67,Gene_or_gene_product	somatic cells,73,86,Cell	ovaries,90,97,Organ	testes,102,108,Organ	"[{""token"": ""tissue"", ""start_span"": 6, ""end_span"": 12, ""type"": ""Tissue""}, {""token"": ""mice"", ""start_span"": 36, ""end_span"": 40, ""type"": ""Organism""}, {""token"": ""BR - SMADs"", ""start_span"": 57, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""somatic cells"", ""start_span"": 73, ""end_span"": 86, ""type"": ""Cell""}, {""token"": ""ovaries"", ""start_span"": 90, ""end_span"": 97, ""type"": ""Organ""}, {""token"": ""testes"", ""start_span"": 102, ""end_span"": 108, ""type"": ""Organ""}]"	test
Female double Smad1 Smad5 and triple Smad1 Smad5 Smad8 conditional knockout mice become infertile and develop metastatic granulosa cell tumors.	Smad1,14,19,Gene_or_gene_product	Smad5,20,25,Gene_or_gene_product	Smad1,37,42,Gene_or_gene_product	Smad5,43,48,Gene_or_gene_product	Smad8,49,54,Gene_or_gene_product	granulosa cell tumors,121,142,Cancer	"[{""token"": ""Smad1"", ""start_span"": 14, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""Smad5"", ""start_span"": 20, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""Smad1"", ""start_span"": 37, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""Smad5"", ""start_span"": 43, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""Smad8"", ""start_span"": 49, ""end_span"": 54, ""type"": ""Gene_or_gene_product""}, {""token"": ""granulosa cell tumors"", ""start_span"": 121, ""end_span"": 142, ""type"": ""Cancer""}]"	test
In this article we have focused on a role of IL - 6 as a prognostic factor in several malignancies such as colorectal cancer, breast cancer, gastric cancer and pancreatic cancer.	IL - 6,45,51,Gene_or_gene_product	malignancies,86,98,Cancer	colorectal cancer,107,124,Cancer	breast cancer,126,139,Cancer	gastric cancer,141,155,Cancer	pancreatic cancer,160,177,Cancer	"[{""token"": ""IL - 6"", ""start_span"": 45, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""malignancies"", ""start_span"": 86, ""end_span"": 98, ""type"": ""Cancer""}, {""token"": ""colorectal cancer"", ""start_span"": 107, ""end_span"": 124, ""type"": ""Cancer""}, {""token"": ""breast cancer"", ""start_span"": 126, ""end_span"": 139, ""type"": ""Cancer""}, {""token"": ""gastric cancer"", ""start_span"": 141, ""end_span"": 155, ""type"": ""Cancer""}, {""token"": ""pancreatic cancer"", ""start_span"": 160, ""end_span"": 177, ""type"": ""Cancer""}]"	test
There was no correlation of survivin with bcl - 2 or bax expression, or with other prognostic parameters ( age, tumor size, histologic type, histologic grade, nodal status, and tumor stage) ( P > 0. 05).	survivin,28,36,Gene_or_gene_product	bcl - 2,42,49,Gene_or_gene_product	bax,53,56,Gene_or_gene_product	tumor,112,117,Cancer	nodal,159,164,Multi	tumor,177,182,Cancer	"[{""token"": ""survivin"", ""start_span"": 28, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""bcl - 2"", ""start_span"": 42, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""bax"", ""start_span"": 53, ""end_span"": 56, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 112, ""end_span"": 117, ""type"": ""Cancer""}, {""token"": ""nodal"", ""start_span"": 159, ""end_span"": 164, ""type"": ""Multi""}, {""token"": ""tumor"", ""start_span"": 177, ""end_span"": 182, ""type"": ""Cancer""}]"	test
Transfection with TSP - 1 and purified TSP - 1 added to NIH3T3 cells did not alter the protein levels of alpha - SMA and desmin but significantly inhibited matrix metalloprotease - 2 activity.	TSP - 1,18,25,Gene_or_gene_product	TSP - 1,39,46,Gene_or_gene_product	NIH3T3 cells,56,68,Cell	alpha - SMA,105,116,Gene_or_gene_product	desmin,121,127,Gene_or_gene_product	matrix metalloprotease - 2,156,182,Gene_or_gene_product	"[{""token"": ""TSP - 1"", ""start_span"": 18, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""TSP - 1"", ""start_span"": 39, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""NIH3T3 cells"", ""start_span"": 56, ""end_span"": 68, ""type"": ""Cell""}, {""token"": ""alpha - SMA"", ""start_span"": 105, ""end_span"": 116, ""type"": ""Gene_or_gene_product""}, {""token"": ""desmin"", ""start_span"": 121, ""end_span"": 127, ""type"": ""Gene_or_gene_product""}, {""token"": ""matrix metalloprotease - 2"", ""start_span"": 156, ""end_span"": 182, ""type"": ""Gene_or_gene_product""}]"	test
Laminin - 332 is critical for squamous cell carcinoma ( SCC) tumorigenesis, but targeting it for cancer therapy has been unachievable due to key role of laminin - 332 in promoting tissue integrity.	Laminin - 332,0,13,Gene_or_gene_product	squamous cell carcinoma,30,53,Cancer	SCC,56,59,Cancer	cancer,97,103,Cancer	laminin - 332,153,166,Gene_or_gene_product	tissue,180,186,Tissue	"[{""token"": ""Laminin - 332"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Gene_or_gene_product""}, {""token"": ""squamous cell carcinoma"", ""start_span"": 30, ""end_span"": 53, ""type"": ""Cancer""}, {""token"": ""SCC"", ""start_span"": 56, ""end_span"": 59, ""type"": ""Cancer""}, {""token"": ""cancer"", ""start_span"": 97, ""end_span"": 103, ""type"": ""Cancer""}, {""token"": ""laminin - 332"", ""start_span"": 153, ""end_span"": 166, ""type"": ""Gene_or_gene_product""}, {""token"": ""tissue"", ""start_span"": 180, ""end_span"": 186, ""type"": ""Tissue""}]"	test
G45 antibody treatment induced SCC tumor apoptosis, decreased SCC tumor proliferation, and markedly impaired human SCC tumorigenesis in vivo without affecting normal tissue adhesion.	G45,0,3,Gene_or_gene_product	SCC tumor,31,40,Cancer	SCC tumor,62,71,Cancer	human,109,114,Organism	SCC,115,118,Cancer	normal tissue,159,172,Tissue	"[{""token"": ""G45"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""SCC tumor"", ""start_span"": 31, ""end_span"": 40, ""type"": ""Cancer""}, {""token"": ""SCC tumor"", ""start_span"": 62, ""end_span"": 71, ""type"": ""Cancer""}, {""token"": ""human"", ""start_span"": 109, ""end_span"": 114, ""type"": ""Organism""}, {""token"": ""SCC"", ""start_span"": 115, ""end_span"": 118, ""type"": ""Cancer""}, {""token"": ""normal tissue"", ""start_span"": 159, ""end_span"": 172, ""type"": ""Tissue""}]"	test
We measured serum IL - 8 and urine IL - 8 levels in patients with NHL, and we compared the concentrations with those of control individuals.	serum,12,17,Organism_substance	IL - 8,18,24,Gene_or_gene_product	urine,29,34,Organism_substance	IL - 8,35,41,Gene_or_gene_product	patients,52,60,Organism	NHL,66,69,Cancer	"[{""token"": ""serum"", ""start_span"": 12, ""end_span"": 17, ""type"": ""Organism_substance""}, {""token"": ""IL - 8"", ""start_span"": 18, ""end_span"": 24, ""type"": ""Gene_or_gene_product""}, {""token"": ""urine"", ""start_span"": 29, ""end_span"": 34, ""type"": ""Organism_substance""}, {""token"": ""IL - 8"", ""start_span"": 35, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 52, ""end_span"": 60, ""type"": ""Organism""}, {""token"": ""NHL"", ""start_span"": 66, ""end_span"": 69, ""type"": ""Cancer""}]"	test
There was no correlation between the serum and urine concentrations of IL - 8 and clinical variables, the only exception being the international prognostic index ( IPI), which showed a marginal correlation with urine IL - 8 / Cr levels ( P = 0. 07).	serum,37,42,Organism_substance	urine,47,52,Organism_substance	IL - 8,71,77,Gene_or_gene_product	urine,211,216,Organism_substance	IL - 8,217,223,Gene_or_gene_product	Cr,226,228,Chemical	"[{""token"": ""serum"", ""start_span"": 37, ""end_span"": 42, ""type"": ""Organism_substance""}, {""token"": ""urine"", ""start_span"": 47, ""end_span"": 52, ""type"": ""Organism_substance""}, {""token"": ""IL - 8"", ""start_span"": 71, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}, {""token"": ""urine"", ""start_span"": 211, ""end_span"": 216, ""type"": ""Organism_substance""}, {""token"": ""IL - 8"", ""start_span"": 217, ""end_span"": 223, ""type"": ""Gene_or_gene_product""}, {""token"": ""Cr"", ""start_span"": 226, ""end_span"": 228, ""type"": ""Chemical""}]"	test
This technique showed strong abdominal neovascularization in wild - type mice, but not eNOS knockout mice, locally injected with VEGF, as well as stimulation of angiogenesis in NO donor - injected mice.	abdominal,29,38,Organism_subdivision	mice,73,77,Organism	eNOS,87,91,Gene_or_gene_product	VEGF,129,133,Gene_or_gene_product	NO,177,179,Chemical	mice,197,201,Organism	"[{""token"": ""abdominal"", ""start_span"": 29, ""end_span"": 38, ""type"": ""Organism_subdivision""}, {""token"": ""mice"", ""start_span"": 73, ""end_span"": 77, ""type"": ""Organism""}, {""token"": ""eNOS"", ""start_span"": 87, ""end_span"": 91, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 129, ""end_span"": 133, ""type"": ""Gene_or_gene_product""}, {""token"": ""NO"", ""start_span"": 177, ""end_span"": 179, ""type"": ""Chemical""}, {""token"": ""mice"", ""start_span"": 197, ""end_span"": 201, ""type"": ""Organism""}]"	test
The p75 receptor of neurotrophins ( p75 ( NTR)), which is scarcely present in healthy endothelial cells ( ECs), becomes strongly expressed by capillary ECs after induction of peripheral ischemia in type - 1 diabetic mice.	p75 receptor of neurotrophins,4,33,Gene_or_gene_product	endothelial cells,86,103,Cell	ECs,106,109,Cell	capillary ECs,142,155,Cell	peripheral,175,185,Tissue	mice,216,220,Organism	"[{""token"": ""p75 receptor of neurotrophins"", ""start_span"": 4, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cells"", ""start_span"": 86, ""end_span"": 103, ""type"": ""Cell""}, {""token"": ""ECs"", ""start_span"": 106, ""end_span"": 109, ""type"": ""Cell""}, {""token"": ""capillary ECs"", ""start_span"": 142, ""end_span"": 155, ""type"": ""Cell""}, {""token"": ""peripheral"", ""start_span"": 175, ""end_span"": 185, ""type"": ""Tissue""}, {""token"": ""mice"", ""start_span"": 216, ""end_span"": 220, ""type"": ""Organism""}]"	test
Also, the combination of docetaxel and ATRA might allow a reduction in docetaxel doses and by this way may diminish docetaxel adverse effects while maintaining the therapeutic effect in patients with HRPC.	docetaxel,25,34,Chemical	ATRA,39,43,Chemical	docetaxel,71,80,Chemical	docetaxel,116,125,Chemical	patients,186,194,Organism	HRPC,200,204,Cancer	"[{""token"": ""docetaxel"", ""start_span"": 25, ""end_span"": 34, ""type"": ""Chemical""}, {""token"": ""ATRA"", ""start_span"": 39, ""end_span"": 43, ""type"": ""Chemical""}, {""token"": ""docetaxel"", ""start_span"": 71, ""end_span"": 80, ""type"": ""Chemical""}, {""token"": ""docetaxel"", ""start_span"": 116, ""end_span"": 125, ""type"": ""Chemical""}, {""token"": ""patients"", ""start_span"": 186, ""end_span"": 194, ""type"": ""Organism""}, {""token"": ""HRPC"", ""start_span"": 200, ""end_span"": 204, ""type"": ""Cancer""}]"	test
Furthermore, the Y705F / S727E but not the Y705F / S727A mutant induced anchorage - independent growth of noncancerous prostate epithelial cells ( RWPE - 1).	Y705F,17,22,Amino_acid	S727E,25,30,Amino_acid	Y705F,43,48,Amino_acid	S727A,51,56,Amino_acid	noncancerous prostate epithelial cells,106,144,Cell	RWPE - 1,147,155,Cell	"[{""token"": ""Y705F"", ""start_span"": 17, ""end_span"": 22, ""type"": ""Amino_acid""}, {""token"": ""S727E"", ""start_span"": 25, ""end_span"": 30, ""type"": ""Amino_acid""}, {""token"": ""Y705F"", ""start_span"": 43, ""end_span"": 48, ""type"": ""Amino_acid""}, {""token"": ""S727A"", ""start_span"": 51, ""end_span"": 56, ""type"": ""Amino_acid""}, {""token"": ""noncancerous prostate epithelial cells"", ""start_span"": 106, ""end_span"": 144, ""type"": ""Cell""}, {""token"": ""RWPE - 1"", ""start_span"": 147, ""end_span"": 155, ""type"": ""Cell""}]"	test
Thus, our data show that allergic respiratory inflammation may represent a risk factor for the development of lung metastases and suggest that amelioration of the pulmonary inflammation associated with asthma will have a direct and immediate benefit to the 7% to 8% of breast cancer patients with this lung disease.	respiratory,34,45,Anatomical_system	lung metastases,110,125,Cancer	pulmonary,163,172,Organ	breast cancer,269,282,Cancer	patients,283,291,Organism	lung,302,306,Organ	"[{""token"": ""respiratory"", ""start_span"": 34, ""end_span"": 45, ""type"": ""Anatomical_system""}, {""token"": ""lung metastases"", ""start_span"": 110, ""end_span"": 125, ""type"": ""Cancer""}, {""token"": ""pulmonary"", ""start_span"": 163, ""end_span"": 172, ""type"": ""Organ""}, {""token"": ""breast cancer"", ""start_span"": 269, ""end_span"": 282, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 283, ""end_span"": 291, ""type"": ""Organism""}, {""token"": ""lung"", ""start_span"": 302, ""end_span"": 306, ""type"": ""Organ""}]"	test
This compound inhibits cellular ATP production owing to its action on glycolysis and oxidative phosphorylation; however, the specific metabolic steps and mechanisms of 3 - BrPA action in human hepatocellular carcinomas, particularly its effects on mitochondrial energetics, are poorly understood.	cellular,23,31,Cell	ATP,32,35,Chemical	3 - BrPA,168,176,Chemical	human,187,192,Organism	hepatocellular carcinomas,193,218,Cancer	mitochondrial,248,261,Cellular_component	"[{""token"": ""cellular"", ""start_span"": 23, ""end_span"": 31, ""type"": ""Cell""}, {""token"": ""ATP"", ""start_span"": 32, ""end_span"": 35, ""type"": ""Chemical""}, {""token"": ""3 - BrPA"", ""start_span"": 168, ""end_span"": 176, ""type"": ""Chemical""}, {""token"": ""human"", ""start_span"": 187, ""end_span"": 192, ""type"": ""Organism""}, {""token"": ""hepatocellular carcinomas"", ""start_span"": 193, ""end_span"": 218, ""type"": ""Cancer""}, {""token"": ""mitochondrial"", ""start_span"": 248, ""end_span"": 261, ""type"": ""Cellular_component""}]"	test
The activity of mitochondrial hexokinase was not inhibited by 150 microM 3 - BrPA, but this concentration caused more than 70% inhibition of GAPDH ( glyceraldehyde - 3 - phosphate dehydrogenase) and 3 - phosphoglycerate kinase activities.	mitochondrial,16,29,Cellular_component	hexokinase,30,40,Gene_or_gene_product	3 - BrPA,73,81,Chemical	GAPDH,141,146,Gene_or_gene_product	glyceraldehyde - 3 - phosphate dehydrogenase,149,193,Gene_or_gene_product	3 - phosphoglycerate kinase,199,226,Gene_or_gene_product	"[{""token"": ""mitochondrial"", ""start_span"": 16, ""end_span"": 29, ""type"": ""Cellular_component""}, {""token"": ""hexokinase"", ""start_span"": 30, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""3 - BrPA"", ""start_span"": 73, ""end_span"": 81, ""type"": ""Chemical""}, {""token"": ""GAPDH"", ""start_span"": 141, ""end_span"": 146, ""type"": ""Gene_or_gene_product""}, {""token"": ""glyceraldehyde - 3 - phosphate dehydrogenase"", ""start_span"": 149, ""end_span"": 193, ""type"": ""Gene_or_gene_product""}, {""token"": ""3 - phosphoglycerate kinase"", ""start_span"": 199, ""end_span"": 226, ""type"": ""Gene_or_gene_product""}]"	test
In this study, we have investigated gene knockdown analysis of endothelial Robos, in particular roundabout 4 ( robo4), the predominant Robo in endothelial cells using small interfering RNA technology in vitro.	endothelial,63,74,Cell	Robos,75,80,Gene_or_gene_product	roundabout 4,96,108,Gene_or_gene_product	robo4,111,116,Gene_or_gene_product	Robo,135,139,Gene_or_gene_product	endothelial cells,143,160,Cell	"[{""token"": ""endothelial"", ""start_span"": 63, ""end_span"": 74, ""type"": ""Cell""}, {""token"": ""Robos"", ""start_span"": 75, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""roundabout 4"", ""start_span"": 96, ""end_span"": 108, ""type"": ""Gene_or_gene_product""}, {""token"": ""robo4"", ""start_span"": 111, ""end_span"": 116, ""type"": ""Gene_or_gene_product""}, {""token"": ""Robo"", ""start_span"": 135, ""end_span"": 139, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cells"", ""start_span"": 143, ""end_span"": 160, ""type"": ""Cell""}]"	test
Robo1 and Robo4 interact and share molecules such as Slit2, Mena and Vilse, a Cdc42 - GAP.	Robo1,0,5,Gene_or_gene_product	Robo4,10,15,Gene_or_gene_product	Slit2,53,58,Gene_or_gene_product	Mena,60,64,Gene_or_gene_product	Vilse,69,74,Gene_or_gene_product	Cdc42 - GAP,78,89,Gene_or_gene_product	"[{""token"": ""Robo1"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene_or_gene_product""}, {""token"": ""Robo4"", ""start_span"": 10, ""end_span"": 15, ""type"": ""Gene_or_gene_product""}, {""token"": ""Slit2"", ""start_span"": 53, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""Mena"", ""start_span"": 60, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""Vilse"", ""start_span"": 69, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""Cdc42 - GAP"", ""start_span"": 78, ""end_span"": 89, ""type"": ""Gene_or_gene_product""}]"	test
Antioxidant N - acetyl - l - aspartate ( NAC) decreased vessels number in tumors formed by cells with inactivated p53 and inhibited their growth.	N - acetyl - l - aspartate,12,38,Chemical	NAC,41,44,Chemical	vessels,56,63,Multi	tumors,74,80,Cancer	cells,91,96,Cell	p53,114,117,Gene_or_gene_product	"[{""token"": ""N - acetyl - l - aspartate"", ""start_span"": 12, ""end_span"": 38, ""type"": ""Chemical""}, {""token"": ""NAC"", ""start_span"": 41, ""end_span"": 44, ""type"": ""Chemical""}, {""token"": ""vessels"", ""start_span"": 56, ""end_span"": 63, ""type"": ""Multi""}, {""token"": ""tumors"", ""start_span"": 74, ""end_span"": 80, ""type"": ""Cancer""}, {""token"": ""cells"", ""start_span"": 91, ""end_span"": 96, ""type"": ""Cell""}, {""token"": ""p53"", ""start_span"": 114, ""end_span"": 117, ""type"": ""Gene_or_gene_product""}]"	test
An anti - IL - 8 Ab inhibited endothelial cell proliferation induced by cancer cell produced IL - 8 and tumors with low IL - 8 levels exhibited decreased angiogenesis.	anti - IL - 8 Ab,3,19,Chemical	endothelial cell,30,46,Cell	cancer cell,72,83,Cell	IL - 8,93,99,Gene_or_gene_product	tumors,104,110,Cancer	IL - 8,120,126,Gene_or_gene_product	"[{""token"": ""anti - IL - 8 Ab"", ""start_span"": 3, ""end_span"": 19, ""type"": ""Chemical""}, {""token"": ""endothelial cell"", ""start_span"": 30, ""end_span"": 46, ""type"": ""Cell""}, {""token"": ""cancer cell"", ""start_span"": 72, ""end_span"": 83, ""type"": ""Cell""}, {""token"": ""IL - 8"", ""start_span"": 93, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 104, ""end_span"": 110, ""type"": ""Cancer""}, {""token"": ""IL - 8"", ""start_span"": 120, ""end_span"": 126, ""type"": ""Gene_or_gene_product""}]"	test
Our results strongly suggest that estradiol has a critical role in the regulation of IL - 8 in normal human breast tissue and human breast cancer.	estradiol,34,43,Chemical	IL - 8,85,91,Gene_or_gene_product	human,102,107,Organism	breast tissue,108,121,Tissue	human,126,131,Organism	breast cancer,132,145,Cancer	"[{""token"": ""estradiol"", ""start_span"": 34, ""end_span"": 43, ""type"": ""Chemical""}, {""token"": ""IL - 8"", ""start_span"": 85, ""end_span"": 91, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 102, ""end_span"": 107, ""type"": ""Organism""}, {""token"": ""breast tissue"", ""start_span"": 108, ""end_span"": 121, ""type"": ""Tissue""}, {""token"": ""human"", ""start_span"": 126, ""end_span"": 131, ""type"": ""Organism""}, {""token"": ""breast cancer"", ""start_span"": 132, ""end_span"": 145, ""type"": ""Cancer""}]"	test
However, MKN - 28, MKN - 45, MKN - 74, and SNU16 cells did not express membrane CXCR4.	MKN - 28,9,17,Cell	MKN - 45,19,27,Cell	MKN - 74,29,37,Cell	SNU16 cells,43,54,Cell	membrane,71,79,Cellular_component	CXCR4,80,85,Gene_or_gene_product	"[{""token"": ""MKN - 28"", ""start_span"": 9, ""end_span"": 17, ""type"": ""Cell""}, {""token"": ""MKN - 45"", ""start_span"": 19, ""end_span"": 27, ""type"": ""Cell""}, {""token"": ""MKN - 74"", ""start_span"": 29, ""end_span"": 37, ""type"": ""Cell""}, {""token"": ""SNU16 cells"", ""start_span"": 43, ""end_span"": 54, ""type"": ""Cell""}, {""token"": ""membrane"", ""start_span"": 71, ""end_span"": 79, ""type"": ""Cellular_component""}, {""token"": ""CXCR4"", ""start_span"": 80, ""end_span"": 85, ""type"": ""Gene_or_gene_product""}]"	test
Using a murine incisional wound healing model this study was carried out to investigate the roles of estrogen and progesterone on macrophage activation during the wound healing response.	murine,8,14,Organism	wound,26,31,Pathological_formation	estrogen,101,109,Chemical	progesterone,114,126,Chemical	macrophage,130,140,Cell	wound,163,168,Pathological_formation	"[{""token"": ""murine"", ""start_span"": 8, ""end_span"": 14, ""type"": ""Organism""}, {""token"": ""wound"", ""start_span"": 26, ""end_span"": 31, ""type"": ""Pathological_formation""}, {""token"": ""estrogen"", ""start_span"": 101, ""end_span"": 109, ""type"": ""Chemical""}, {""token"": ""progesterone"", ""start_span"": 114, ""end_span"": 126, ""type"": ""Chemical""}, {""token"": ""macrophage"", ""start_span"": 130, ""end_span"": 140, ""type"": ""Cell""}, {""token"": ""wound"", ""start_span"": 163, ""end_span"": 168, ""type"": ""Pathological_formation""}]"	test
The effects on endothelial cells occur in vitro at low drug concentrations, which do not affect microtubule gross morphology, do not cause microtubule bundling or microtubule loss and do not induce cell cycle arrest, apoptosis, or cell death.	endothelial cells,15,32,Cell	microtubule,96,107,Cellular_component	microtubule,139,150,Cellular_component	microtubule,163,174,Cellular_component	cell,198,202,Cell	cell,231,235,Cell	"[{""token"": ""endothelial cells"", ""start_span"": 15, ""end_span"": 32, ""type"": ""Cell""}, {""token"": ""microtubule"", ""start_span"": 96, ""end_span"": 107, ""type"": ""Cellular_component""}, {""token"": ""microtubule"", ""start_span"": 139, ""end_span"": 150, ""type"": ""Cellular_component""}, {""token"": ""microtubule"", ""start_span"": 163, ""end_span"": 174, ""type"": ""Cellular_component""}, {""token"": ""cell"", ""start_span"": 198, ""end_span"": 202, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 231, ""end_span"": 235, ""type"": ""Cell""}]"	test
In addition, cisplatin markedly reduced MMP2 activity in both conditioned media and cell lysates, increased p38 MAPK and JNK phosphorylation, but did not affect ERK phosphorylation.	cisplatin,13,22,Chemical	MMP2,40,44,Gene_or_gene_product	cell lysates,84,96,Organism_substance	p38 MAPK,108,116,Gene_or_gene_product	JNK,121,124,Gene_or_gene_product	ERK,161,164,Gene_or_gene_product	"[{""token"": ""cisplatin"", ""start_span"": 13, ""end_span"": 22, ""type"": ""Chemical""}, {""token"": ""MMP2"", ""start_span"": 40, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell lysates"", ""start_span"": 84, ""end_span"": 96, ""type"": ""Organism_substance""}, {""token"": ""p38 MAPK"", ""start_span"": 108, ""end_span"": 116, ""type"": ""Gene_or_gene_product""}, {""token"": ""JNK"", ""start_span"": 121, ""end_span"": 124, ""type"": ""Gene_or_gene_product""}, {""token"": ""ERK"", ""start_span"": 161, ""end_span"": 164, ""type"": ""Gene_or_gene_product""}]"	test
However, treatment of cells with SB202190 or SP600125, inhibitors of p38 MAPK and JNK respectively, did not affect HUVEC migration.	cells,22,27,Cell	SB202190,33,41,Chemical	SP600125,45,53,Chemical	p38 MAPK,69,77,Gene_or_gene_product	JNK,82,85,Gene_or_gene_product	HUVEC,115,120,Cell	"[{""token"": ""cells"", ""start_span"": 22, ""end_span"": 27, ""type"": ""Cell""}, {""token"": ""SB202190"", ""start_span"": 33, ""end_span"": 41, ""type"": ""Chemical""}, {""token"": ""SP600125"", ""start_span"": 45, ""end_span"": 53, ""type"": ""Chemical""}, {""token"": ""p38 MAPK"", ""start_span"": 69, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}, {""token"": ""JNK"", ""start_span"": 82, ""end_span"": 85, ""type"": ""Gene_or_gene_product""}, {""token"": ""HUVEC"", ""start_span"": 115, ""end_span"": 120, ""type"": ""Cell""}]"	test
Expanded polytetrafluoroethylene ( ePTFE) vascular grafts were coated with perlecan and tested in an ovine carotid interposition model for a period of 6 weeks and assessed using light and scanning microscopy.	polytetrafluoroethylene,9,32,Chemical	ePTFE,35,40,Chemical	vascular grafts,42,57,Multi	perlecan,75,83,Gene_or_gene_product	ovine,101,106,Organism	carotid,107,114,Multi	"[{""token"": ""polytetrafluoroethylene"", ""start_span"": 9, ""end_span"": 32, ""type"": ""Chemical""}, {""token"": ""ePTFE"", ""start_span"": 35, ""end_span"": 40, ""type"": ""Chemical""}, {""token"": ""vascular grafts"", ""start_span"": 42, ""end_span"": 57, ""type"": ""Multi""}, {""token"": ""perlecan"", ""start_span"": 75, ""end_span"": 83, ""type"": ""Gene_or_gene_product""}, {""token"": ""ovine"", ""start_span"": 101, ""end_span"": 106, ""type"": ""Organism""}, {""token"": ""carotid"", ""start_span"": 107, ""end_span"": 114, ""type"": ""Multi""}]"	test
Conditioned medium from progestin - treated breast cancer cells stimulates endothelial cell proliferation in the absence though not in the presence of antibody to TSP - 1, indicating that TSP - 1 secreted by breast cancer cells could be pro - angiogenic.	progestin,24,33,Chemical	breast cancer cells,44,63,Cell	endothelial cell,75,91,Cell	antibody to TSP - 1,151,170,Gene_or_gene_product	TSP - 1,188,195,Gene_or_gene_product	breast cancer cells,208,227,Cell	"[{""token"": ""progestin"", ""start_span"": 24, ""end_span"": 33, ""type"": ""Chemical""}, {""token"": ""breast cancer cells"", ""start_span"": 44, ""end_span"": 63, ""type"": ""Cell""}, {""token"": ""endothelial cell"", ""start_span"": 75, ""end_span"": 91, ""type"": ""Cell""}, {""token"": ""antibody to TSP - 1"", ""start_span"": 151, ""end_span"": 170, ""type"": ""Gene_or_gene_product""}, {""token"": ""TSP - 1"", ""start_span"": 188, ""end_span"": 195, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast cancer cells"", ""start_span"": 208, ""end_span"": 227, ""type"": ""Cell""}]"	test
To understand the molecular mechanisms underlying compound - induced hemangiosarcomas in mice, and therefore, their human relevance, a systems biology approach was undertaken using transcriptomics and Causal Network Modeling from mice treated with 2 - butoxyethanol ( 2 - BE).	hemangiosarcomas,69,85,Cancer	mice,89,93,Organism	human,116,121,Organism	mice,230,234,Organism	2 - butoxyethanol,248,265,Chemical	2 - BE,268,274,Chemical	"[{""token"": ""hemangiosarcomas"", ""start_span"": 69, ""end_span"": 85, ""type"": ""Cancer""}, {""token"": ""mice"", ""start_span"": 89, ""end_span"": 93, ""type"": ""Organism""}, {""token"": ""human"", ""start_span"": 116, ""end_span"": 121, ""type"": ""Organism""}, {""token"": ""mice"", ""start_span"": 230, ""end_span"": 234, ""type"": ""Organism""}, {""token"": ""2 - butoxyethanol"", ""start_span"": 248, ""end_span"": 265, ""type"": ""Chemical""}, {""token"": ""2 - BE"", ""start_span"": 268, ""end_span"": 274, ""type"": ""Chemical""}]"	test
CONCLUSION: Our results strongly support a role for PI3K / Akt / mTOR pathway in PET, which ties in with the fact that mTOR inhibitors have reached phase III trials in neuroendocrine tumors.	PI3K,52,56,Gene_or_gene_product	Akt,59,62,Gene_or_gene_product	mTOR,65,69,Gene_or_gene_product	PET,81,84,Cancer	mTOR,119,123,Gene_or_gene_product	neuroendocrine tumors,168,189,Cancer	"[{""token"": ""PI3K"", ""start_span"": 52, ""end_span"": 56, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 59, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""mTOR"", ""start_span"": 65, ""end_span"": 69, ""type"": ""Gene_or_gene_product""}, {""token"": ""PET"", ""start_span"": 81, ""end_span"": 84, ""type"": ""Cancer""}, {""token"": ""mTOR"", ""start_span"": 119, ""end_span"": 123, ""type"": ""Gene_or_gene_product""}, {""token"": ""neuroendocrine tumors"", ""start_span"": 168, ""end_span"": 189, ""type"": ""Cancer""}]"	test
Several members were detected in insulinoma cell lines and rat islets and expression levels positively correlated with insulin abundance, particularly for p24delta1 and p24beta1.	insulinoma cell lines,33,54,Cell	rat,59,62,Organism	islets,63,69,Multi	insulin,119,126,Gene_or_gene_product	p24delta1,155,164,Gene_or_gene_product	p24beta1,169,177,Gene_or_gene_product	"[{""token"": ""insulinoma cell lines"", ""start_span"": 33, ""end_span"": 54, ""type"": ""Cell""}, {""token"": ""rat"", ""start_span"": 59, ""end_span"": 62, ""type"": ""Organism""}, {""token"": ""islets"", ""start_span"": 63, ""end_span"": 69, ""type"": ""Multi""}, {""token"": ""insulin"", ""start_span"": 119, ""end_span"": 126, ""type"": ""Gene_or_gene_product""}, {""token"": ""p24delta1"", ""start_span"": 155, ""end_span"": 164, ""type"": ""Gene_or_gene_product""}, {""token"": ""p24beta1"", ""start_span"": 169, ""end_span"": 177, ""type"": ""Gene_or_gene_product""}]"	test
RESULTS: SPARC expression was mainly in the stromal cells surrounding the colon cancer, and was significant difference in those tissues with the lymph node metastasis and differentiation degree of tumor.	SPARC,9,14,Gene_or_gene_product	stromal cells,44,57,Cell	colon cancer,74,86,Cancer	tissues,128,135,Tissue	lymph node,145,155,Multi	tumor,197,202,Cancer	"[{""token"": ""SPARC"", ""start_span"": 9, ""end_span"": 14, ""type"": ""Gene_or_gene_product""}, {""token"": ""stromal cells"", ""start_span"": 44, ""end_span"": 57, ""type"": ""Cell""}, {""token"": ""colon cancer"", ""start_span"": 74, ""end_span"": 86, ""type"": ""Cancer""}, {""token"": ""tissues"", ""start_span"": 128, ""end_span"": 135, ""type"": ""Tissue""}, {""token"": ""lymph node"", ""start_span"": 145, ""end_span"": 155, ""type"": ""Multi""}, {""token"": ""tumor"", ""start_span"": 197, ""end_span"": 202, ""type"": ""Cancer""}]"	test
We show here that constitutively active STAT3 acts as a master regulator of cell metabolism, inducing aerobic glycolysis and down - regulating mitochondrial activity both in primary fibroblasts and in STAT3 - dependent tumour cell lines.	STAT3,40,45,Gene_or_gene_product	cell,76,80,Cell	mitochondrial,143,156,Cellular_component	fibroblasts,182,193,Cell	STAT3,201,206,Gene_or_gene_product	tumour cell lines,219,236,Cell	"[{""token"": ""STAT3"", ""start_span"": 40, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Cell""}, {""token"": ""mitochondrial"", ""start_span"": 143, ""end_span"": 156, ""type"": ""Cellular_component""}, {""token"": ""fibroblasts"", ""start_span"": 182, ""end_span"": 193, ""type"": ""Cell""}, {""token"": ""STAT3"", ""start_span"": 201, ""end_span"": 206, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumour cell lines"", ""start_span"": 219, ""end_span"": 236, ""type"": ""Cell""}]"	test
Mild mutations in BRCA2 ( FANCD1) cause Fanconi anemia ( FA) when homozygous, while severe mutations cause common cancers including breast, ovarian, and prostate cancers when heterozygous.	BRCA2,18,23,Gene_or_gene_product	FANCD1,26,32,Gene_or_gene_product	cancers,114,121,Cancer	breast,132,138,Cancer	ovarian,140,147,Cancer	prostate cancers,153,169,Cancer	"[{""token"": ""BRCA2"", ""start_span"": 18, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""FANCD1"", ""start_span"": 26, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancers"", ""start_span"": 114, ""end_span"": 121, ""type"": ""Cancer""}, {""token"": ""breast"", ""start_span"": 132, ""end_span"": 138, ""type"": ""Cancer""}, {""token"": ""ovarian"", ""start_span"": 140, ""end_span"": 147, ""type"": ""Cancer""}, {""token"": ""prostate cancers"", ""start_span"": 153, ""end_span"": 169, ""type"": ""Cancer""}]"	test
Associations of KISS1 methylation and its expression with histopathological variables and poor survival suggest the utility of incorporating KISS1 measurement using paraffin - embedded material for tumor stratification and clinical outcome prognosis of patients with uroepithelial neoplasias.	KISS1,16,21,Gene_or_gene_product	KISS1,141,146,Gene_or_gene_product	paraffin,165,173,Chemical	tumor,198,203,Cancer	patients,253,261,Organism	uroepithelial neoplasias,267,291,Cancer	"[{""token"": ""KISS1"", ""start_span"": 16, ""end_span"": 21, ""type"": ""Gene_or_gene_product""}, {""token"": ""KISS1"", ""start_span"": 141, ""end_span"": 146, ""type"": ""Gene_or_gene_product""}, {""token"": ""paraffin"", ""start_span"": 165, ""end_span"": 173, ""type"": ""Chemical""}, {""token"": ""tumor"", ""start_span"": 198, ""end_span"": 203, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 253, ""end_span"": 261, ""type"": ""Organism""}, {""token"": ""uroepithelial neoplasias"", ""start_span"": 267, ""end_span"": 291, ""type"": ""Cancer""}]"	test
Finally, sorafenib induced autophagy in Huh7 xenograft tumors in nude mice and coadministration with chloroquine significantly suppressed tumor growth compared with sorafenib alone.	sorafenib,9,18,Chemical	Huh7 xenograft tumors,40,61,Cancer	nude mice,65,74,Organism	chloroquine,101,112,Chemical	tumor,138,143,Cancer	sorafenib,165,174,Chemical	"[{""token"": ""sorafenib"", ""start_span"": 9, ""end_span"": 18, ""type"": ""Chemical""}, {""token"": ""Huh7 xenograft tumors"", ""start_span"": 40, ""end_span"": 61, ""type"": ""Cancer""}, {""token"": ""nude mice"", ""start_span"": 65, ""end_span"": 74, ""type"": ""Organism""}, {""token"": ""chloroquine"", ""start_span"": 101, ""end_span"": 112, ""type"": ""Chemical""}, {""token"": ""tumor"", ""start_span"": 138, ""end_span"": 143, ""type"": ""Cancer""}, {""token"": ""sorafenib"", ""start_span"": 165, ""end_span"": 174, ""type"": ""Chemical""}]"	test
Desensitization of prostaglandin F2 alpha - stimulated inositol phosphate generation in NIH - 3T3 fibroblasts transformed by overexpression of normal c - Ha - ras - 1, c - Ki - ras - 2 and c - N - ras genes.	prostaglandin F2 alpha,19,41,Chemical	inositol phosphate,55,73,Chemical	NIH - 3T3 fibroblasts,88,109,Cell	c - Ha - ras - 1,150,166,Gene_or_gene_product	c - Ki - ras - 2,168,184,Gene_or_gene_product	c - N - ras,189,200,Gene_or_gene_product	"[{""token"": ""prostaglandin F2 alpha"", ""start_span"": 19, ""end_span"": 41, ""type"": ""Chemical""}, {""token"": ""inositol phosphate"", ""start_span"": 55, ""end_span"": 73, ""type"": ""Chemical""}, {""token"": ""NIH - 3T3 fibroblasts"", ""start_span"": 88, ""end_span"": 109, ""type"": ""Cell""}, {""token"": ""c - Ha - ras - 1"", ""start_span"": 150, ""end_span"": 166, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - Ki - ras - 2"", ""start_span"": 168, ""end_span"": 184, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - N - ras"", ""start_span"": 189, ""end_span"": 200, ""type"": ""Gene_or_gene_product""}]"	test
The stimulation of inositol phosphate generation in control and ras - gene - transformed NIH - 3T3 cells by prostaglandin F2 alpha ( PGF2 alpha) was investigated.	inositol phosphate,19,37,Chemical	control,52,59,Cell	ras,64,67,Gene_or_gene_product	NIH - 3T3 cells,89,104,Cell	prostaglandin F2 alpha,108,130,Chemical	PGF2 alpha,133,143,Chemical	"[{""token"": ""inositol phosphate"", ""start_span"": 19, ""end_span"": 37, ""type"": ""Chemical""}, {""token"": ""control"", ""start_span"": 52, ""end_span"": 59, ""type"": ""Cell""}, {""token"": ""ras"", ""start_span"": 64, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""NIH - 3T3 cells"", ""start_span"": 89, ""end_span"": 104, ""type"": ""Cell""}, {""token"": ""prostaglandin F2 alpha"", ""start_span"": 108, ""end_span"": 130, ""type"": ""Chemical""}, {""token"": ""PGF2 alpha"", ""start_span"": 133, ""end_span"": 143, ""type"": ""Chemical""}]"	test
These results suggest that desensitization of certain agonist - induced inositol phospholipid responses in ras - transformed cells is a consequence of increased cell proliferation and associated amplification in C - kinase activity and is an indirect consequence of transformation by ras.	inositol phospholipid,72,93,Chemical	ras,107,110,Gene_or_gene_product	cells,125,130,Cell	cell,161,165,Cell	C - kinase,212,222,Gene_or_gene_product	ras,284,287,Gene_or_gene_product	"[{""token"": ""inositol phospholipid"", ""start_span"": 72, ""end_span"": 93, ""type"": ""Chemical""}, {""token"": ""ras"", ""start_span"": 107, ""end_span"": 110, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 125, ""end_span"": 130, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 161, ""end_span"": 165, ""type"": ""Cell""}, {""token"": ""C - kinase"", ""start_span"": 212, ""end_span"": 222, ""type"": ""Gene_or_gene_product""}, {""token"": ""ras"", ""start_span"": 284, ""end_span"": 287, ""type"": ""Gene_or_gene_product""}]"	test
Our results suggest that blood flow limits glucose supply to tumor tissue at much higher flow rates than in normal brain which, in turn, is associated with a decrease in tumor glucose utilization.	blood,25,30,Organism_substance	glucose,43,50,Chemical	tumor tissue,61,73,Tissue	brain,115,120,Organ	tumor,170,175,Cancer	glucose,176,183,Chemical	"[{""token"": ""blood"", ""start_span"": 25, ""end_span"": 30, ""type"": ""Organism_substance""}, {""token"": ""glucose"", ""start_span"": 43, ""end_span"": 50, ""type"": ""Chemical""}, {""token"": ""tumor tissue"", ""start_span"": 61, ""end_span"": 73, ""type"": ""Tissue""}, {""token"": ""brain"", ""start_span"": 115, ""end_span"": 120, ""type"": ""Organ""}, {""token"": ""tumor"", ""start_span"": 170, ""end_span"": 175, ""type"": ""Cancer""}, {""token"": ""glucose"", ""start_span"": 176, ""end_span"": 183, ""type"": ""Chemical""}]"	test
Depletion of ARD1 by shRNA suppressed PCa cell proliferation, anchorage - independent growth, and xenograft tumor formation in SCID mice, suggesting that AR - dependent ARD1 expression is biologically germane.	ARD1,13,17,Gene_or_gene_product	PCa cell,38,46,Cell	xenograft tumor,98,113,Cancer	SCID mice,127,136,Organism	AR,154,156,Gene_or_gene_product	ARD1,169,173,Gene_or_gene_product	"[{""token"": ""ARD1"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Gene_or_gene_product""}, {""token"": ""PCa cell"", ""start_span"": 38, ""end_span"": 46, ""type"": ""Cell""}, {""token"": ""xenograft tumor"", ""start_span"": 98, ""end_span"": 113, ""type"": ""Cancer""}, {""token"": ""SCID mice"", ""start_span"": 127, ""end_span"": 136, ""type"": ""Organism""}, {""token"": ""AR"", ""start_span"": 154, ""end_span"": 156, ""type"": ""Gene_or_gene_product""}, {""token"": ""ARD1"", ""start_span"": 169, ""end_span"": 173, ""type"": ""Gene_or_gene_product""}]"	test
Samples were assayed for glucose, lactate, and insulin concentrations and compared statistically with ten control dogs of similar weight and age undergoing an identical dextrose challenge.	Samples,0,7,Organism_substance	glucose,25,32,Chemical	lactate,34,41,Chemical	insulin,47,54,Gene_or_gene_product	dogs,114,118,Organism	dextrose,169,177,Chemical	"[{""token"": ""Samples"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Organism_substance""}, {""token"": ""glucose"", ""start_span"": 25, ""end_span"": 32, ""type"": ""Chemical""}, {""token"": ""lactate"", ""start_span"": 34, ""end_span"": 41, ""type"": ""Chemical""}, {""token"": ""insulin"", ""start_span"": 47, ""end_span"": 54, ""type"": ""Gene_or_gene_product""}, {""token"": ""dogs"", ""start_span"": 114, ""end_span"": 118, ""type"": ""Organism""}, {""token"": ""dextrose"", ""start_span"": 169, ""end_span"": 177, ""type"": ""Chemical""}]"	test
We assessed the effects of these mutations on the ability of the v - fos protein to transform chicken embryo fibroblasts and to stimulate cellular proliferation of chicken neuroretinal cells.	v - fos,65,72,Gene_or_gene_product	chicken,94,101,Organism	embryo fibroblasts,102,120,Cell	cellular,138,146,Cell	chicken,164,171,Organism	neuroretinal cells,172,190,Cell	"[{""token"": ""v - fos"", ""start_span"": 65, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""chicken"", ""start_span"": 94, ""end_span"": 101, ""type"": ""Organism""}, {""token"": ""embryo fibroblasts"", ""start_span"": 102, ""end_span"": 120, ""type"": ""Cell""}, {""token"": ""cellular"", ""start_span"": 138, ""end_span"": 146, ""type"": ""Cell""}, {""token"": ""chicken"", ""start_span"": 164, ""end_span"": 171, ""type"": ""Organism""}, {""token"": ""neuroretinal cells"", ""start_span"": 172, ""end_span"": 190, ""type"": ""Cell""}]"	test
This effect was observed whether the cells had been treated with all - trans - RA in serum - free medium or in medium supplemented with heat - inactivated or acid - treated fetal bovine serum.	cells,37,42,Cell	all - trans - RA,65,81,Chemical	serum,85,90,Organism_substance	fetal,173,178,Developing_anatomical_structure	bovine,179,185,Organism	serum,186,191,Organism_substance	"[{""token"": ""cells"", ""start_span"": 37, ""end_span"": 42, ""type"": ""Cell""}, {""token"": ""all - trans - RA"", ""start_span"": 65, ""end_span"": 81, ""type"": ""Chemical""}, {""token"": ""serum"", ""start_span"": 85, ""end_span"": 90, ""type"": ""Organism_substance""}, {""token"": ""fetal"", ""start_span"": 173, ""end_span"": 178, ""type"": ""Developing_anatomical_structure""}, {""token"": ""bovine"", ""start_span"": 179, ""end_span"": 185, ""type"": ""Organism""}, {""token"": ""serum"", ""start_span"": 186, ""end_span"": 191, ""type"": ""Organism_substance""}]"	test
Adult rat urothelial cells were transformed in vitro following treatment with a single dose of N - methyl - N - nitrosourea ( MNU) or MNU treatment followed by promotion with sodium saccharin.	rat,6,9,Organism	urothelial cells,10,26,Cell	N - methyl - N - nitrosourea,95,123,Chemical	MNU,126,129,Chemical	MNU,134,137,Chemical	sodium saccharin,175,191,Chemical	"[{""token"": ""rat"", ""start_span"": 6, ""end_span"": 9, ""type"": ""Organism""}, {""token"": ""urothelial cells"", ""start_span"": 10, ""end_span"": 26, ""type"": ""Cell""}, {""token"": ""N - methyl - N - nitrosourea"", ""start_span"": 95, ""end_span"": 123, ""type"": ""Chemical""}, {""token"": ""MNU"", ""start_span"": 126, ""end_span"": 129, ""type"": ""Chemical""}, {""token"": ""MNU"", ""start_span"": 134, ""end_span"": 137, ""type"": ""Chemical""}, {""token"": ""sodium saccharin"", ""start_span"": 175, ""end_span"": 191, ""type"": ""Chemical""}]"	test
They defined also the predominant origin of new vessels from venules and capillaries, and enabled the evolution of proliferating vessels into arterioles and venules to be documented.	vessels,48,55,Multi	venules,61,68,Multi	capillaries,73,84,Tissue	vessels,129,136,Multi	arterioles,142,152,Multi	venules,157,164,Multi	"[{""token"": ""vessels"", ""start_span"": 48, ""end_span"": 55, ""type"": ""Multi""}, {""token"": ""venules"", ""start_span"": 61, ""end_span"": 68, ""type"": ""Multi""}, {""token"": ""capillaries"", ""start_span"": 73, ""end_span"": 84, ""type"": ""Tissue""}, {""token"": ""vessels"", ""start_span"": 129, ""end_span"": 136, ""type"": ""Multi""}, {""token"": ""arterioles"", ""start_span"": 142, ""end_span"": 152, ""type"": ""Multi""}, {""token"": ""venules"", ""start_span"": 157, ""end_span"": 164, ""type"": ""Multi""}]"	test
Previous work has shown that a rabbit anti - VCSA serum lyses specifically, in the presence of complement, 51Cr - labelled RSV - transformed cells from different animal species.	rabbit,31,37,Organism	VCSA,45,49,Gene_or_gene_product	serum lyses,50,61,Organism_substance	51Cr,107,111,Chemical	RSV,123,126,Organism	cells,141,146,Cell	"[{""token"": ""rabbit"", ""start_span"": 31, ""end_span"": 37, ""type"": ""Organism""}, {""token"": ""VCSA"", ""start_span"": 45, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""serum lyses"", ""start_span"": 50, ""end_span"": 61, ""type"": ""Organism_substance""}, {""token"": ""51Cr"", ""start_span"": 107, ""end_span"": 111, ""type"": ""Chemical""}, {""token"": ""RSV"", ""start_span"": 123, ""end_span"": 126, ""type"": ""Organism""}, {""token"": ""cells"", ""start_span"": 141, ""end_span"": 146, ""type"": ""Cell""}]"	test
The migration activity of heparin and mast cell conditioned medium was blocked by specific antagonists of heparin ( protamine and heparinase), but not by chondroitinase ABC.	heparin,26,33,Chemical	mast cell,38,47,Cell	heparin,106,113,Chemical	protamine,116,125,Gene_or_gene_product	heparinase,130,140,Gene_or_gene_product	chondroitinase ABC,154,172,Gene_or_gene_product	"[{""token"": ""heparin"", ""start_span"": 26, ""end_span"": 33, ""type"": ""Chemical""}, {""token"": ""mast cell"", ""start_span"": 38, ""end_span"": 47, ""type"": ""Cell""}, {""token"": ""heparin"", ""start_span"": 106, ""end_span"": 113, ""type"": ""Chemical""}, {""token"": ""protamine"", ""start_span"": 116, ""end_span"": 125, ""type"": ""Gene_or_gene_product""}, {""token"": ""heparinase"", ""start_span"": 130, ""end_span"": 140, ""type"": ""Gene_or_gene_product""}, {""token"": ""chondroitinase ABC"", ""start_span"": 154, ""end_span"": 172, ""type"": ""Gene_or_gene_product""}]"	test
Monitoring peroxide - induced changes in GSH and GSSG gave consistent results; e. g., glucose - depleted L. Se ( +) cells exhibited a first order loss of GSH that was substantially faster than that of glucose - depleted L. Se ( -) cells.	peroxide,11,19,Chemical	GSH,41,44,Chemical	GSSG,49,53,Chemical	glucose,86,93,Chemical	GSH,154,157,Chemical	glucose,201,208,Chemical	"[{""token"": ""peroxide"", ""start_span"": 11, ""end_span"": 19, ""type"": ""Chemical""}, {""token"": ""GSH"", ""start_span"": 41, ""end_span"": 44, ""type"": ""Chemical""}, {""token"": ""GSSG"", ""start_span"": 49, ""end_span"": 53, ""type"": ""Chemical""}, {""token"": ""glucose"", ""start_span"": 86, ""end_span"": 93, ""type"": ""Chemical""}, {""token"": ""GSH"", ""start_span"": 154, ""end_span"": 157, ""type"": ""Chemical""}, {""token"": ""glucose"", ""start_span"": 201, ""end_span"": 208, ""type"": ""Chemical""}]"	test
The putative metastasis suppressor genes, NME1 ( nm23 - 1) and NME2 ( nm23 - 2), were examined in a model system we developed to approximate the dissemination of melanoma from a primary skin tumor.	NME1,42,46,Gene_or_gene_product	nm23 - 1,49,57,Gene_or_gene_product	NME2,63,67,Gene_or_gene_product	nm23 - 2,70,78,Gene_or_gene_product	melanoma,162,170,Cancer	skin tumor,186,196,Cancer	"[{""token"": ""NME1"", ""start_span"": 42, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""nm23 - 1"", ""start_span"": 49, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""NME2"", ""start_span"": 63, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""nm23 - 2"", ""start_span"": 70, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""melanoma"", ""start_span"": 162, ""end_span"": 170, ""type"": ""Cancer""}, {""token"": ""skin tumor"", ""start_span"": 186, ""end_span"": 196, ""type"": ""Cancer""}]"	test
We utilized two autologous human melanoma cell lines, IV Cl 1 and IV Cl 3, which displayed qualitatively different metastatic phenotypes following subdermal inoculation into nude mice.	human,27,32,Organism	melanoma cell lines,33,52,Cell	IV Cl 1,54,61,Cell	IV Cl 3,66,73,Cell	subdermal,147,156,Organism_subdivision	nude mice,174,183,Organism	"[{""token"": ""human"", ""start_span"": 27, ""end_span"": 32, ""type"": ""Organism""}, {""token"": ""melanoma cell lines"", ""start_span"": 33, ""end_span"": 52, ""type"": ""Cell""}, {""token"": ""IV Cl 1"", ""start_span"": 54, ""end_span"": 61, ""type"": ""Cell""}, {""token"": ""IV Cl 3"", ""start_span"": 66, ""end_span"": 73, ""type"": ""Cell""}, {""token"": ""subdermal"", ""start_span"": 147, ""end_span"": 156, ""type"": ""Organism_subdivision""}, {""token"": ""nude mice"", ""start_span"": 174, ""end_span"": 183, ""type"": ""Organism""}]"	test
A similar ser120 - gly mutation in NME1 has been found in human neuroblastoma, suggesting that mutation in this region may be a general phenomenon related to tumor progression.	ser120,10,16,Amino_acid	gly,19,22,Amino_acid	NME1,35,39,Gene_or_gene_product	human,58,63,Organism	neuroblastoma,64,77,Cancer	tumor,158,163,Cancer	"[{""token"": ""ser120"", ""start_span"": 10, ""end_span"": 16, ""type"": ""Amino_acid""}, {""token"": ""gly"", ""start_span"": 19, ""end_span"": 22, ""type"": ""Amino_acid""}, {""token"": ""NME1"", ""start_span"": 35, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 58, ""end_span"": 63, ""type"": ""Organism""}, {""token"": ""neuroblastoma"", ""start_span"": 64, ""end_span"": 77, ""type"": ""Cancer""}, {""token"": ""tumor"", ""start_span"": 158, ""end_span"": 163, ""type"": ""Cancer""}]"	test
E mu cyclin D1 transgenic mice show only very subtle alterations in the cycling behaviour of B - cell populations in the bone marrow compared with normal mice and do not develop lymphoid tumours.	E mu,0,4,Gene_or_gene_product	cyclin D1,5,14,Gene_or_gene_product	B - cell populations,93,113,Cell	bone marrow,121,132,Multi	mice,154,158,Organism	lymphoid tumours,178,194,Cancer	"[{""token"": ""E mu"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""cyclin D1"", ""start_span"": 5, ""end_span"": 14, ""type"": ""Gene_or_gene_product""}, {""token"": ""B - cell populations"", ""start_span"": 93, ""end_span"": 113, ""type"": ""Cell""}, {""token"": ""bone marrow"", ""start_span"": 121, ""end_span"": 132, ""type"": ""Multi""}, {""token"": ""mice"", ""start_span"": 154, ""end_span"": 158, ""type"": ""Organism""}, {""token"": ""lymphoid tumours"", ""start_span"": 178, ""end_span"": 194, ""type"": ""Cancer""}]"	test
None of the transformants differentiated into melanophores or iridophores or other neural crest derivatives as seen in goldfish erythrophoroma cells.	transformants,12,25,Cell	melanophores,46,58,Cell	iridophores,62,73,Cell	neural crest,83,95,Tissue	goldfish,119,127,Organism	erythrophoroma cells,128,148,Cell	"[{""token"": ""transformants"", ""start_span"": 12, ""end_span"": 25, ""type"": ""Cell""}, {""token"": ""melanophores"", ""start_span"": 46, ""end_span"": 58, ""type"": ""Cell""}, {""token"": ""iridophores"", ""start_span"": 62, ""end_span"": 73, ""type"": ""Cell""}, {""token"": ""neural crest"", ""start_span"": 83, ""end_span"": 95, ""type"": ""Tissue""}, {""token"": ""goldfish"", ""start_span"": 119, ""end_span"": 127, ""type"": ""Organism""}, {""token"": ""erythrophoroma cells"", ""start_span"": 128, ""end_span"": 148, ""type"": ""Cell""}]"	test
Rats were immunized with irradiated hepatoma cells transduced by herpes viral amplicon vectors containing the genes for GM - CSF, IL - 2 or LacZ.	Rats,0,4,Organism	hepatoma cells,36,50,Cell	herpes viral,65,77,Organism	GM - CSF,120,128,Gene_or_gene_product	IL - 2,130,136,Gene_or_gene_product	LacZ,140,144,Gene_or_gene_product	"[{""token"": ""Rats"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Organism""}, {""token"": ""hepatoma cells"", ""start_span"": 36, ""end_span"": 50, ""type"": ""Cell""}, {""token"": ""herpes viral"", ""start_span"": 65, ""end_span"": 77, ""type"": ""Organism""}, {""token"": ""GM - CSF"", ""start_span"": 120, ""end_span"": 128, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 2"", ""start_span"": 130, ""end_span"": 136, ""type"": ""Gene_or_gene_product""}, {""token"": ""LacZ"", ""start_span"": 140, ""end_span"": 144, ""type"": ""Gene_or_gene_product""}]"	test
Separate rats underwent splenocyte and KC harvest for assessment of lymphocyte - and macrophage - mediated tumor cell kill in vitro.	rats,9,13,Organism	splenocyte,24,34,Cell	KC,39,41,Cell	lymphocyte,68,78,Cell	macrophage,85,95,Cell	tumor cell,107,117,Cell	"[{""token"": ""rats"", ""start_span"": 9, ""end_span"": 13, ""type"": ""Organism""}, {""token"": ""splenocyte"", ""start_span"": 24, ""end_span"": 34, ""type"": ""Cell""}, {""token"": ""KC"", ""start_span"": 39, ""end_span"": 41, ""type"": ""Cell""}, {""token"": ""lymphocyte"", ""start_span"": 68, ""end_span"": 78, ""type"": ""Cell""}, {""token"": ""macrophage"", ""start_span"": 85, ""end_span"": 95, ""type"": ""Cell""}, {""token"": ""tumor cell"", ""start_span"": 107, ""end_span"": 117, ""type"": ""Cell""}]"	test
GM - CSF or IL - 2 vaccines or gammaIFN decreased tumor nodules significantly ( GM - CSF 13 + / - 4, IL - 2 14 + / - 6 vs. control 75 + / - 24, P < 0. 001).	GM - CSF,0,8,Gene_or_gene_product	IL - 2,12,18,Gene_or_gene_product	gammaIFN,31,39,Gene_or_gene_product	tumor nodules,50,63,Cancer	GM - CSF,80,88,Gene_or_gene_product	IL - 2,101,107,Gene_or_gene_product	"[{""token"": ""GM - CSF"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 2"", ""start_span"": 12, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""gammaIFN"", ""start_span"": 31, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor nodules"", ""start_span"": 50, ""end_span"": 63, ""type"": ""Cancer""}, {""token"": ""GM - CSF"", ""start_span"": 80, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 2"", ""start_span"": 101, ""end_span"": 107, ""type"": ""Gene_or_gene_product""}]"	test
Suppression of tumor growth by the 3 ' untranslated region of mel - 18 in 3Y1 cells transformed by the E6 and E7 genes of human papillomavirus type 18.	tumor,15,20,Cancer	mel - 18,62,70,Gene_or_gene_product	3Y1 cells,74,83,Cell	E6,103,105,Gene_or_gene_product	E7,110,112,Gene_or_gene_product	human papillomavirus type 18,122,150,Organism	"[{""token"": ""tumor"", ""start_span"": 15, ""end_span"": 20, ""type"": ""Cancer""}, {""token"": ""mel - 18"", ""start_span"": 62, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""3Y1 cells"", ""start_span"": 74, ""end_span"": 83, ""type"": ""Cell""}, {""token"": ""E6"", ""start_span"": 103, ""end_span"": 105, ""type"": ""Gene_or_gene_product""}, {""token"": ""E7"", ""start_span"": 110, ""end_span"": 112, ""type"": ""Gene_or_gene_product""}, {""token"": ""human papillomavirus type 18"", ""start_span"": 122, ""end_span"": 150, ""type"": ""Organism""}]"	test
STUDY DESIGN: Thirty - three archival cytologic specimens from eight patients with histologically confirmed malignant mesothelioma and 13 from patients with metastatic serous effusions were destained and then immunostained with anticalretinin antiserum.	cytologic specimens,38,57,Tissue	patients,69,77,Organism	malignant mesothelioma,108,130,Cancer	patients,143,151,Organism	serous effusions,168,184,Organism_substance	antiserum,243,252,Organism_substance	"[{""token"": ""cytologic specimens"", ""start_span"": 38, ""end_span"": 57, ""type"": ""Tissue""}, {""token"": ""patients"", ""start_span"": 69, ""end_span"": 77, ""type"": ""Organism""}, {""token"": ""malignant mesothelioma"", ""start_span"": 108, ""end_span"": 130, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 143, ""end_span"": 151, ""type"": ""Organism""}, {""token"": ""serous effusions"", ""start_span"": 168, ""end_span"": 184, ""type"": ""Organism_substance""}, {""token"": ""antiserum"", ""start_span"": 243, ""end_span"": 252, ""type"": ""Organism_substance""}]"	test
We attempted to correlate the expression of human leukocyte antigen DR ( HLA - DR) and tumor infiltration by S - 100 - protein - positive dendritic cells with clinicopathologic features in 165 patients with gastric cancer.	human leukocyte antigen DR,44,70,Gene_or_gene_product	HLA - DR,73,81,Gene_or_gene_product	tumor,87,92,Cancer	S - 100,109,116,Gene_or_gene_product	patients,193,201,Organism	gastric cancer,207,221,Cancer	"[{""token"": ""human leukocyte antigen DR"", ""start_span"": 44, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""HLA - DR"", ""start_span"": 73, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 87, ""end_span"": 92, ""type"": ""Cancer""}, {""token"": ""S - 100"", ""start_span"": 109, ""end_span"": 116, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 193, ""end_span"": 201, ""type"": ""Organism""}, {""token"": ""gastric cancer"", ""start_span"": 207, ""end_span"": 221, ""type"": ""Cancer""}]"	test
The absence of functional von Hippel - Lindau ( VHL) tumor suppressor gene leads to the development of neoplasias characteristic of VHL disease, including renal cell carcinoma ( RCC).	von Hippel - Lindau,26,45,Gene_or_gene_product	VHL,48,51,Gene_or_gene_product	tumor,53,58,Cancer	VHL,132,135,Gene_or_gene_product	renal cell carcinoma,155,175,Cancer	RCC,178,181,Cancer	"[{""token"": ""von Hippel - Lindau"", ""start_span"": 26, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""VHL"", ""start_span"": 48, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 53, ""end_span"": 58, ""type"": ""Cancer""}, {""token"": ""VHL"", ""start_span"": 132, ""end_span"": 135, ""type"": ""Gene_or_gene_product""}, {""token"": ""renal cell carcinoma"", ""start_span"": 155, ""end_span"": 175, ""type"": ""Cancer""}, {""token"": ""RCC"", ""start_span"": 178, ""end_span"": 181, ""type"": ""Cancer""}]"	test
While the response to most treatments was not affected by the VHL gene status, glucose deprivation was found to be much more cytotoxic for RCC cells lacking VHL gene function than for wtVHL - expressing cells.	VHL,62,65,Gene_or_gene_product	glucose,79,86,Chemical	RCC cells,139,148,Cell	VHL,157,160,Gene_or_gene_product	wtVHL,184,189,Gene_or_gene_product	cells,203,208,Cell	"[{""token"": ""VHL"", ""start_span"": 62, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""glucose"", ""start_span"": 79, ""end_span"": 86, ""type"": ""Chemical""}, {""token"": ""RCC cells"", ""start_span"": 139, ""end_span"": 148, ""type"": ""Cell""}, {""token"": ""VHL"", ""start_span"": 157, ""end_span"": 160, ""type"": ""Gene_or_gene_product""}, {""token"": ""wtVHL"", ""start_span"": 184, ""end_span"": 189, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 203, ""end_span"": 208, ""type"": ""Cell""}]"	test
Furthermore, ubiquitination of cellular proteins was elevated in VHL - deficient cells, particularly after glucose deprivation, supporting a role for the VHL gene in ubiquitin - mediated proteolysis.	cellular,31,39,Cell	VHL,65,68,Gene_or_gene_product	cells,81,86,Cell	glucose,107,114,Chemical	VHL,154,157,Gene_or_gene_product	ubiquitin,166,175,Gene_or_gene_product	"[{""token"": ""cellular"", ""start_span"": 31, ""end_span"": 39, ""type"": ""Cell""}, {""token"": ""VHL"", ""start_span"": 65, ""end_span"": 68, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 81, ""end_span"": 86, ""type"": ""Cell""}, {""token"": ""glucose"", ""start_span"": 107, ""end_span"": 114, ""type"": ""Chemical""}, {""token"": ""VHL"", ""start_span"": 154, ""end_span"": 157, ""type"": ""Gene_or_gene_product""}, {""token"": ""ubiquitin"", ""start_span"": 166, ""end_span"": 175, ""type"": ""Gene_or_gene_product""}]"	test
